rfhg_97072.1

Basic information about the TSS

---

TSS ID: rfhg_97072.1 TSS ID(Version3): hg_79825.1 hg_79824.1 hg_79826.1 hg_79822.1 hg_79823.1 Species: human Chr: chr7		Start: 98281611 End: 98281747 Strand: +
Source datasets
Protocol
TSS cluster detected*

  * The number of TSS cluster called data-sets (maximum 17)

cCREs annotation

---

Description:	PLS,CTCF-bound (EH38D4006308,EH38E2574186)
Category:	PLS

  * cCREs are candidates for cis regulatory elements generated from the subset of representative DNase hypersensitivity sites supported by either histone modifications or CTCF-binding data. Find more details here.

Gene and protein annotation

---

Nearest transcript id and distance: ENST00000539286.5:0 ENST00000297290.4:0 AB055977:0 BC018737:0 AF041430:0 BC062370:0 AF106966:0 GeneID: 25798 HGNC/MGI_ID: HGNC:1109 UniProt_ID: O95415 Nearer transcript ids and distances:

Gene_name: BRI3 Gene_symbol: BRI3 Gene_synonyms: Gene_source: HGNC:1109

TATA-Box annotation

---

Distance to TSS:	-7
Nearest PromoterID:	NM_015379
Entrez ID:	25798
Nearest Unigene:	Hs.567438
Nearest Refseq:	NM_015379
Nearest Ensembl:	ENSG00000164713
Gene Name:	BRI3
Gene Alias:	I3
Gene Type:	protein-coding
CpG%:	0.176471
GC%:	0.854015
TATA-Box(TBP)/Promoter/Homer Distance From Peak(sequence,strand,conservation):

TSS expression

Sample Category  All in vivo cell sample cell line sample tissue sample human bronchial epithelial cell sample CD19-positive B cell sample CD8-positive T cell sample CD4-positive T cell sample common myeloid progenitor sample human monocyte immature derived dendritic cell sample human endothelial cell of the aorta sample human cardiac fibroblast sample human dermal fibroblast sample human fibroblast of gingiva sample human fibroblast of periodontium sample granulocyte macrophage progenitor cell sample human hepatocyte sample human mesenchymal stem cell of umbilical cord-Sciencell sample human mesenchymal stem cell of adipose sample human mesenchymal stem cell of bone marrow sample mouse sample mouse granule cell sample mouse hepatocyte sample human neutrophil sample human osteoblast-Sciencell sample human osteoblast-Cell applications sample human renal glomerular endothelial cell sample human retinal pigment epithelial cell sample human skeletal muscle cell sample human aortic smooth muscle cell sample human smooth muscle cell of umbilical artery sample human urothelial cell sample cerebellar granule cell sample human sample mast cell- heparinase treated sample human mature adipocyte sample human cardiac mesenchymal precursor cell sample human mesenchymal precursor cell- ovarian cancer-left ovary sample human mesenchymal precursor cell- ovarian cancer-metastasis sample human mesenchymal precursor cell- ovarian cancer-right ovary sample human whole blood sample control treatment sample human adipose tissue - adult sample human brain - adult sample human parietal lobe - adult sample hippocampus - adult sample human CD14-CD16-positive Monocytes sample mouse cerebellum- embryo E13 sample mouse cerebellum- embryo E15 sample mouse cerebellum- embryo E18 sample human Monocyte-derived macrophages 0h after mock infection sample human Monocyte-derived macrophages 0h after udorn influenza infection sample human Monocyte-derived macrophages 2h after udorn influenza infection sample human Monocyte-derived macrophages 7h after udorn influenza infection sample human Monocyte-derived macrophages 24h after udorn influenza infection sample human Monocyte-derived macrophages 24h after mock infection sample mouse whole body- embryo E17.5 sample adenocarcinoma cell line sample small cell lung cancer cell sample carcinoma cell line sample teratocarcinoma cell line sample sarcoma cell line sample K-562 cell sample embryonic cell line sample epithelial cell line sample THP-1 cell sample gastrointestinal cancer cell sample acute myeloid leukemia cell line sample cervical cancer cell line sample squamous cell carcinoma cell line sample mesothelioma cell line sample NCI cell sample human nasal epithelial cell sample macrophage, TB infection sample iPS differentiation to neuron, control sample iPS differentiation to neuron, down-syndrome donor sample myoblast differentiation to myotubes, control sample H1 embryonic stem cells differentiation to CD34+ HSC sample 293SLAM rinderpest infection sample COBL-a rinderpest infection sample partial hepatectomy sample sham operation sample ES-OS25 embryonic stem cells sample ES-OS25 embryonic stem cells, untreated sample ES-46C embryonic stem cells, neuronal differentiation sample ES-OS25 embryonic stem cells, KD for exosomal component EXOSC3, biol_rep1 sample ARPE-19 EMT induced with TGF-beta and TNF-alpha sample hIPS sample

		Promoter select All p1@BRI3 p2@BRI3 p3@BRI3 p4@BRI3 p5@BRI3 p6@BRI3 p7@BRI3 p8@BRI3 p9@BRI3 p10@BRI3
Sample		p1@BRI3	p2@BRI3	p3@BRI3	p4@BRI3	p5@BRI3	p6@BRI3	p7@BRI3	p8@BRI3	p9@BRI3	p10@BRI3
293SLAM rinderpest infection, 00hr, biol_rep1	13541-145H4	11.49	2.53	3.31	2.73	2.14	1.36	0.78	0.39	0.19	0.00
293SLAM rinderpest infection, 00hr, biol_rep2	13542-145H5	8.90	3.84	2.23	3.84	1.42	0.81	0.40	0.00	0.20	0.00
293SLAM rinderpest infection, 00hr, biol_rep3	13543-145H6	11.96	3.28	2.70	2.31	1.54	1.16	1.16	0.00	0.00	0.00
293SLAM rinderpest infection, 06hr, biol_rep1	13544-145H7	8.32	2.29	2.49	2.91	0.62	0.00	0.21	0.62	0.21	0.00
293SLAM rinderpest infection, 06hr, biol_rep2	13545-145H8	8.55	3.82	2.25	2.70	0.90	1.35	0.45	0.22	0.00	0.00
293SLAM rinderpest infection, 06hr, biol_rep3	13546-145H9	9.30	2.52	2.52	2.33	0.19	0.19	0.58	0.19	0.19	0.00
293SLAM rinderpest infection, 12hr, biol_rep1	13547-145I1	16.78	5.66	3.92	2.61	1.53	0.00	1.09	1.31	0.00	0.00
293SLAM rinderpest infection, 12hr, biol_rep2	13548-145I2	7.02	3.39	2.91	4.60	1.70	0.73	0.97	0.48	0.00	0.00
293SLAM rinderpest infection, 12hr, biol_rep3	13549-145I3	12.40	3.21	2.56	3.21	2.35	0.85	0.85	0.00	0.00	0.00
293SLAM rinderpest infection, 24hr, biol_rep1	13550-145I4	17.39	2.90	2.90	0.00	0.58	0.58	0.58	0.00	0.58	0.00
293SLAM rinderpest infection, 24hr, biol_rep2	13551-145I5	14.15	1.62	0.40	2.83	2.02	0.81	0.81	0.81	0.00	0.00
293SLAM rinderpest infection, 24hr, biol_rep3	13552-145I6	10.16	2.03	1.22	0.81	0.81	0.00	0.41	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr00min, biol_rep1	13625-146H7	239.85	32.40	39.98	5.80	3.87	3.06	2.90	2.26	0.64	0.32
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr00min, biol_rep2	13626-146H8	178.47	25.41	34.13	4.36	2.86	1.95	4.51	3.01	1.95	0.30
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr00min, biol_rep3	13627-146H9	210.55	26.13	32.49	2.63	2.20	3.51	4.17	2.20	1.10	0.22
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr15min, biol_rep1	13628-146I1	176.80	25.65	30.43	4.02	2.51	1.26	3.52	3.02	1.26	0.25
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr15min, biol_rep2	13629-146I2	172.32	28.39	27.74	2.84	2.18	3.49	2.40	2.18	0.66	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr15min, biol_rep3	13630-146I3	169.15	22.78	29.95	4.64	2.53	0.84	3.37	4.22	0.84	0.42
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr30min, biol_rep1	13631-146I4	113.03	18.66	20.26	2.67	1.07	2.67	6.93	5.86	1.60	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr30min, biol_rep2	13632-146I5	214.53	24.52	33.70	5.42	2.26	2.56	5.12	4.06	1.35	0.15
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr30min, biol_rep3	13633-146I6	179.76	26.60	30.74	4.41	2.41	1.34	4.54	2.54	1.20	0.94
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr45min, biol_rep1	13634-146I7	208.70	21.58	36.42	3.97	1.55	1.55	6.90	2.93	1.21	0.35
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr45min, biol_rep2	13635-146I8	172.69	26.76	26.76	3.88	2.71	2.20	4.27	2.97	1.16	0.39
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr45min, biol_rep3	13636-146I9	184.43	30.09	33.49	4.61	2.18	2.67	4.37	2.18	0.73	0.24
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr00min, biol_rep1	13637-147A1	197.36	31.73	31.73	4.64	3.87	5.42	4.13	5.68	1.29	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr00min, biol_rep2	13638-147A2	228.21	26.59	38.61	5.70	1.27	2.85	6.01	3.17	0.63	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr00min, biol_rep3	13639-147A3	138.46	18.68	21.43	4.95	1.65	2.75	2.20	1.65	1.65	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr20min, biol_rep1	13640-147A4	242.59	25.46	31.36	3.54	2.83	2.36	8.49	3.77	1.41	0.24
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr20min, biol_rep2	13641-147A5	213.05	29.24	28.11	5.98	2.58	1.13	5.01	2.58	0.97	0.32
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr20min, biol_rep3	13642-147A6	194.00	24.79	28.77	3.98	3.62	1.81	4.52	2.71	1.09	0.36
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr40min, biol_rep1	13643-147A7	175.64	19.89	26.38	2.30	1.47	2.09	3.35	2.09	0.84	0.21
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr40min, biol_rep2	13644-147A8	188.54	20.12	29.31	2.93	2.15	1.95	3.32	2.34	0.98	0.20
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr40min, biol_rep3	13645-147A9	164.39	26.17	29.97	5.49	1.90	2.11	6.12	2.53	0.42	0.21
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr00min, biol_rep1	13646-147B1	167.74	13.20	18.31	3.13	1.48	0.99	8.08	5.28	1.15	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr00min, biol_rep2	13647-147B2	208.87	23.75	32.54	2.80	2.06	2.24	3.37	3.93	0.56	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr00min, biol_rep3	13648-147B3	198.71	26.25	34.11	3.64	2.49	1.72	3.64	1.53	0.19	0.38
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr30min, biol_rep1	13649-147B4	211.53	25.55	29.64	2.86	5.11	2.04	4.50	3.47	0.20	0.61
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr30min, biol_rep2	13650-147B5	173.28	18.94	25.59	2.22	2.42	2.22	3.43	1.61	1.61	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr30min, biol_rep3	13651-147B6	202.85	23.77	28.63	4.59	2.97	2.97	4.86	1.89	0.81	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr00min, biol_rep1	13652-147B7	185.57	22.33	28.33	2.16	2.88	1.68	2.40	2.40	0.72	0.24
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr00min, biol_rep2	13653-147B8	191.03	23.53	35.05	2.82	2.12	1.65	2.59	0.94	1.18	0.47
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr00min, biol_rep3	13654-147B9	155.18	16.40	19.32	2.78	1.76	0.73	3.51	3.37	1.02	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr30min, biol_rep1	13655-147C1	185.59	19.40	32.06	3.16	1.69	1.48	3.37	2.95	0.84	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr30min, biol_rep2	13656-147C2	191.79	23.78	33.74	1.57	3.15	2.45	2.80	2.10	0.52	0.17
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr30min, biol_rep3	13657-147C3	179.69	21.28	31.92	2.61	2.61	1.81	2.21	2.21	1.00	0.20
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 04hr00min, biol_rep1	13658-147C4	187.28	25.36	30.71	1.86	2.33	2.79	4.89	3.02	0.70	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 04hr00min, biol_rep2	13659-147C5	183.77	29.27	29.03	1.68	4.56	2.40	5.76	2.40	0.24	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 04hr00min, biol_rep3	13660-147C6	214.60	28.31	34.87	0.89	3.58	1.79	3.28	2.98	0.89	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 05hr00min, biol_rep1	13661-147C7	164.69	16.04	26.33	3.59	2.63	1.91	1.91	2.63	0.72	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 05hr00min, biol_rep2	13662-147C8	156.30	18.60	22.65	1.62	2.63	2.63	2.63	2.22	1.42	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 05hr00min, biol_rep3	13663-147C9	91.20	12.91	19.68	2.87	1.23	0.82	5.74	8.20	1.02	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 06hr00min, biol_rep1	13664-147D1	107.63	15.57	18.23	4.67	3.11	0.89	3.11	4.00	1.78	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 06hr00min, biol_rep2	13665-147D2	55.97	13.99	0.00	0.00	0.00	0.00	13.99	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 06hr00min, biol_rep3	13666-147D3	62.10	6.39	8.52	1.77	0.35	0.35	1.06	1.42	0.71	0.35
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 07hr00min, biol_rep1	13667-147D4	64.29	8.62	10.27	2.98	1.66	0.33	2.98	5.63	0.99	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 07hr00min, biol_rep2	13668-147D5	125.00	4.19	7.55	1.68	1.68	0.00	17.62	5.03	1.68	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 07hr00min, biol_rep3	13669-147D6	107.00	12.40	10.56	3.21	0.92	1.38	14.24	9.64	1.84	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 08hr00min, biol_rep1	13670-147D7	66.44	9.72	16.21	4.86	0.32	0.32	3.57	7.78	1.94	0.32
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 08hr00min, biol_rep2	13671-147D8	63.59	7.07	13.49	3.85	0.32	1.28	1.61	3.85	0.32	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 08hr00min, biol_rep3	13672-147D9	104.36	7.86	16.35	3.14	0.63	0.31	5.97	8.49	1.57	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 12hr00min, biol_rep2	13674-147E2	54.29	4.94	11.28	0.00	1.41	0.00	3.53	3.53	0.71	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 12hr00min, biol_rep3	13675-147E3	61.69	5.05	8.97	2.24	0.56	1.12	2.24	2.24	0.56	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 16hr00min, biol_rep1	13676-147E4	190.28	7.17	22.29	3.18	1.59	0.80	8.76	9.55	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 16hr00min, biol_rep2	13677-147E5	93.44	8.83	15.63	3.40	1.02	0.34	6.80	5.10	0.68	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 16hr00min, biol_rep3	13678-147E6	67.91	4.22	16.25	2.60	1.62	0.65	1.30	2.60	0.32	0.97
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 24hr00min, biol_rep1	13679-147E7	56.80	11.71	12.78	2.84	0.71	1.42	0.71	2.84	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 24hr00min, biol_rep2	13680-147E8	16.16	0.00	0.00	0.00	0.00	0.00	0.00	16.16	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 24hr00min, biol_rep3	13681-147E9	110.56	7.90	0.00	0.00	7.90	0.00	0.00	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 42hr00min, biol_rep1	13682-147F1	53.14	6.34	12.19	1.95	0.00	0.98	1.95	1.95	0.98	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 42hr00min, biol_rep2	13683-147F2	45.12	2.98	7.93	1.49	0.00	0.50	1.49	2.48	0.50	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 42hr00min, biol_rep3	13684-147F3	38.00	5.16	7.97	0.47	0.47	0.94	0.47	1.41	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 60hr00min, biol_rep1	13685-147F4	67.23	5.63	15.23	5.96	0.00	0.66	1.32	1.32	1.66	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 60hr00min, biol_rep2	13686-147F5	48.26	8.35	11.45	4.64	0.62	0.00	2.47	2.78	0.62	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 60hr00min, biol_rep3	13687-147F6	47.39	4.89	9.78	4.28	1.22	0.92	0.61	0.92	1.53	0.00
Adipocyte - breast, donor1	11376-118A8	235.36	19.80	42.76	2.38	1.74	1.90	4.75	1.90	0.16	0.63
Adipocyte - breast, donor2	11327-117E4	174.70	15.24	35.78	1.93	1.60	1.60	4.81	3.05	1.60	0.48
Adipocyte - omental, donor1	11473-119C6	99.36	9.80	18.07	1.53	1.53	2.80	3.44	1.78	0.00	0.13
Adipocyte - omental, donor2	11474-119C7	248.17	9.72	29.90	3.74	5.98	2.24	3.74	5.23	0.75	0.75
Adipocyte - omental, donor3	11475-119C8	153.06	9.38	17.08	1.67	2.34	0.33	3.68	2.01	0.00	0.33
Adipocyte - perirenal, donor1	11476-119C9	101.44	5.10	14.67	1.28	2.55	1.28	7.02	1.91	0.64	0.00
Adipocyte - subcutaneous, donor1	11259-116F8	136.34	11.00	11.00	1.10	1.10	1.10	4.40	0.00	0.00	0.00
Adipocyte - subcutaneous, donor2	11336-117F4	119.68	7.68	16.71	1.35	1.35	0.00	2.26	0.00	0.00	0.00
Adipocyte - subcutaneous, donor3	11408-118E4	96.79	17.20	14.08	3.13	2.78	0.87	2.09	0.00	0.17	0.17
Adipocyte differentiation, day04, donor1	13019-139D4	148.83	18.58	24.06	3.13	4.50	2.15	2.93	0.20	0.00	0.00
Adipocyte differentiation, day04, donor2	13022-139D7	114.02	12.10	20.85	3.35	1.29	0.51	2.83	0.26	0.00	0.26
Adipocyte differentiation, day04, donor3	13025-139E1	149.70	17.84	22.30	2.23	0.56	0.84	2.79	0.56	0.00	0.00
Adipocyte differentiation, day04, donor4	13028-139E4	98.16	22.34	12.93	1.76	1.18	0.59	1.18	0.00	0.00	0.00
Adipocyte differentiation, day08, donor1	13020-139D5	91.05	8.69	14.16	1.85	1.85	1.29	1.85	0.56	0.00	0.08
Adipocyte differentiation, day08, donor2	13023-139D8	178.48	18.72	35.50	2.58	1.29	1.29	1.29	0.97	0.00	0.65
Adipocyte differentiation, day08, donor3	13026-139E2	127.97	11.20	21.86	1.07	1.07	0.53	3.20	1.60	0.53	0.00
Adipocyte differentiation, day08, donor4	13029-139E5	60.10	16.14	7.23	1.11	0.00	1.67	2.23	0.00	0.00	0.56
Adipocyte differentiation, day12, donor1	13021-139D6	67.79	9.15	10.81	1.66	2.91	1.66	2.08	0.83	0.42	0.42
Adipocyte differentiation, day12, donor2	13024-139D9	155.72	14.07	33.66	2.01	1.76	2.01	3.77	0.50	0.00	0.75
Adipocyte differentiation, day12, donor3	13027-139E3	74.94	10.47	14.40	2.62	0.00	0.98	1.64	1.31	0.00	0.00
Adipocyte differentiation, day12, donor4	13030-139E6	75.20	9.44	11.87	2.44	1.83	0.91	1.22	0.61	0.00	0.30
Alveolar Epithelial Cells, donor1	11510-119G7	74.26	10.61	8.84	0.88	1.33	1.10	0.44	0.00	0.00	0.00
Alveolar Epithelial Cells, donor2	11590-120G6	198.65	20.80	18.29	1.43	3.59	6.10	2.87	2.51	0.00	0.00
Alveolar Epithelial Cells, donor3	11671-122G6	58.70	10.78	14.38	1.20	2.40	2.40	1.20	0.00	0.00	0.00
Amniotic Epithelial Cells, donor1	11533-120A3	128.09	12.59	15.11	0.90	0.54	2.16	0.54	0.54	0.00	0.18
Amniotic Epithelial Cells, donor2	11613-122A2	170.70	16.73	31.80	0.00	1.67	1.67	0.00	0.00	0.00	0.00
Amniotic Epithelial Cells, donor3	11694-123A2	163.13	21.78	29.17	3.08	2.05	2.67	2.26	0.82	0.00	0.00
Anulus Pulposus Cell, donor1	11248-116E6	94.29	20.48	11.10	1.03	1.95	1.49	1.60	0.11	0.00	0.00
Anulus Pulposus Cell, donor2	11463-119B5	93.55	18.61	6.86	1.71	5.14	1.22	1.47	0.73	0.24	0.00
Aortic smooth muscle cell response to FGF2, 00hr00min, biol_rep1 (LK1)	12642-134G5	97.95	12.13	12.58	0.90	2.70	0.00	6.29	5.39	0.00	0.00
Aortic smooth muscle cell response to FGF2, 00hr00min, biol_rep2 (LK2)	12740-135I4	107.23	16.50	8.25	0.43	0.87	1.74	4.78	1.30	0.43	0.00
Aortic smooth muscle cell response to FGF2, 00hr00min, biol_rep3 (LK3)	12838-137B3	59.93	10.70	14.98	0.00	2.14	2.14	6.42	2.14	0.00	0.00
Aortic smooth muscle cell response to FGF2, 00hr15min, biol_rep1 (LK4)	12643-134G6	95.36	12.55	12.55	0.60	4.48	0.30	2.99	2.09	0.60	0.30
Aortic smooth muscle cell response to FGF2, 00hr15min, biol_rep2 (LK5)	12741-135I5	104.97	17.71	7.59	0.00	3.79	1.26	3.79	5.06	0.00	0.00
Aortic smooth muscle cell response to FGF2, 00hr15min, biol_rep3 (LK6)	12839-137B4	68.65	14.52	15.84	0.66	1.32	1.32	1.32	4.62	0.66	0.00
Aortic smooth muscle cell response to FGF2, 00hr30min, biol_rep1 (LK7)	12644-134G7	94.54	11.05	11.37	1.30	1.30	0.32	3.25	0.65	0.32	0.00
Aortic smooth muscle cell response to FGF2, 00hr30min, biol_rep2 (LK8)	12742-135I6	99.52	14.08	12.14	1.46	3.40	0.00	4.37	0.97	0.00	0.00
Aortic smooth muscle cell response to FGF2, 00hr30min, biol_rep3 (LK9)	12840-137B5	72.45	17.22	10.69	1.78	0.59	1.19	3.56	1.19	0.59	0.00
Aortic smooth muscle cell response to FGF2, 00hr45min, biol_rep1 (LK10)	12645-134G8	93.41	13.94	12.05	0.75	2.64	1.88	4.14	3.39	0.00	0.00
Aortic smooth muscle cell response to FGF2, 00hr45min, biol_rep2 (LK11)	12743-135I7	99.42	10.89	12.34	0.73	4.35	0.73	3.63	2.18	0.00	0.00
Aortic smooth muscle cell response to FGF2, 00hr45min, biol_rep3 (LK12)	12841-137B6	87.76	8.78	12.54	3.76	0.00	0.00	1.25	1.25	0.00	0.00
Aortic smooth muscle cell response to FGF2, 01hr, biol_rep1 (LK13)	12646-134G9	83.03	17.46	10.71	2.14	1.81	1.15	0.99	0.66	0.00	0.00
Aortic smooth muscle cell response to FGF2, 01hr, biol_rep2 (LK14)	12744-135I8	109.18	16.38	9.55	2.73	1.36	0.00	0.00	5.46	0.00	1.36
Aortic smooth muscle cell response to FGF2, 01hr, biol_rep3 (LK15)	12842-137B7	79.01	13.42	12.97	1.36	0.90	1.51	0.60	0.45	0.15	0.00
Aortic smooth muscle cell response to FGF2, 02hr, biol_rep1 (LK16)	12647-134H1	100.73	13.39	9.64	1.07	1.07	0.54	2.68	1.61	0.54	0.00
Aortic smooth muscle cell response to FGF2, 02hr, biol_rep2 (LK17)	12745-135I9	114.12	15.87	14.55	1.51	4.16	2.08	3.21	1.51	0.00	0.00
Aortic smooth muscle cell response to FGF2, 02hr, biol_rep3 (LK18)	12843-137B8	65.49	21.12	13.90	1.60	1.87	2.41	4.01	2.14	0.00	0.27
Aortic smooth muscle cell response to FGF2, 03hr, biol_rep1 (LK19)	12648-134H2	120.96	10.73	10.73	1.95	0.00	0.98	0.98	0.98	0.00	0.00
Aortic smooth muscle cell response to FGF2, 03hr, biol_rep2 (LK20)	12746-136A1	106.98	17.42	13.10	1.49	1.66	1.00	2.99	0.50	0.00	0.33
Aortic smooth muscle cell response to FGF2, 03hr, biol_rep3 (LK21)	12844-137B9	61.24	15.61	12.01	1.20	1.20	0.00	1.20	3.60	0.00	0.00
Aortic smooth muscle cell response to FGF2, 04hr, biol_rep1 (LK22)	12649-134H3	70.80	17.70	3.54	0.00	3.54	0.00	0.00	3.54	0.00	0.00
Aortic smooth muscle cell response to FGF2, 04hr, biol_rep2 (LK23)	12747-136A2	106.52	13.04	14.75	0.86	1.89	1.89	1.37	1.20	0.00	0.00
Aortic smooth muscle cell response to FGF2, 04hr, biol_rep3 (LK24)	12845-137C1	46.14	12.58	8.39	4.19	4.19	0.00	8.39	4.19	0.00	0.00
Aortic smooth muscle cell response to FGF2, 05hr, biol_rep1 (LK25)	12650-134H4	91.26	12.14	11.16	1.94	3.88	0.00	4.37	0.97	0.00	0.00
Aortic smooth muscle cell response to FGF2, 05hr, biol_rep2 (LK26)	12748-136A3	115.73	17.08	12.14	0.76	4.55	1.14	3.04	2.66	0.00	0.00
Aortic smooth muscle cell response to FGF2, 05hr, biol_rep3 (LK27)	12846-137C2	71.47	10.90	12.11	1.21	0.00	0.00	4.85	4.85	0.00	0.00
Aortic smooth muscle cell response to FGF2, 06hr, biol_rep1 (LK28)	12651-134H5	88.36	13.11	8.55	2.28	0.57	1.14	2.85	0.57	0.00	0.00
Aortic smooth muscle cell response to FGF2, 06hr, biol_rep2 (LK29)	12749-136A4	100.47	15.39	14.96	1.28	2.78	1.92	1.50	0.00	0.43	0.43
Aortic smooth muscle cell response to FGF2, 06hr, biol_rep3 (LK30)	12847-137C3	74.59	19.36	17.55	1.81	1.03	1.81	3.10	1.81	1.55	0.26
Aortic smooth muscle cell response to IL1b, 00hr00min, biol_rep1 (LK31)	12652-134H6	99.94	12.67	7.04	0.94	2.82	1.41	4.69	2.35	0.94	0.00
Aortic smooth muscle cell response to IL1b, 00hr00min, biol_rep2 (LK32)	12750-136A5	109.33	18.01	12.22	1.29	3.54	1.61	2.57	1.29	0.64	0.00
Aortic smooth muscle cell response to IL1b, 00hr00min, biol_rep3 (LK33)	12848-137C4	74.20	14.98	12.84	2.85	2.14	2.85	4.28	2.85	1.43	0.00
Aortic smooth muscle cell response to IL1b, 00hr15min, biol_rep1 (LK34)	12653-134H7	81.31	9.36	9.36	1.17	2.92	1.75	1.17	0.58	0.58	0.00
Aortic smooth muscle cell response to IL1b, 00hr15min, biol_rep2 (LK35)	12751-136A6	120.73	20.47	15.96	1.51	2.11	2.11	2.71	2.71	0.00	0.00
Aortic smooth muscle cell response to IL1b, 00hr15min, biol_rep3 (LK36)	12849-137C5	89.10	19.01	16.63	0.00	0.00	2.38	1.19	2.38	1.19	0.00
Aortic smooth muscle cell response to IL1b, 00hr30min, biol_rep1 (LK37)	12654-134H8	99.68	17.80	12.71	1.53	2.54	1.02	5.09	5.09	0.51	0.00
Aortic smooth muscle cell response to IL1b, 00hr30min, biol_rep2 (LK38)	12752-136A7	107.99	14.77	12.48	1.27	2.80	0.76	4.33	2.80	0.51	0.00
Aortic smooth muscle cell response to IL1b, 00hr30min, biol_rep3 (LK39)	12850-137C6	94.03	13.98	22.24	0.64	0.64	0.64	3.18	1.27	0.00	0.00
Aortic smooth muscle cell response to IL1b, 00hr45min, biol_rep1 (LK40)	12655-134H9	107.02	14.67	14.67	0.43	3.45	0.00	3.88	1.29	0.00	0.00
Aortic smooth muscle cell response to IL1b, 00hr45min, biol_rep2 (LK41)	12753-136A8	106.05	13.55	15.03	0.85	3.60	1.91	1.91	0.00	0.21	0.00
Aortic smooth muscle cell response to IL1b, 00hr45min, biol_rep3 (LK42)	12851-137C7	88.44	19.72	13.63	0.29	2.32	2.03	4.64	1.16	0.29	0.29
Aortic smooth muscle cell response to IL1b, 01hr, biol_rep1 (LK43)	12656-134I1	128.48	10.39	10.39	0.00	0.00	0.00	6.61	1.89	0.00	0.00
Aortic smooth muscle cell response to IL1b, 01hr, biol_rep2 (LK44)	12754-136A9	101.04	13.22	18.48	1.36	3.90	2.71	1.36	1.02	0.17	0.34
Aortic smooth muscle cell response to IL1b, 01hr, biol_rep3 (LK45)	12852-137C8	76.44	13.90	23.16	0.00	0.00	0.00	0.00	2.32	0.00	0.00
Aortic smooth muscle cell response to IL1b, 02hr, biol_rep1 (LK46)	12657-134I2	107.74	19.01	6.34	2.11	6.34	0.00	2.11	2.11	0.00	0.00
Aortic smooth muscle cell response to IL1b, 02hr, biol_rep2 (LK47)	12755-136B1	90.91	12.01	14.37	0.86	2.36	0.86	3.43	1.50	0.43	0.43
Aortic smooth muscle cell response to IL1b, 02hr, biol_rep3 (LK48)	12853-137C9	66.78	11.43	16.85	3.01	0.60	1.80	0.60	3.01	0.00	0.00
Aortic smooth muscle cell response to IL1b, 03hr, biol_rep1 (LK49)	12658-134I3	72.90	8.02	7.29	3.64	0.73	0.73	2.92	1.46	0.73	0.00
Aortic smooth muscle cell response to IL1b, 03hr, biol_rep2 (LK50)	12756-136B2	106.89	14.25	15.40	0.92	3.91	1.61	3.68	3.45	0.46	0.46
Aortic smooth muscle cell response to IL1b, 03hr, biol_rep3 (LK51)	12854-137D1	89.26	12.75	5.10	0.00	2.55	2.55	2.55	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 04hr, biol_rep1 (LK52)	12659-134I4	86.95	13.22	13.73	1.78	2.03	1.53	2.03	0.51	0.25	0.00
Aortic smooth muscle cell response to IL1b, 04hr, biol_rep2 (LK53)	12757-136B3	94.96	15.28	13.01	2.27	2.27	1.86	2.27	1.24	0.00	0.00
Aortic smooth muscle cell response to IL1b, 04hr, biol_rep3 (LK54)	12855-137D2	83.54	17.44	15.30	0.92	1.22	2.45	2.75	3.06	0.31	0.00
Aortic smooth muscle cell response to IL1b, 05hr, biol_rep1 (LK55)	12660-134I5	94.17	14.34	12.91	1.43	4.30	0.00	5.74	2.39	0.48	0.00
Aortic smooth muscle cell response to IL1b, 05hr, biol_rep2 (LK56)	12758-136B4	84.48	13.97	11.31	1.77	2.44	1.55	1.33	0.89	0.67	0.00
Aortic smooth muscle cell response to IL1b, 05hr, biol_rep3 (LK57)	12856-137D3	61.03	21.36	7.63	1.53	1.53	1.53	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 06hr, biol_rep1 (LK58)	12661-134I6	89.73	13.29	12.74	0.55	3.32	0.55	0.55	1.11	0.00	0.00
Aortic smooth muscle cell response to IL1b, 06hr, biol_rep2 (LK59)	12759-136B5	82.35	16.42	13.77	1.06	2.38	1.32	0.79	2.12	0.53	0.26
Aortic smooth muscle cell response to IL1b, 06hr, biol_rep3 (LK60)	12857-137D4	84.32	15.63	16.36	1.09	1.82	1.45	2.91	2.18	0.00	0.00
Astrocyte - cerebellum, donor1	11500-119F6	46.18	10.81	2.46	1.23	2.21	2.09	0.12	0.12	0.00	0.00
Astrocyte - cerebellum, donor2	11580-120F5	75.14	17.46	5.82	1.20	4.79	1.88	0.68	0.51	0.17	0.17
Astrocyte - cerebellum, donor3	11661-122F5	30.83	11.54	6.29	2.10	4.19	1.89	0.84	0.21	0.00	0.00
Astrocyte - cerebral cortex, donor1	11235-116D2	49.50	7.32	7.32	4.18	3.14	1.39	0.70	0.35	0.00	0.00
Astrocyte - cerebral cortex, donor2	11316-117D2	53.06	13.27	6.47	3.56	2.26	1.13	0.81	0.81	0.00	0.00
Astrocyte - cerebral cortex, donor3	11392-118C6	47.43	11.49	12.23	4.03	3.28	1.49	0.60	0.60	0.30	0.00
B lymphoblastoid cell line: GM12878 ENCODE, biol_rep1	10821-111C2	26.61	17.09	3.10	4.36	2.64	1.15	0.34	0.11	0.00	0.00
B lymphoblastoid cell line: GM12878 ENCODE, biol_rep2	10822-111C3	27.94	14.03	4.01	2.63	1.25	1.88	0.50	0.13	0.00	0.00
B lymphoblastoid cell line: GM12878 ENCODE, biol_rep3	10823-111C4	21.17	14.57	2.39	2.96	1.59	1.93	0.34	0.34	0.00	0.00
Basophils, donor1	12241-129G9	250.55	14.38	23.28	2.88	1.57	1.31	3.40	1.05	0.00	0.26
Basophils, donor2	12242-129H1	168.13	11.18	17.68	5.77	1.08	0.36	1.44	0.36	0.00	0.36
Basophils, donor3	12243-129H2	325.30	13.82	30.58	2.79	2.06	1.47	2.06	0.73	0.00	0.29
Bronchial Epithelial Cell, donor1	11511-119G8	54.33	8.84	5.17	1.29	0.86	0.86	0.43	0.00	0.00	0.00
Bronchial Epithelial Cell, donor2	11591-120G7	121.61	25.60	12.34	1.37	4.57	0.91	2.29	0.91	0.46	0.00
Bronchial Epithelial Cell, donor3	11672-122G7	71.74	14.35	7.17	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Bronchial Epithelial Cell, donor4	11453-119A4	54.61	11.93	5.65	0.00	1.26	1.26	2.51	1.88	0.00	0.00
Bronchial Epithelial Cell, donor5	11457-119A8	99.19	13.52	12.48	0.62	2.70	2.50	1.66	0.21	0.00	0.00
Bronchial Epithelial Cell, donor6	11461-119B3	35.70	11.05	8.06	1.61	2.07	3.22	0.69	0.23	0.00	0.00
Bronchial Epithelial Cell, donor7	11769-123I5	78.82	14.22	9.54	1.80	3.42	0.90	0.90	0.18	0.18	0.00
Burkitt's lymphoma cell line:DAUDI	10422-106C8	30.20	12.68	2.06	1.75	3.09	1.44	0.00	0.10	0.21	0.00
Burkitt's lymphoma cell line:RAJI	10476-106I8	12.58	6.29	0.70	2.56	2.33	0.93	0.23	0.00	0.00	0.00
CD133+ stem cells - adult bone marrow derived, pool1	12224-129F1	60.12	20.47	3.84	4.80	1.92	1.28	0.00	0.00	0.00	0.00
CD133+ stem cells - cord blood derived, pool1	12223-129E9	51.71	41.37	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
CD14+ Monocytes, donor1	11224-116B9	331.93	16.34	29.30	3.38	0.56	0.00	1.69	1.13	0.00	0.00
CD14+ Monocytes, donor2	11305-117B9	231.82	17.82	25.61	1.86	0.37	0.93	1.86	1.48	0.19	0.00
CD14+ Monocytes, donor3	11381-118B4	246.10	22.17	33.59	4.39	0.66	1.32	2.85	1.10	0.00	0.00
CD14+ monocyte derived endothelial progenitor cells, donor1	11229-116C5	555.05	21.79	110.39	9.06	1.42	2.83	11.89	3.40	0.85	0.28
CD14+ monocyte derived endothelial progenitor cells, donor2	11310-117C5	516.30	25.40	95.15	7.96	1.90	7.20	6.07	1.90	0.38	1.14
CD14+ monocyte derived endothelial progenitor cells, donor3	11386-118B9	468.13	29.59	100.59	8.22	1.97	5.92	7.23	0.66	0.33	0.00
CD14+ monocytes - mock treated, donor1	11863-125A9	448.82	27.18	64.90	2.02	1.59	2.46	9.97	10.26	3.04	0.00
CD14+ monocytes - mock treated, donor2	11873-125C1	348.21	12.97	58.24	1.21	1.51	2.11	6.94	8.45	2.72	0.00
CD14+ monocytes - mock treated, donor3	11883-125D2	384.00	18.95	59.46	2.37	0.47	1.90	6.63	7.11	0.95	0.24
CD14+ monocytes - treated with B-glucan, donor1	11869-125B6	358.40	16.40	48.04	1.17	1.00	1.34	5.19	9.88	2.34	0.17
CD14+ monocytes - treated with B-glucan, donor2	11879-125C7	345.84	13.25	56.31	1.66	0.00	1.93	4.69	7.18	0.28	0.28
CD14+ monocytes - treated with B-glucan, donor3	11889-125D8	381.56	13.88	51.57	1.49	0.99	2.48	4.71	6.20	0.50	0.00
CD14+ monocytes - treated with BCG, donor1	11860-125A6	325.42	19.78	50.52	1.17	0.20	2.15	4.90	6.46	2.15	0.20
CD14+ monocytes - treated with BCG, donor2	11870-125B7	386.72	16.74	56.26	1.25	1.07	1.25	5.16	5.70	1.78	0.00
CD14+ monocytes - treated with BCG, donor3	11880-125C8	327.32	11.32	35.26	1.31	0.87	1.96	4.13	8.92	0.44	0.00
CD14+ monocytes - treated with Candida, donor1	11868-125B5	285.17	16.15	29.03	2.34	0.70	1.17	3.04	4.21	0.47	0.23
CD14+ monocytes - treated with Candida, donor2	11878-125C6	290.94	12.14	34.85	2.11	1.06	2.11	4.75	6.86	0.00	0.53
CD14+ monocytes - treated with Candida, donor3	11888-125D7	228.53	7.77	33.28	1.11	0.00	0.00	2.22	2.22	1.11	0.00
CD14+ monocytes - treated with Cryptococcus, donor1	11867-125B4	399.84	22.91	56.23	1.64	1.34	3.12	8.78	9.82	3.12	0.15
CD14+ monocytes - treated with Cryptococcus, donor2	11877-125C5	362.38	19.76	61.46	0.80	1.80	1.60	6.19	12.97	2.20	0.00
CD14+ monocytes - treated with Cryptococcus, donor3	11887-125D6	322.29	9.79	40.39	1.04	1.04	1.25	5.41	7.29	1.04	0.21
CD14+ monocytes - treated with Group A streptococci, donor1	11864-125B1	372.46	18.30	46.90	0.92	1.14	1.60	7.55	5.95	2.06	0.23
CD14+ monocytes - treated with Group A streptococci, donor2	11874-125C2	292.26	9.27	26.47	0.90	0.23	1.36	2.71	4.75	0.00	0.00
CD14+ monocytes - treated with Group A streptococci, donor3	11884-125D3	182.88	10.04	35.79	1.31	1.31	1.31	3.06	3.06	1.31	0.00
CD14+ monocytes - treated with IFN + N-hexane, donor1	11861-125A7	330.59	20.17	43.85	0.81	1.08	1.34	4.84	6.72	0.81	0.00
CD14+ monocytes - treated with IFN + N-hexane, donor2	11871-125B8	490.58	25.65	66.47	2.97	1.05	2.09	9.42	12.21	2.79	0.17
CD14+ monocytes - treated with IFN + N-hexane, donor3	11881-125C9	295.84	18.52	48.82	1.68	1.68	2.95	5.05	9.26	0.42	0.84
CD14+ monocytes - treated with Salmonella, donor1	11866-125B3	309.37	14.70	39.13	0.37	0.37	0.92	4.41	6.98	0.92	0.37
CD14+ monocytes - treated with Salmonella, donor2	11876-125C4	272.65	11.98	37.34	0.00	0.00	0.35	3.17	2.47	0.70	0.00
CD14+ monocytes - treated with Salmonella, donor3	11886-125D5	222.00	10.97	26.76	0.88	0.44	0.44	0.88	3.51	1.32	0.00
CD14+ monocytes - treated with Trehalose dimycolate (TDM), donor1	11862-125A8	382.23	21.62	50.39	2.27	0.17	1.57	5.75	5.58	0.70	0.35
CD14+ monocytes - treated with Trehalose dimycolate (TDM), donor2	11872-125B9	363.87	15.61	45.34	2.23	0.74	1.86	4.46	5.20	1.86	0.00
CD14+ monocytes - treated with Trehalose dimycolate (TDM), donor3	11882-125D1	453.52	16.38	36.64	3.66	0.86	2.37	6.04	10.56	1.08	0.65
CD14+ monocytes - treated with lipopolysaccharide, donor1	11865-125B2	238.73	14.74	20.06	1.64	0.82	0.82	2.87	6.55	0.00	0.00
CD14+ monocytes - treated with lipopolysaccharide, donor2	11875-125C3	221.37	10.66	17.15	1.39	0.70	0.70	2.09	3.25	0.00	0.23
CD14+ monocytes - treated with lipopolysaccharide, donor3	11885-125D4	189.54	4.64	16.01	1.16	0.23	0.70	2.55	3.71	0.46	0.23
CD14+CD16+ Monocytes, donor1	11789-124B7	203.36	13.08	25.28	5.45	0.65	0.44	3.49	7.63	0.22	0.00
CD14+CD16+ Monocytes, donor2	11801-124D1	265.64	16.17	42.96	4.62	1.39	1.39	3.70	5.31	1.15	0.00
CD14+CD16+ Monocytes, donor3	11912-125G4	233.73	8.45	28.16	4.55	1.30	2.82	1.30	2.82	0.00	0.00
CD14+CD16- Monocytes, donor1	11788-124B6	383.23	36.44	39.40	8.10	2.34	1.56	2.02	2.02	0.31	0.47
CD14+CD16- Monocytes, donor2	11799-124C8	300.74	26.20	25.15	4.37	0.70	1.57	1.75	2.79	0.35	0.52
CD14+CD16- Monocytes, donor3	11910-125G2	245.93	20.96	20.07	5.80	0.45	1.11	2.01	1.34	0.00	0.22
CD14-CD16+ Monocytes, donor1	11790-124B8	410.58	17.61	69.41	9.95	1.28	4.34	2.04	2.81	0.51	0.00
CD14-CD16+ Monocytes, donor2	11800-124C9	297.73	18.44	46.55	4.39	0.66	2.20	3.51	3.73	0.88	0.44
CD14-CD16+ Monocytes, donor3	11911-125G3	264.66	12.84	38.74	7.37	1.05	1.26	3.79	2.95	0.21	0.42
CD19+ B Cells (pluriselect), donor090309, donation1	12189-129B2	30.48	10.16	2.03	0.00	2.03	0.00	0.00	0.00	0.00	0.00
CD19+ B Cells (pluriselect), donor090309, donation2	12194-129B7	39.32	12.88	2.71	6.10	0.68	0.68	0.00	0.00	0.00	0.00
CD19+ B Cells (pluriselect), donor090309, donation3	12199-129C3	33.14	7.25	3.11	12.43	0.00	0.00	0.00	0.00	0.00	0.00
CD19+ B Cells (pluriselect), donor090325, donation1	12151-128F9	44.78	10.13	5.33	2.67	0.00	0.53	0.00	0.00	0.00	0.00
CD19+ B Cells (pluriselect), donor090325, donation2	12174-128I5	28.95	11.79	2.14	4.82	1.61	0.54	0.54	0.00	0.00	0.00
CD19+ B Cells (pluriselect), donor090612, donation1	12204-129C8	38.61	9.83	2.11	14.74	0.00	1.40	0.00	0.00	0.00	0.00
CD19+ B Cells (pluriselect), donor090612, donation2	12209-129D4	36.86	5.49	3.92	13.33	0.78	0.00	0.78	0.00	0.00	0.00
CD19+ B Cells (pluriselect), donor090612, donation3	12214-129D9	38.23	10.55	5.27	13.18	0.00	0.00	0.00	0.00	1.32	0.00
CD19+ B Cells, donor1	11544-120B5	37.81	9.04	4.93	4.11	0.82	0.00	0.82	0.82	0.00	0.00
CD19+ B Cells, donor2	11624-122B4	39.17	5.08	5.08	4.35	0.73	0.73	3.63	0.00	0.00	0.00
CD19+ B Cells, donor3	11705-123B4	52.00	7.07	2.02	5.05	1.51	1.01	0.50	0.00	0.00	0.00
CD34 cells differentiated to erythrocyte lineage, biol_ rep1	11931-125I5	44.45	14.14	3.64	3.23	3.23	0.81	0.40	0.40	0.00	0.00
CD34 cells differentiated to erythrocyte lineage, biol_ rep2	11932-125I6	48.34	12.78	1.20	3.20	0.00	0.80	1.60	0.00	0.00	0.00
CD34+ Progenitors, donor1	11545-120B6	35.14	10.04	2.01	1.00	1.00	0.00	0.00	1.00	0.00	0.00
CD34+ Progenitors, donor2	11625-122B5	89.89	8.99	5.06	5.06	1.12	0.56	0.00	0.00	0.00	0.00
CD34+ stem cells - adult bone marrow derived, donor1, tech_rep1	12225-129F2	33.44	10.15	2.25	2.63	2.25	0.00	0.00	0.00	0.00	0.00
CD34+ stem cells - adult bone marrow derived, donor1, tech_rep2	12225-129F2	33.60	12.40	3.38	5.64	2.48	1.13	0.45	0.00	0.00	0.00
CD4+ T Cells, donor1	11225-116C1	38.56	12.85	1.79	7.86	0.36	2.50	0.00	0.00	0.36	0.00
CD4+ T Cells, donor2	11306-117C1	41.64	15.31	4.29	4.90	0.61	0.00	2.45	0.61	0.00	0.00
CD4+ T Cells, donor3	11382-118B5	25.92	10.98	2.44	3.66	0.61	0.30	1.52	0.30	0.00	0.00
CD4+CD25+CD45RA+ naive regulatory T cells expanded, donor1	11793-124C2	29.61	12.51	0.51	20.67	0.51	0.51	0.26	0.26	0.00	0.00
CD4+CD25+CD45RA+ naive regulatory T cells expanded, donor2	11915-125G7	35.71	17.97	2.25	18.19	0.45	0.22	0.00	0.45	0.00	0.00
CD4+CD25+CD45RA+ naive regulatory T cells expanded, donor3	11919-125H2	34.78	15.81	1.44	19.26	1.15	0.86	0.57	0.00	0.00	0.00
CD4+CD25+CD45RA+ naive regulatory T cells, donor1	11780-124A7	53.10	14.70	3.32	10.43	0.95	1.42	0.47	0.00	0.47	0.47
CD4+CD25+CD45RA+ naive regulatory T cells, donor2	11796-124C5	76.55	17.56	2.81	17.56	2.11	0.70	0.00	0.70	0.00	0.00
CD4+CD25+CD45RA+ naive regulatory T cells, donor3	11907-125F8	32.96	16.48	6.59	19.78	0.00	0.00	3.30	3.30	0.00	0.00
CD4+CD25+CD45RA- memory regulatory T cells expanded, donor1	11794-124C3	20.38	12.86	1.88	9.68	0.14	0.58	0.43	0.58	0.00	0.00
CD4+CD25+CD45RA- memory regulatory T cells expanded, donor2	11916-125G8	33.89	20.84	2.71	11.86	0.85	0.85	0.34	0.34	0.34	0.00
CD4+CD25+CD45RA- memory regulatory T cells expanded, donor3	11920-125H3	28.05	18.06	1.13	9.35	0.64	1.45	0.97	0.32	0.16	0.00
CD4+CD25+CD45RA- memory regulatory T cells, donor1	11782-124A9	27.79	4.93	1.34	6.28	0.45	0.90	0.00	0.00	0.00	0.00
CD4+CD25+CD45RA- memory regulatory T cells, donor2	11797-124C6	33.19	11.18	1.05	7.69	1.05	1.75	1.40	0.35	0.00	0.00
CD4+CD25+CD45RA- memory regulatory T cells, donor3	11908-125F9	22.44	5.72	0.44	13.64	0.00	0.44	0.88	0.00	0.00	0.00
CD4+CD25-CD45RA+ naive conventional T cells expanded, donor1	11791-124B9	13.91	10.54	0.00	9.70	0.00	0.84	0.42	1.26	0.42	0.00
CD4+CD25-CD45RA+ naive conventional T cells expanded, donor2	11913-125G5	23.06	13.30	1.87	8.52	1.25	0.62	0.00	0.21	0.00	0.00
CD4+CD25-CD45RA+ naive conventional T cells expanded, donor3	11917-125G9	20.05	20.72	1.00	6.68	0.00	0.67	0.33	0.33	0.00	0.00
CD4+CD25-CD45RA+ naive conventional T cells, donor1	11784-124B2	34.81	14.68	2.72	13.32	0.54	0.27	0.82	0.27	0.00	0.00
CD4+CD25-CD45RA+ naive conventional T cells, donor2	11795-124C4	40.20	8.04	2.68	15.01	1.07	0.54	0.54	0.54	0.00	0.00
CD4+CD25-CD45RA+ naive conventional T cells, donor3	11906-125F7	19.73	10.76	3.59	17.93	0.00	1.79	0.00	0.00	0.00	0.00
CD4+CD25-CD45RA- memory conventional T cells expanded, donor1	11792-124C1	19.10	10.57	1.11	10.01	1.11	0.37	0.56	0.00	0.00	0.00
CD4+CD25-CD45RA- memory conventional T cells expanded, donor2	11914-125G6	24.26	16.03	1.08	6.50	1.08	1.08	0.43	0.00	0.43	0.00
CD4+CD25-CD45RA- memory conventional T cells expanded, donor3	11918-125H1	22.91	13.24	0.63	10.72	0.21	1.05	0.42	0.42	0.00	0.00
CD4+CD25-CD45RA- memory conventional T cells, donor1	11786-124B4	37.41	10.11	1.01	12.13	1.01	0.00	0.00	1.01	0.00	0.00
CD4+CD25-CD45RA- memory conventional T cells, donor2	11798-124C7	39.86	23.40	0.87	11.26	0.43	1.30	0.00	0.87	0.00	0.00
CD4+CD25-CD45RA- memory conventional T cells, donor3	11909-125G1	21.35	9.59	1.31	10.02	0.00	1.31	0.44	0.00	0.00	0.00
CD8+ T Cells (pluriselect), donor090309, donation1	12186-129A8	51.96	14.35	2.97	10.89	1.48	2.47	0.00	0.49	0.00	0.00
CD8+ T Cells (pluriselect), donor090309, donation2	12191-129B4	26.77	10.16	4.62	13.85	0.00	0.92	0.00	0.00	0.00	0.00
CD8+ T Cells (pluriselect), donor090309, donation3	12196-129B9	41.87	13.96	1.40	11.17	1.40	2.79	0.00	1.40	0.00	0.00
CD8+ T Cells (pluriselect), donor090325, donation1	12148-128F6	62.03	14.95	3.05	9.14	0.83	0.55	0.55	0.00	0.00	0.00
CD8+ T Cells (pluriselect), donor090325, donation2	12171-128I2	48.10	10.06	3.44	13.74	0.49	0.98	0.98	0.25	0.00	0.00
CD8+ T Cells (pluriselect), donor090612, donation1	12201-129C5	35.42	10.78	0.00	12.32	0.00	0.00	0.00	1.54	0.00	0.00
CD8+ T Cells (pluriselect), donor090612, donation2	12206-129D1	65.54	16.83	5.73	10.74	1.07	0.72	0.72	0.72	0.00	0.00
CD8+ T Cells (pluriselect), donor090612, donation3	12211-129D6	55.40	23.54	0.00	18.00	1.38	1.38	0.00	0.00	0.00	0.00
CD8+ T Cells, donor1	11226-116C2	28.81	10.48	3.27	5.89	0.00	0.00	0.33	0.00	0.00	0.00
CD8+ T Cells, donor2	11307-117C2	27.41	9.76	1.88	6.38	0.38	0.75	0.75	0.75	0.00	0.00
CD8+ T Cells, donor3	11383-118B6	42.67	10.60	4.80	9.85	0.50	0.00	0.50	0.25	0.00	0.00
COBL-a rinderpest infection, 00hr, biol_rep1	13553-145I7	41.52	11.47	5.51	2.75	0.23	1.38	2.06	0.69	0.23	0.00
COBL-a rinderpest infection, 00hr, biol_rep2	13554-145I8	32.11	7.91	5.03	2.40	0.48	1.44	0.72	0.24	0.24	0.00
COBL-a rinderpest infection, 00hr, biol_rep3	13555-145I9	45.69	8.21	7.11	1.09	0.00	1.09	1.64	0.00	0.00	0.00
COBL-a rinderpest infection, 06hr, biol_rep1	13556-146A1	29.12	3.90	3.30	1.50	0.90	0.30	1.20	0.60	0.00	0.00
COBL-a rinderpest infection, 06hr, biol_rep2	13557-146A2	46.32	12.24	9.12	2.88	0.72	0.72	0.72	0.48	0.00	0.00
COBL-a rinderpest infection, 06hr, biol_rep3	13558-146A3	43.89	8.19	6.37	2.27	0.45	1.82	1.14	0.68	0.00	0.00
COBL-a rinderpest infection, 12hr, biol_rep1	13559-146A4	41.72	7.82	5.87	1.52	0.43	0.65	0.87	0.00	0.22	0.00
COBL-a rinderpest infection, 12hr, biol_rep2	13560-146A5	27.37	5.53	4.74	3.42	0.53	1.58	1.05	0.53	0.00	0.00
COBL-a rinderpest infection, 12hr, biol_rep3	13561-146A6	29.31	7.74	7.04	3.05	1.17	0.70	1.41	1.17	0.00	0.00
COBL-a rinderpest infection, 24hr, biol_rep1	13562-146A7	28.98	5.43	7.85	1.21	0.30	0.00	0.91	0.60	0.00	0.00
COBL-a rinderpest infection, 24hr, biol_rep2	13563-146A8	34.86	9.88	6.39	1.74	1.45	1.16	0.29	0.29	0.29	0.00
COBL-a rinderpest infection, 24hr, biol_rep3	13564-146A9	30.91	10.12	7.19	1.87	0.80	0.80	1.33	1.07	0.00	0.00
COBL-a rinderpest infection, 48hr, biol_rep1	13565-146B1	46.40	5.69	12.26	2.63	0.44	2.19	0.88	0.44	0.44	0.00
COBL-a rinderpest infection, 48hr, biol_rep2	13566-146B2	43.72	5.92	6.83	0.91	1.37	0.46	0.91	0.46	0.00	0.00
COBL-a rinderpest infection, 48hr, biol_rep3	13567-146B3	41.77	2.98	9.70	0.00	2.24	0.00	0.00	0.00	0.00	0.00
COBL-a rinderpest(-C) infection, 06hr, biol_rep1	13568-146B4	38.54	10.80	10.80	2.16	0.36	1.44	0.36	0.00	0.00	0.00
COBL-a rinderpest(-C) infection, 06hr, biol_rep2	13569-146B5	44.31	11.80	9.49	1.73	0.58	2.88	0.29	0.00	0.00	0.00
COBL-a rinderpest(-C) infection, 06hr, biol_rep3	13570-146B6	57.75	10.84	9.19	3.06	1.18	1.89	1.65	0.47	0.24	0.00
COBL-a rinderpest(-C) infection, 12hr, biol_rep1	13571-146B7	33.59	5.70	6.97	0.95	0.63	0.95	0.00	0.00	0.00	0.00
COBL-a rinderpest(-C) infection, 12hr, biol_rep2	13572-146B8	29.22	9.53	9.23	1.54	1.23	0.62	0.92	1.23	0.31	0.00
COBL-a rinderpest(-C) infection, 12hr, biol_rep3	13573-146B9	28.53	7.37	6.41	2.89	0.00	0.64	0.64	0.00	0.00	0.00
COBL-a rinderpest(-C) infection, 24hr, biol_rep1	13574-146C1	30.60	7.27	6.88	1.53	0.38	1.53	0.38	0.00	0.00	0.00
COBL-a rinderpest(-C) infection, 24hr, biol_rep2	13575-146C2	35.08	6.70	3.94	1.58	0.00	0.00	0.79	0.39	0.39	0.00
COBL-a rinderpest(-C) infection, 24hr, biol_rep3	13576-146C3	31.01	6.05	3.03	3.03	0.00	2.27	1.51	0.76	0.00	0.00
COBL-a rinderpest(-C) infection, 48hr, biol_rep1	13577-146C4	85.11	12.04	18.47	4.82	1.61	1.61	0.80	0.80	0.00	0.00
COBL-a rinderpest(-C) infection, 48hr, biol_rep2	13578-146C5	114.01	18.19	19.58	9.09	0.00	0.70	0.70	2.10	0.00	0.00
COBL-a rinderpest(-C) infection, 48hr, biol_rep3	13579-146C6	103.18	20.04	17.03	7.01	0.00	3.01	4.01	0.00	0.00	0.00
Cardiac Myocyte, donor1	11525-119I4	67.63	3.66	16.45	3.66	1.83	1.83	0.00	0.00	0.00	0.00
Cardiac Myocyte, donor2	11605-120I3	50.89	10.87	4.94	0.00	4.94	0.00	0.49	0.00	0.00	0.00
Cardiac Myocyte, donor3	11686-122I3	69.77	9.37	6.95	0.95	2.84	1.79	0.21	0.00	0.11	0.00
Chondrocyte - de diff, donor1	11261-116G1	260.00	25.31	27.04	3.12	4.16	4.85	4.85	0.69	0.00	0.00
Chondrocyte - de diff, donor2	11338-117F6	68.59	11.02	9.24	2.13	2.49	0.36	3.20	0.00	0.00	0.00
Chondrocyte - de diff, donor3	11410-118E6	142.34	23.44	21.39	2.84	3.87	2.05	2.84	0.46	0.68	0.11
Chondrocyte - re diff, donor2	11339-117F7	100.27	9.85	12.53	0.90	4.48	0.90	3.58	0.00	0.00	0.00
Chondrocyte - re diff, donor3	11411-118E7	114.04	13.35	17.79	4.85	2.43	1.62	4.85	0.40	0.00	0.00
Ciliary Epithelial Cells, donor1	11242-116D9	55.89	16.18	4.93	1.49	3.33	1.95	1.03	0.46	0.23	0.00
Ciliary Epithelial Cells, donor2	11323-117D9	59.00	12.18	7.05	2.35	4.06	1.28	1.50	0.43	0.00	0.00
Ciliary Epithelial Cells, donor3	11399-118D4	49.74	13.45	5.31	1.86	3.89	2.12	0.44	0.09	0.27	0.00
Clontech Human Universal Reference Total RNA, pool1	10000-101A1	92.07	21.46	11.37	7.79	4.13	2.38	2.02	0.55	0.00	0.18
Corneal Epithelial Cells, donor1	11526-119I5	57.09	9.44	4.61	1.76	0.44	1.10	0.66	0.66	0.00	0.00
Corneal Epithelial Cells, donor2	11606-120I4	23.89	11.38	0.00	0.00	0.00	1.14	0.00	0.00	0.00	0.00
Corneal Epithelial Cells, donor3	11687-122I4	53.17	10.74	7.16	1.53	2.56	2.81	1.02	0.51	0.00	0.00
Dendritic Cells - monocyte immature derived, donor1, rep2	11227-116C3	266.46	24.27	40.45	2.97	1.82	4.13	2.97	1.49	0.17	0.00
Dendritic Cells - monocyte immature derived, donor1, tech_rep1	11227-116C3	276.61	20.82	48.26	2.84	2.21	5.36	0.32	0.32	1.26	0.00
Dendritic Cells - monocyte immature derived, donor2	11308-117C3	162.18	10.35	37.96	0.00	3.45	0.00	0.00	0.00	3.45	0.00
Dendritic Cells - monocyte immature derived, donor3	11384-118B7	227.53	21.92	49.03	3.24	3.24	3.78	4.64	3.67	1.08	0.00
Dendritic Cells - plasmacytoid, donor1	11228-116C4	185.17	18.45	19.13	6.15	0.68	1.37	0.68	0.68	0.34	0.00
Dendritic Cells - plasmacytoid, donor2	11309-117C4	195.21	22.85	22.85	5.22	0.65	1.96	1.96	0.00	0.00	0.00
Dendritic Cells - plasmacytoid, donor3	11385-118B8	161.64	15.97	7.26	9.68	1.45	1.94	0.48	1.94	0.48	0.00
Endothelial Cells - Aortic, donor0	11207-116A1	138.92	15.01	20.18	1.33	1.33	2.00	1.17	0.00	0.33	0.00
Endothelial Cells - Aortic, donor1	11263-116G3	123.22	9.39	26.99	0.59	2.93	1.17	2.35	0.00	0.00	0.00
Endothelial Cells - Aortic, donor2	11340-117F8	154.12	15.55	20.64	0.28	2.83	1.13	1.41	0.28	0.57	0.00
Endothelial Cells - Aortic, donor3	11412-118E8	82.18	15.73	19.66	2.75	0.39	1.18	0.39	0.39	0.00	0.00
Endothelial Cells - Artery, donor1	11264-116G4	193.72	12.22	28.80	0.58	6.11	1.16	3.78	2.33	0.29	0.00
Endothelial Cells - Artery, donor2	11341-117F9	105.64	15.76	28.47	0.47	3.29	3.29	6.82	1.41	0.24	0.00
Endothelial Cells - Artery, donor3	11413-118E9	115.70	16.13	24.54	1.05	1.93	1.75	0.70	0.18	0.53	0.18
Endothelial Cells - Lymphatic, donor1	11236-116D3	183.97	9.75	34.58	2.22	1.55	0.89	1.33	1.77	0.44	0.00
Endothelial Cells - Lymphatic, donor2	11317-117D3	183.78	12.78	31.34	3.35	0.61	2.13	2.43	0.30	0.30	0.00
Endothelial Cells - Lymphatic, donor3	11393-118C7	108.81	7.05	14.10	2.26	0.85	1.13	0.56	1.13	0.00	0.00
Endothelial Cells - Microvascular, donor1	11265-116G5	197.89	17.83	12.78	0.30	3.27	2.08	2.97	0.89	0.00	0.00
Endothelial Cells - Microvascular, donor2	11342-117G1	87.99	11.98	16.66	1.04	1.04	0.00	2.08	0.52	0.00	0.00
Endothelial Cells - Microvascular, donor3	11414-118F1	180.21	28.07	37.29	1.13	3.40	1.70	3.83	1.13	0.28	0.14
Endothelial Cells - Thoracic, donor1	11266-116G6	177.65	14.40	12.00	1.60	3.20	2.00	1.20	0.00	0.00	0.40
Endothelial Cells - Thoracic, donor2	11343-117G2	183.44	26.21	16.77	0.00	1.57	2.10	2.62	0.00	0.00	0.52
Endothelial Cells - Umbilical vein, donor1	11243-116E1	141.02	18.39	20.00	2.73	1.74	1.86	1.24	0.99	0.25	0.00
Endothelial Cells - Umbilical vein, donor2	11324-117E1	139.48	14.77	24.99	1.09	2.17	2.39	0.87	0.00	0.22	0.22
Endothelial Cells - Umbilical vein, donor3	11400-118D5	134.71	16.00	27.60	4.03	3.42	2.93	1.71	0.49	0.00	0.00
Endothelial Cells - Vein, donor1	11267-116G7	113.75	15.93	17.06	0.00	1.14	0.00	1.14	1.14	0.00	0.00
Endothelial Cells - Vein, donor2	11344-117G3	105.47	15.37	11.18	0.70	1.40	1.40	0.00	0.70	0.00	0.00
Endothelial Cells - Vein, donor3	11416-118F3	172.39	17.58	27.95	1.26	1.73	2.04	1.41	0.63	0.16	0.00
Eosinophils, donor1	12244-129H3	91.48	0.00	15.25	0.00	0.00	15.25	0.00	0.00	0.00	0.00
Eosinophils, donor2	12245-129H4	570.99	56.11	42.91	8.25	0.00	3.30	6.60	1.65	0.00	0.00
Eosinophils, donor3	12246-129H5	649.16	57.07	32.10	3.57	3.57	3.57	0.00	0.00	0.00	0.00
Esophageal Epithelial Cells, donor1	11507-119G4	41.29	7.82	4.64	0.73	1.95	0.49	0.24	0.24	0.00	0.00
Esophageal Epithelial Cells, donor2	11587-120G3	43.68	10.40	4.16	2.08	0.00	0.00	2.08	0.00	0.00	0.00
Esophageal Epithelial Cells, donor3	11668-122G3	130.15	0.00	16.27	16.27	0.00	0.00	0.00	0.00	0.00	0.00
Ewing's sarcoma cell line:Hs 863.T	10705-109H3	96.47	10.67	17.24	3.28	3.28	4.11	1.23	1.64	0.00	0.00
Fibroblast - Aortic Adventitial donor2 (cytoplasmic fraction)	14331-155F2	102.15	9.53	46.75	1.75	2.41	3.28	9.42	4.49	1.53	0.22
Fibroblast - Aortic Adventitial donor3 (cytoplasmic fraction)	14310-155C8	256.11	25.35	59.91	1.63	3.90	3.25	10.08	3.58	1.41	0.11
Fibroblast - Aortic Adventitial, donor1	11245-116E3	122.13	11.64	20.50	1.21	2.67	2.06	2.67	0.61	0.12	0.00
Fibroblast - Aortic Adventitial, donor2 (nuclear fraction)	14332-155F3	46.54	3.96	8.32	3.55	0.68	0.68	1.36	0.27	0.00	0.96
Fibroblast - Aortic Adventitial, donor2	11326-117E3	129.83	14.45	28.27	2.00	3.38	1.90	3.16	2.95	0.95	0.11
Fibroblast - Aortic Adventitial, donor3 (nuclear fraction)	14311-155C9	35.31	4.22	3.95	2.11	0.53	0.79	0.26	0.53	0.00	0.00
Fibroblast - Aortic Adventitial, donor3	11401-118D6	151.48	17.61	27.90	1.00	3.99	1.99	3.99	1.33	0.00	0.00
Fibroblast - Cardiac, donor1	11268-116G8	83.47	10.89	9.53	0.45	3.18	0.45	1.81	0.45	0.00	0.00
Fibroblast - Cardiac, donor2	11345-117G4	46.23	9.10	5.31	0.76	1.52	1.52	0.00	1.52	0.00	0.00
Fibroblast - Cardiac, donor3	11417-118F4	195.09	30.28	22.87	0.95	5.84	4.26	3.94	1.89	0.47	0.16
Fibroblast - Cardiac, donor4	11452-119A3	90.33	10.31	13.34	1.21	4.24	1.21	2.42	0.00	0.00	0.00
Fibroblast - Cardiac, donor5	11456-119A7	103.05	17.51	15.74	2.28	2.66	2.16	1.65	0.63	0.00	0.00
Fibroblast - Cardiac, donor6	11460-119B2	73.98	9.70	12.28	1.97	2.27	1.36	0.91	1.67	0.00	0.00
Fibroblast - Choroid Plexus, donor1	11492-119E7	81.87	12.86	5.09	1.21	2.55	1.61	0.27	0.13	0.00	0.00
Fibroblast - Choroid Plexus, donor2	11572-120E6	73.77	8.63	6.47	0.43	2.59	0.86	1.29	0.43	1.29	0.00
Fibroblast - Choroid Plexus, donor3	11653-122E6	46.87	13.18	1.46	1.46	0.00	1.46	1.46	0.00	0.00	0.00
Fibroblast - Conjunctival, donor1	11531-120A1	89.49	11.30	6.69	0.92	2.08	2.31	0.69	0.23	0.00	0.00
Fibroblast - Conjunctival, donor3	11692-122I9	85.65	21.54	16.96	2.54	2.54	1.53	2.04	0.51	0.17	0.00
Fibroblast - Dermal, donor1	11269-116G9	141.57	15.26	27.00	1.17	3.29	1.41	4.23	0.23	0.00	0.00
Fibroblast - Dermal, donor2	11346-117G5	182.54	16.51	22.17	0.00	2.36	1.42	1.42	1.42	0.00	0.00
Fibroblast - Dermal, donor3	11418-118F5	229.44	19.22	49.56	1.33	1.93	1.45	4.23	1.45	0.60	0.12
Fibroblast - Dermal, donor4	11450-119A1	65.68	13.57	8.03	1.70	2.60	1.47	0.68	0.45	0.00	0.00
Fibroblast - Dermal, donor5	11454-119A5	11.69	8.20	9.07	1.74	2.97	1.57	1.05	0.87	0.00	0.00
Fibroblast - Dermal, donor6	11458-119A9	37.03	8.93	10.07	1.62	3.90	1.95	1.30	0.49	0.32	0.00
Fibroblast - Gingival, donor1	11237-116D4	124.52	10.20	20.82	3.12	1.04	1.67	1.46	0.21	0.21	0.21
Fibroblast - Gingival, donor10 (periodontitis)	11928-125I2	151.17	15.46	26.72	2.10	1.57	1.83	3.93	2.10	1.05	0.26
Fibroblast - Gingival, donor2	11318-117D4	106.88	14.89	18.85	3.29	2.24	2.64	3.16	1.32	0.26	0.00
Fibroblast - Gingival, donor3	11394-118C8	130.14	17.50	26.30	2.80	1.74	1.06	1.84	0.77	0.29	0.00
Fibroblast - Gingival, donor4 (GFH2)	11222-116B7	236.87	25.97	35.32	2.08	2.08	4.16	2.08	0.00	2.08	0.00
Fibroblast - Gingival, donor5 (GFH3)	11303-117B7	212.85	27.84	36.47	2.11	1.76	1.76	6.17	3.35	1.94	0.00
Fibroblast - Gingival, donor6 (aggressive periodontitis)	11921-125H4	116.77	13.41	19.64	1.40	1.09	1.87	0.62	0.94	0.78	0.16
Fibroblast - Gingival, donor6 (control)	11922-125H5	77.21	11.36	10.55	2.16	1.49	1.22	1.49	0.41	0.41	0.00
Fibroblast - Gingival, donor7 (aggressive periodontitis)	11923-125H6	263.95	28.58	44.11	1.76	3.18	7.06	1.06	0.35	0.35	0.00
Fibroblast - Gingival, donor7 (control)	11924-125H7	102.96	14.62	15.06	3.07	0.88	1.32	1.46	0.15	1.17	0.15
Fibroblast - Gingival, donor8 (chronic periodontitis)	11925-125H8	76.22	12.14	12.27	1.36	0.68	1.09	2.73	1.09	0.41	0.00
Fibroblast - Gingival, donor8 (control)	11926-125H9	121.32	16.12	18.43	1.10	1.65	2.19	2.19	1.65	0.77	0.00
Fibroblast - Gingival, donor9 (control)	11927-125I1	93.03	14.82	9.98	3.23	2.05	0.59	1.91	0.73	1.91	0.15
Fibroblast - Lung, donor1	11270-116H1	55.73	21.75	5.44	1.36	2.72	1.36	0.00	0.00	0.00	0.00
Fibroblast - Lung, donor2	11347-117G6	53.72	16.41	1.49	2.98	2.98	0.00	2.98	0.00	0.00	0.00
Fibroblast - Lung, donor3	11419-118F6	142.66	29.76	18.57	1.06	6.33	3.17	3.38	2.11	0.21	0.00
Fibroblast - Lymphatic, donor1	11506-119G3	69.97	19.16	8.33	0.83	2.50	2.50	0.00	0.00	0.00	0.00
Fibroblast - Lymphatic, donor2	11586-120G2	125.88	18.18	12.59	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Fibroblast - Lymphatic, donor3	11667-122G2	96.00	16.23	14.55	1.40	1.68	2.24	1.12	0.56	0.00	0.00
Fibroblast - Mammary, donor1	11540-120B1	108.39	8.12	14.61	2.03	4.47	3.65	0.81	0.00	0.00	0.00
Fibroblast - Mammary, donor2	11620-122A9	143.79	15.98	11.98	0.00	3.99	0.00	0.00	0.00	0.00	0.00
Fibroblast - Mammary, donor3	11701-123A9	101.26	5.96	23.83	0.00	5.96	5.96	0.00	0.00	0.00	0.00
Fibroblast - Periodontal Ligament, donor1	11238-116D5	91.75	9.50	10.28	1.94	0.78	2.33	0.58	0.19	0.00	0.00
Fibroblast - Periodontal Ligament, donor2	11319-117D5	83.12	14.41	6.83	2.28	2.43	3.03	1.21	0.30	0.15	0.00
Fibroblast - Periodontal Ligament, donor3	11395-118C9	161.87	13.16	21.42	2.14	0.92	0.92	0.31	0.00	0.00	0.00
Fibroblast - Periodontal Ligament, donor4 (PL29)	11223-116B8	88.16	12.98	13.36	1.91	3.05	3.05	1.14	1.14	0.38	0.38
Fibroblast - Periodontal Ligament, donor5 (PL30)	11304-117B8	193.31	23.22	37.53	1.62	3.24	1.62	4.59	1.35	1.08	0.00
Fibroblast - Periodontal Ligament, donor6 (PLH3)	11380-118B3	214.32	26.79	43.61	2.78	4.87	2.32	4.87	1.62	0.81	0.12
Fibroblast - Pulmonary Artery, donor1	11250-116E8	77.48	10.72	14.15	0.44	1.88	1.66	0.66	0.44	0.11	0.00
Fibroblast - Villous Mesenchymal, donor1	11535-120A5	107.28	10.77	13.82	1.83	2.64	1.22	0.61	0.00	0.00	0.00
Fibroblast - Villous Mesenchymal, donor2	11615-122A4	136.31	14.03	30.07	1.34	2.00	4.01	1.34	0.67	0.67	0.00
Fibroblast - Villous Mesenchymal, donor3	11696-123A4	156.17	18.98	29.65	1.58	5.54	1.19	1.98	0.79	0.79	0.00
Fibroblast - skin dystrophia myotonica, donor1 (nuclear fraction)	14329-155E9	35.72	4.17	2.78	3.77	0.40	0.99	0.20	0.20	0.00	0.20
Fibroblast - skin dystrophia myotonica, donor1	11556-120C8	130.02	10.66	13.85	3.02	1.78	1.60	1.78	0.36	0.00	0.00
Fibroblast - skin dystrophia myotonica, donor2	11557-120C9	94.80	10.64	10.64	1.58	1.18	0.99	1.18	0.39	0.20	0.00
Fibroblast - skin dystrophia myotonica, donor3 (nuclear fraction)	14308-155C6	28.88	2.41	3.61	3.61	0.90	0.00	1.20	0.00	0.00	0.00
Fibroblast - skin dystrophia myotonica, donor3	11560-120D3	103.42	12.63	7.66	2.37	2.27	0.54	1.08	2.16	0.32	0.00
Fibroblast - skin normal, donor1 (nuclear fraction)	14323-155E3	35.43	2.53	2.28	6.07	0.25	0.51	0.51	1.01	0.00	0.00
Fibroblast - skin normal, donor1	11553-120C5	162.77	13.45	9.68	2.79	2.13	1.48	1.97	1.48	0.16	0.00
Fibroblast - skin normal, donor2 (nuclear fraction)	14302-155B9	59.15	7.22	5.01	2.41	1.20	0.60	0.60	0.20	0.20	0.00
Fibroblast - skin normal, donor2	11561-120D4	153.71	12.66	9.95	1.91	3.21	1.81	2.21	2.51	0.60	0.10
Fibroblast - skin spinal muscular atrophy, donor1 (nuclear fraction)	14326-155E6	29.32	4.84	2.72	6.04	0.30	0.60	0.60	0.30	0.00	0.00
Fibroblast - skin spinal muscular atrophy, donor1	11555-120C7	106.95	16.57	14.25	3.48	1.49	1.33	1.16	0.50	0.08	0.00
Fibroblast - skin spinal muscular atrophy, donor2	11558-120D1	116.76	16.75	5.47	2.74	1.54	1.54	1.37	2.56	0.00	0.00
Fibroblast - skin spinal muscular atrophy, donor3 (nuclear fraction)	14305-155C3	22.33	5.58	2.30	1.31	0.33	0.00	0.33	0.00	0.00	0.00
Fibroblast - skin spinal muscular atrophy, donor3	11559-120D2	183.64	13.63	13.21	2.45	3.30	2.88	2.24	2.34	0.21	0.00
Fibroblast - skin walker warburg, donor1	11554-120C6	101.88	8.27	9.95	1.01	2.02	1.01	1.01	0.67	0.17	0.00
Fibroblast - skin, normal donor1 (cytoplasmic fraction)	14322-155E2	268.00	16.78	20.23	0.94	3.14	2.67	21.64	5.18	3.29	0.00
Fibroblast - skin, normal donor2 (cytoplasmic fraction)	14301-155B8	243.76	0.00	22.16	0.00	0.00	0.00	110.80	0.00	0.00	0.00
Fingernail (including nail plate, eponychium and hyponychium), donor2	10301-104H4	15.69	9.59	1.74	6.10	0.00	0.00	0.87	1.74	0.00	0.00
Gingival epithelial cells, donor1 (GEA11)	11221-116B6	133.66	13.35	20.46	0.35	0.69	1.73	0.69	1.04	0.00	0.00
Gingival epithelial cells, donor2 (GEA14)	11302-117B6	64.54	11.71	7.03	1.04	0.78	0.52	1.04	0.26	0.00	0.26
Gingival epithelial cells, donor3 (GEA15)	11379-118B2	87.64	8.18	14.56	0.77	2.56	1.28	1.02	0.51	0.00	0.00
H1 embryonic stem cells differentiation to CD34+ HSC, day00, biol_rep1	13523-145F4	72.73	30.62	7.66	1.53	4.59	2.30	5.36	1.53	0.00	0.00
H1 embryonic stem cells differentiation to CD34+ HSC, day00, biol_rep2	13524-145F5	56.15	17.87	5.74	1.28	1.91	1.28	2.55	1.28	0.00	0.00
H1 embryonic stem cells differentiation to CD34+ HSC, day00, biol_rep3	13525-145F6	141.78	39.08	10.84	1.71	5.42	0.57	5.13	4.28	2.00	0.00
H1 embryonic stem cells differentiation to CD34+ HSC, day03, biol_rep1	13526-145F7	166.28	28.95	18.20	13.51	8.82	1.93	7.45	1.65	0.55	0.00
H1 embryonic stem cells differentiation to CD34+ HSC, day03, biol_rep2	13527-145F8	96.58	26.26	13.01	7.99	4.57	2.74	5.25	2.05	1.37	0.00
H1 embryonic stem cells differentiation to CD34+ HSC, day03, biol_rep3	13528-145F9	147.81	39.63	20.80	3.37	6.54	1.78	3.17	2.18	0.59	0.00
H1 embryonic stem cells differentiation to CD34+ HSC, day09, biol_rep1	13529-145G1	186.09	36.21	19.83	8.99	5.02	0.79	6.87	3.17	1.06	0.00
H1 embryonic stem cells differentiation to CD34+ HSC, day09, biol_rep2	13530-145G2	130.78	29.35	18.92	10.44	4.89	1.63	3.59	0.65	0.65	0.00
H1 embryonic stem cells differentiation to CD34+ HSC, day09, biol_rep3	13531-145G3	87.12	31.84	8.84	3.10	6.19	0.00	1.33	2.65	0.88	0.00
H9 Embryoid body cells, melanocytic induction, day00, biol_rep1 (H9EB-1 d0)	12627-134E8	83.24	20.77	12.01	3.11	2.69	1.13	3.25	1.27	0.00	0.00
H9 Embryoid body cells, melanocytic induction, day00, biol_rep2 (H9EB-2 d0)	12725-135G7	112.92	20.44	20.69	3.69	5.17	1.97	2.09	2.09	0.86	0.12
H9 Embryoid body cells, melanocytic induction, day00, biol_rep3 (H9EB-3 d0)	12823-136I6	93.21	15.85	15.85	1.07	3.49	2.95	0.81	1.07	0.54	0.00
H9 Embryoid body cells, melanocytic induction, day01, biol_rep1 (H9EB-1 d1)	12628-134E9	166.27	21.43	26.27	3.59	3.10	2.11	2.11	2.11	0.25	0.00
H9 Embryoid body cells, melanocytic induction, day01, biol_rep2 (H9EB-2 d1)	12726-135G8	113.51	17.86	21.18	2.77	1.66	0.83	2.21	0.83	0.42	0.00
H9 Embryoid body cells, melanocytic induction, day01, biol_rep3 (H9EB-3 d1)	12824-136I7	88.44	17.08	15.04	1.83	2.85	2.24	2.24	1.83	0.20	0.00
H9 Embryoid body cells, melanocytic induction, day03, biol_rep1 (H9EB-1 d3)	12629-134F1	149.23	22.13	27.61	1.83	3.42	2.51	2.05	1.14	0.46	0.00
H9 Embryoid body cells, melanocytic induction, day03, biol_rep2 (H9EB-2 d3)	12727-135G9	154.46	17.19	30.39	3.74	3.61	1.37	4.48	1.99	0.25	0.00
H9 Embryoid body cells, melanocytic induction, day03, biol_rep3 (H9EB-3 d3)	12825-136I8	153.00	18.58	27.98	1.53	2.62	2.40	3.06	1.75	0.22	0.22
H9 Embryoid body cells, melanocytic induction, day06, biol_rep1 (H9EB-1 d6)	12630-134F2	163.10	18.02	30.73	4.43	4.14	2.07	5.61	1.77	0.59	0.00
H9 Embryoid body cells, melanocytic induction, day06, biol_rep2 (H9EB-2 d6)	12728-135H1	108.41	22.73	18.76	6.36	2.54	1.91	1.11	1.43	0.32	0.00
H9 Embryoid body cells, melanocytic induction, day06, biol_rep3 (H9EB-3 d6)	12826-136I9	134.72	20.33	21.00	1.34	2.46	2.68	1.79	0.45	0.00	0.00
H9 Embryoid body cells, melanocytic induction, day09, biol_rep1 (H9EB-1 d9)	12631-134F3	141.55	20.97	24.40	3.43	1.61	2.02	2.82	1.61	0.20	0.00
H9 Embryoid body cells, melanocytic induction, day09, biol_rep2 (H9EB-2 d9)	12729-135H2	115.36	19.85	17.30	3.90	2.21	1.53	2.88	2.37	0.34	0.17
H9 Embryoid body cells, melanocytic induction, day09, biol_rep3 (H9EB-3 d9)	12827-137A1	112.08	17.65	18.00	0.80	2.75	1.60	1.51	0.80	0.18	0.00
H9 Embryoid body cells, melanocytic induction, day12, biol_rep1 (H9EB-1 d12)	12632-134F4	193.54	27.57	20.29	4.16	2.71	1.56	2.29	0.10	0.31	0.10
H9 Embryoid body cells, melanocytic induction, day12, biol_rep1 (H9EB-1 d12)	12632-134F4	128.77	17.93	16.74	3.24	2.73	1.20	0.85	0.17	0.34	0.00
H9 Embryoid body cells, melanocytic induction, day12, biol_rep2 (H9EB-2 d12)	12730-135H3	154.58	20.91	23.35	5.31	2.99	2.21	2.21	1.11	0.66	0.11
H9 Embryoid body cells, melanocytic induction, day12, biol_rep3 (H9EB-3 d12)	12828-137A2	116.97	19.14	14.81	2.00	1.75	2.08	1.66	0.17	0.00	0.17
H9 Embryoid body cells, melanocytic induction, day12, biol_rep3 (H9EB-3 d12)	12828-137A2	83.92	14.70	11.03	1.43	1.63	1.02	2.04	0.41	0.00	0.00
H9 Embryoid body cells, melanocytic induction, day15, biol_rep1 (H9EB-1 d15)	12633-134F5	156.79	18.77	19.39	4.33	4.33	2.27	3.30	0.41	0.62	0.00
H9 Embryoid body cells, melanocytic induction, day15, biol_rep2 (H9EB-2 d15)	12731-135H4	143.31	21.79	20.64	5.42	3.00	1.61	1.61	1.04	0.35	0.00
H9 Embryoid body cells, melanocytic induction, day15, biol_rep3 (H9EB-3 d15)	12829-137A3	160.93	21.51	29.68	3.67	3.50	2.00	2.17	1.50	0.17	0.33
H9 Embryoid body cells, melanocytic induction, day18, biol_rep1 (H9EB-1 d18)	12634-134F6	168.63	21.16	29.98	2.42	3.09	1.98	1.54	1.10	0.44	0.22
H9 Embryoid body cells, melanocytic induction, day18, biol_rep2 (H9EB-2 d18)	12732-135H5	182.52	17.10	27.67	6.89	3.07	1.60	4.43	1.35	0.25	0.12
H9 Embryoid body cells, melanocytic induction, day18, biol_rep3 (H9EB-3 d18)	12830-137A4	121.57	17.02	17.02	4.21	1.46	1.30	2.11	1.46	0.16	0.16
H9 Embryoid body cells, melanocytic induction, day21, biol_rep1 (H9EB-1 d21)	12635-134F7	170.30	20.53	23.09	5.77	1.92	0.96	4.17	2.25	0.32	0.00
H9 Embryoid body cells, melanocytic induction, day21, biol_rep2 (H9EB-2 d21)	12733-135H6	150.66	16.68	24.64	3.41	2.75	1.80	2.75	1.04	0.76	0.00
H9 Embryoid body cells, melanocytic induction, day21, biol_rep3 (H9EB-3 d21)	12831-137A5	152.01	13.44	23.25	2.53	3.16	2.21	1.27	0.63	0.00	0.16
H9 Embryoid body cells, melanocytic induction, day24, biol_rep1 (H9EB-1 d24)	12636-134F8	135.32	13.68	18.85	3.04	0.61	2.43	3.34	0.61	0.00	0.61
H9 Embryoid body cells, melanocytic induction, day24, biol_rep2 (H9EB-2 d24)	12734-135H7	152.10	17.25	24.46	3.97	1.46	0.94	2.30	0.84	0.10	0.21
H9 Embryoid body cells, melanocytic induction, day24, biol_rep3 (H9EB-3 d24)	12832-137A6	157.64	19.54	17.34	3.73	1.98	1.98	2.42	0.88	0.66	0.44
H9 Embryoid body cells, melanocytic induction, day27, biol_rep1 (H9EB-1 d27)	12637-134F9	125.97	15.71	14.31	4.77	1.96	1.68	4.21	1.12	0.28	0.28
H9 Embryoid body cells, melanocytic induction, day27, biol_rep2 (H9EB-2 d27)	12735-135H8	114.34	12.13	20.09	2.96	0.46	0.83	1.39	3.52	1.20	0.19
H9 Embryoid body cells, melanocytic induction, day27, biol_rep3 (H9EB-3 d27)	12833-137A7	132.63	16.04	17.65	2.14	1.60	1.07	5.08	1.34	1.07	0.27
H9 Embryoid body cells, melanocytic induction, day30, biol_rep1 (H9EB-1 d30)	12638-134G1	147.65	16.07	20.50	1.53	1.53	1.07	2.45	0.92	0.00	0.46
H9 Embryoid body cells, melanocytic induction, day30, biol_rep2 (H9EB-2 d30)	12736-135H9	136.79	11.40	25.26	2.59	1.17	1.81	0.91	0.78	0.52	0.00
H9 Embryoid body cells, melanocytic induction, day30, biol_rep3 (H9EB-3 d30)	12834-137A8	159.39	16.81	29.00	4.88	3.25	2.17	2.17	0.00	0.54	0.27
H9 Embryoid body cells, melanocytic induction, day34, biol_rep1 (H9EB-1 d34)	12639-134G2	123.52	18.99	16.96	3.32	2.40	2.03	2.21	0.74	0.37	0.00
H9 Embryoid body cells, melanocytic induction, day34, biol_rep2 (H9EB-2 d34)	12737-135I1	120.84	14.04	16.67	3.07	1.10	0.88	3.29	0.66	0.44	0.00
H9 Embryoid body cells, melanocytic induction, day34, biol_rep3 (H9EB-3 d34)	12835-137A9	194.38	18.84	31.74	5.95	2.98	1.98	0.00	0.00	0.00	0.00
H9 Embryoid body cells, melanocytic induction, day41, biol_rep1 (H9EB-1 d41)	12640-134G3	113.58	14.25	18.86	1.32	1.45	1.32	1.58	1.19	0.40	0.13
H9 Embryoid body cells, melanocytic induction, day41, biol_rep2 (H9EB-2 d41)	12738-135I2	125.09	13.32	17.15	3.03	2.22	2.02	2.02	1.41	0.61	0.20
H9 Embryoid body cells, melanocytic induction, day41, biol_rep3 (H9EB-3 d41)	12836-137B1	216.04	29.99	30.25	5.34	3.30	5.08	0.51	0.00	0.00	0.00
H9 Embryonic Stem cells, biol_rep1 (H9ES-1)	12626-134E7	85.20	15.73	4.18	1.79	4.98	1.99	0.80	0.80	0.00	0.00
H9 Embryonic Stem cells, biol_rep2 (H9ES-2)	12724-135G6	105.08	20.95	18.64	3.54	3.70	2.16	1.69	0.92	0.46	0.15
H9 Embryonic Stem cells, biol_rep3 (H9ES-3)	12822-136I5	71.81	21.48	10.64	5.93	3.27	2.05	1.84	0.61	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day00, biol_rep1 (UH-1)	13364-143F7	68.22	18.15	10.95	0.94	3.13	2.82	0.94	1.56	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day00, biol_rep2 (UH-2)	13365-143F8	65.55	19.78	9.89	0.28	2.54	3.67	0.57	0.57	0.28	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day00, biol_rep3 (UH-3)	13366-143F9	27.21	12.91	0.92	1.38	4.61	1.38	3.23	0.46	0.46	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day01, biol_rep1	13328-143B7	111.37	12.37	9.90	4.95	9.90	0.00	2.47	0.00	2.47	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day01, biol_rep2	13340-143D1	61.89	17.41	9.28	1.55	3.87	1.16	1.16	1.93	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day01, biol_rep3	13352-143E4	70.60	14.44	4.81	1.60	1.60	3.21	3.21	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day02, biol_rep1	13329-143B8	85.20	13.91	12.17	3.48	8.69	3.48	0.00	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day02, biol_rep2	13341-143D2	66.07	19.85	9.11	2.93	3.91	1.95	4.23	1.63	0.33	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day02, biol_rep3	13353-143E5	49.42	14.82	6.59	3.71	4.12	1.65	2.47	0.82	0.00	0.41
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day03, biol_rep1	13330-143B9	106.63	6.66	6.66	3.33	6.66	0.00	3.33	6.66	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day03, biol_rep2	13342-143D3	49.22	16.50	9.23	2.52	2.24	0.28	1.12	0.28	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day03, biol_rep3	13354-143E6	55.89	15.03	6.21	1.63	3.27	0.98	0.65	0.65	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day04, biol_rep1	13331-143C1	76.33	21.81	10.90	6.71	0.84	0.84	2.52	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day04, biol_rep2	13343-143D4	60.12	18.13	2.54	3.82	3.18	1.27	1.27	0.64	0.32	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day04, biol_rep3	13355-143E7	51.97	19.02	5.09	3.06	4.08	1.36	1.70	0.68	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day05, biol_rep1	13332-143C2	79.35	8.35	4.18	4.18	6.26	0.00	2.09	2.09	2.09	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day05, biol_rep2	13344-143D5	58.99	26.92	5.73	2.86	1.15	2.29	1.72	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day05, biol_rep3	13356-143E8	58.01	24.27	4.44	1.48	3.26	2.07	1.48	0.59	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day06, biol_rep1	13333-143C3	60.99	11.86	6.78	3.39	3.39	0.00	3.39	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day06, biol_rep2	13345-143D6	58.40	14.91	5.38	2.07	1.66	1.24	3.31	1.66	0.41	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day06, biol_rep3	13357-143E9	54.54	14.50	4.14	2.53	2.53	1.15	2.53	0.46	0.23	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day07, biol_rep1	13334-143C4	68.49	21.07	5.27	5.27	5.27	5.27	10.54	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day07, biol_rep2	13346-143D7	43.05	10.38	4.23	1.15	3.08	1.54	1.54	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day07, biol_rep3	13358-143F1	62.26	19.23	6.19	2.28	1.96	0.65	0.98	0.65	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day08, biol_rep1	13335-143C5	137.11	32.10	14.71	3.34	4.68	2.01	1.34	2.01	0.67	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day08, biol_rep2	13347-143D8	76.67	26.97	6.16	5.78	3.08	1.93	4.62	1.93	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day08, biol_rep3	13359-143F2	84.56	21.91	9.24	3.08	0.68	2.05	2.05	1.03	0.34	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day09, biol_rep1	13336-143C6	104.36	12.42	9.94	4.97	0.00	0.00	4.97	2.48	2.48	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day09, biol_rep2	13348-143D9	111.36	27.37	6.61	6.61	3.77	2.36	2.36	1.42	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day09, biol_rep3	13360-143F3	103.20	29.57	4.83	6.64	2.41	1.21	1.81	1.21	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day10, biol_rep1	13337-143C7	112.93	17.80	8.65	8.14	2.54	0.00	2.03	1.53	1.02	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day10, biol_rep2	13349-143E1	83.36	27.52	6.38	5.18	2.79	1.60	2.79	0.40	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day10, biol_rep3	13361-143F4	97.19	22.69	7.40	7.40	5.92	0.99	2.47	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day11, biol_rep1	13338-143C8	88.53	17.71	8.26	5.90	4.72	0.00	1.18	2.36	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day11, biol_rep2	13350-143E2	91.02	17.50	4.08	5.83	4.08	2.92	1.17	0.58	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day11, biol_rep3	13362-143F5	79.44	19.75	8.34	10.53	3.51	0.88	2.63	1.76	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day12, biol_rep1	13339-143C9	62.73	14.41	9.32	5.93	1.70	0.00	1.70	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day12, biol_rep2	13351-143E3	49.54	13.13	2.98	4.18	3.58	0.60	1.19	0.60	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day12, biol_rep3	13363-143F6	39.79	15.04	6.31	0.97	2.43	1.46	0.49	0.49	0.00	0.00
Hair Follicle Dermal Papilla Cells, donor1	11271-116H2	101.58	13.70	11.41	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Hair Follicle Dermal Papilla Cells, donor2	11348-117G7	112.27	19.54	19.13	0.83	2.91	2.49	4.16	0.42	0.00	0.00
Hair Follicle Dermal Papilla Cells, donor3	11420-118F7	167.54	32.61	33.73	1.12	1.12	2.25	1.12	1.12	0.00	0.00
Hair Follicle Outer Root Sheath Cells, donor1	11504-119G1	97.69	11.73	17.76	2.54	0.95	0.63	1.59	0.63	0.32	0.32
Hair Follicle Outer Root Sheath Cells, donor2	11584-120F9	136.18	13.37	24.23	3.76	0.42	2.09	2.51	0.00	0.42	0.42
Hep-2 cells mock treated, biol_rep1	11898-125E8	42.70	12.53	5.34	0.81	2.55	1.51	1.16	0.58	0.12	0.12
Hep-2 cells mock treated, biol_rep2	11899-125E9	29.88	7.93	3.71	0.17	2.19	1.69	0.34	0.68	0.34	0.00
Hep-2 cells mock treated, biol_rep3	11900-125F1	32.31	11.15	4.55	0.91	1.59	0.23	1.59	0.23	0.00	0.23
Hep-2 cells treated with Streptococci strain 5448, biol_rep1	11890-125D9	44.27	12.24	8.09	0.66	3.50	1.20	0.87	0.87	0.22	0.22
Hep-2 cells treated with Streptococci strain 5448, biol_rep2	11891-125E1	42.98	8.60	5.59	0.86	3.01	1.50	0.86	0.21	0.21	0.00
Hep-2 cells treated with Streptococci strain 5448, biol_rep3	11892-125E2	33.58	8.18	4.09	0.43	1.51	1.51	0.65	0.43	0.00	0.22
Hep-2 cells treated with Streptococci strain JRS4, biol_rep1	11894-125E4	50.94	13.45	7.10	1.25	2.99	1.62	1.62	1.62	0.12	0.00
Hep-2 cells treated with Streptococci strain JRS4, biol_rep2	11895-125E5	40.14	9.78	4.97	0.86	1.37	1.03	1.20	0.51	0.17	0.17
Hep-2 cells treated with Streptococci strain JRS4, biol_rep3	11896-125E6	31.40	8.33	5.77	0.96	1.92	0.32	1.28	0.00	0.00	0.32
Hepatic Sinusoidal Endothelial Cells, donor1	11521-119H9	272.54	30.78	21.27	2.80	0.56	5.60	1.12	2.24	0.56	0.00
Hepatic Sinusoidal Endothelial Cells, donor2	11601-120H8	144.55	20.34	18.61	0.43	2.60	3.03	3.03	0.00	0.00	0.00
Hepatic Sinusoidal Endothelial Cells, donor3	11682-122H8	145.41	10.58	18.51	0.00	0.00	0.00	5.29	0.00	0.00	2.64
Hepatic Stellate Cells (lipocyte), donor1	11524-119I3	74.78	10.58	7.41	2.12	3.17	1.76	0.00	0.00	0.00	0.00
Hepatic Stellate Cells (lipocyte), donor2	11604-120I2	53.04	12.35	7.27	0.00	1.45	0.73	0.73	1.45	0.00	0.00
Hepatic Stellate Cells (lipocyte), donor3	11685-122I2	63.64	9.79	8.92	0.17	3.50	1.05	0.70	0.17	0.00	0.00
Hepatocyte, donor1	11523-119I2	90.80	20.58	7.26	1.21	3.63	0.00	2.42	0.00	0.00	0.00
Hepatocyte, donor2	11603-120I1	87.26	15.08	9.70	2.15	1.08	1.08	4.31	2.15	0.00	0.00
Hepatocyte, donor3	11684-122I1	67.49	9.82	0.61	2.45	0.61	1.84	0.61	0.61	0.00	0.00
Hodgkin's lymphoma cell line:HD-Mar2	10435-106E3	7.18	5.87	1.31	5.22	1.96	1.31	0.00	0.65	0.00	0.00
Intestinal epithelial cells (polarized), donor1	11246-116E4	99.28	15.21	23.77	5.59	1.92	2.27	1.40	0.52	0.17	0.35
Iris Pigment Epithelial Cells, donor1	11530-119I9	101.67	11.25	11.11	0.55	2.20	2.20	0.55	0.27	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr00min, biol_rep1	13079-140B1	19.10	6.37	0.00	3.18	9.55	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr00min, biol_rep2	13145-140I4	6.68	6.68	0.00	0.00	6.68	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr00min, biol_rep3	13211-141G7	27.08	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr15min, biol_rep1	13080-140B2	11.08	5.54	1.38	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr15min, biol_rep2	13146-140I5	7.51	5.01	2.50	0.00	2.50	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr15min, biol_rep3	13212-141G8	0.00	11.87	0.00	0.00	11.87	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr30min, biol_rep1	13081-140B3	7.69	7.69	2.56	5.13	10.25	2.56	0.00	2.56	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr30min, biol_rep2	13147-140I6	22.85	4.57	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr30min, biol_rep3	13213-141G9	24.36	3.25	0.00	0.00	0.00	0.00	1.62	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr45min, biol_rep1	13082-140B4	10.00	8.34	0.00	0.00	1.67	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr45min, biol_rep2	13148-140I7	3.63	0.00	3.63	0.00	3.63	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr45min, biol_rep3	13214-141H1	15.88	11.91	3.97	2.65	1.32	1.32	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr00min, biol_rep1	13083-140B5	17.74	4.43	0.00	1.11	4.43	1.11	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr00min, biol_rep2	13149-140I8	15.71	5.24	0.00	0.00	5.24	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr00min, biol_rep3	13215-141H2	13.23	4.41	1.26	3.15	2.52	1.89	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr20min, biol_rep1	13084-140B6	13.92	9.28	0.00	0.00	3.09	1.55	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr20min, biol_rep2	13150-140I9	14.63	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr20min, biol_rep3	13216-141H3	9.04	3.88	0.65	2.58	1.29	0.65	0.65	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr40min, biol_rep1	13085-140B7	17.71	8.05	0.00	0.00	1.61	3.22	1.61	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr40min, biol_rep2	13151-141A1	11.95	11.95	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr40min, biol_rep3	13217-141H4	13.04	9.78	0.00	0.00	1.63	0.81	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 02hr00min, biol_rep1	13086-140B8	13.01	8.40	1.26	1.26	1.26	0.42	0.84	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 02hr00min, biol_rep2	13152-141A2	14.37	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 02hr00min, biol_rep3	13218-141H5	8.84	4.82	0.00	0.00	2.41	0.80	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 02hr30min, biol_rep1	13087-140B9	8.31	3.69	0.00	0.00	2.77	3.69	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 02hr30min, biol_rep2	13153-141A3	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 02hr30min, biol_rep3	13219-141H6	13.22	6.14	1.89	1.42	1.42	0.47	1.89	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 03hr00min, biol_rep1	13088-140C1	8.16	5.44	3.63	0.00	1.81	0.91	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 03hr00min, biol_rep2	13154-141A4	0.00	0.00	0.00	14.74	0.00	14.74	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 03hr00min, biol_rep3	13220-141H7	18.29	6.46	3.23	3.23	0.00	1.08	0.00	1.08	0.00	0.00
K562 erythroblastic leukemia response to hemin, 03hr30min, biol_rep1	13089-140C2	16.52	8.89	0.00	1.27	2.54	0.00	1.27	1.27	0.00	0.00
K562 erythroblastic leukemia response to hemin, 03hr30min, biol_rep2	13155-141A5	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 03hr30min, biol_rep3	13221-141H8	19.77	7.65	1.91	0.64	1.28	0.64	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 04hr, biol_rep1	13090-140C3	7.29	7.29	0.00	0.00	3.65	0.00	1.82	0.00	1.82	0.00
K562 erythroblastic leukemia response to hemin, 04hr, biol_rep2	13156-141A6	15.80	0.00	0.00	0.00	15.80	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 04hr, biol_rep3	13222-141H9	15.00	6.43	0.71	0.00	1.43	0.71	0.00	0.71	0.00	0.00
K562 erythroblastic leukemia response to hemin, 06hr, biol_rep1	13091-140C4	3.32	3.32	0.00	3.32	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 06hr, biol_rep2	13157-141A7	0.00	20.85	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 06hr, biol_rep3	13223-141I1	8.03	4.32	0.93	1.23	1.54	1.23	0.62	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 12hr, biol_rep1	13092-140C5	7.02	7.02	0.00	0.00	1.76	1.76	1.76	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 12hr, biol_rep2	13158-141A8	9.43	3.14	0.00	0.00	3.14	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 12hr, biol_rep3	13224-141I2	11.13	7.65	0.70	2.09	0.70	2.09	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 24hr, biol_rep1	13093-140C6	22.13	4.43	0.00	2.21	0.00	2.21	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 24hr, biol_rep2	13159-141A9	9.73	6.48	3.24	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 24hr, biol_rep3	13225-141I3	16.57	12.21	0.87	4.36	2.62	3.49	0.87	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day02, biol_rep1	13094-140C7	9.00	6.75	2.25	2.25	0.00	2.25	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day02, biol_rep2	13160-141B1	13.94	3.48	0.00	3.48	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day02, biol_rep3	13226-141I4	17.07	8.53	3.20	3.20	0.00	0.00	0.00	1.07	0.00	0.00
K562 erythroblastic leukemia response to hemin, day03, biol_rep1	13095-140C8	9.70	4.16	4.16	0.00	2.77	1.39	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day03, biol_rep2	13161-141B2	5.70	0.00	0.00	0.00	5.70	2.85	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day03, biol_rep3	13227-141I5	12.89	6.44	4.60	3.68	3.68	1.84	0.92	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day04, biol_rep1	13096-140C9	33.28	27.23	0.00	0.00	3.03	3.03	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day04, biol_rep2	13162-141B3	12.42	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day04, biol_rep3	13228-141I6	27.49	19.03	3.17	4.23	3.17	2.11	0.00	0.00	0.00	0.00
Keratinocyte - epidermal, donor1	11272-116H3	63.89	12.40	9.55	0.73	0.90	0.98	1.06	0.41	0.24	0.00
Keratinocyte - epidermal, donor2	11349-117G8	59.73	9.96	4.10	0.00	0.00	0.59	0.00	0.00	0.00	0.00
Keratinocyte - epidermal, donor3	11421-118F8	56.13	13.16	8.52	0.95	0.95	0.95	0.57	0.47	0.19	0.00
Keratinocyte - oral, donor1	11251-116E9	39.73	9.88	3.97	0.91	1.02	2.27	0.57	0.23	0.00	0.00
Keratocytes, donor1	11527-119I6	296.73	14.78	28.54	7.91	2.41	2.75	0.34	0.69	0.00	0.00
Keratocytes, donor2	11607-120I5	80.85	10.55	8.20	1.17	4.69	3.52	0.00	2.34	0.00	0.00
Keratocytes, donor3	11688-122I5	208.47	15.02	21.34	5.93	1.19	2.37	1.98	0.99	0.40	0.00
Krukenberg tumor cell line:HSKTC	10687-109F3	145.06	24.18	19.78	10.99	4.40	0.00	0.00	0.00	0.00	0.00
Lens Epithelial Cells, donor1	11529-119I8	42.07	7.55	2.16	2.16	1.08	0.00	1.08	0.00	0.00	0.00
Lens Epithelial Cells, donor2	11609-120I7	65.97	15.45	9.46	2.31	5.88	1.96	0.23	0.35	0.12	0.00
Lens Epithelial Cells, donor3	11690-122I7	64.48	8.27	11.30	0.61	3.43	1.51	0.30	0.10	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr00min, biol_rep1 (MM XIX - 1)	12260-130A1	176.56	15.30	23.72	1.19	2.85	1.54	0.95	0.83	0.12	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr00min, biol_rep2 (MM XIV - 1)	12382-131E6	120.00	15.91	24.00	1.12	0.84	0.56	1.40	0.56	0.28	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr00min, biol_rep3 (MM XXII - 1 )	12504-133A2	141.51	13.85	19.36	0.94	1.73	1.26	1.57	1.10	0.16	0.16
Lymphatic Endothelial cells response to VEGFC, 00hr15min, biol_rep1 (MM XIX - 2)	12261-130A2	141.42	11.83	16.67	1.61	0.00	0.54	3.23	2.15	0.54	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr15min, biol_rep2 (MM XIV - 2)	12383-131E7	137.10	20.17	30.89	0.32	1.89	0.95	3.47	0.32	0.63	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr15min, biol_rep3 (MM XXII - 2)	12505-133A3	148.57	19.30	26.52	0.97	1.62	1.08	2.80	0.97	0.11	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr30min, biol_rep1 (MM XIX - 3)	12262-130A3	130.09	13.13	16.42	0.82	1.23	1.23	0.82	0.82	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr30min, biol_rep2 (MM XIV - 3)	12384-131E8	142.08	20.48	26.55	1.77	1.52	1.77	3.03	0.76	1.26	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr30min, biol_rep3 (MM XXII - 3)	12506-133A4	133.71	14.78	20.27	0.84	1.83	0.56	2.11	1.41	0.28	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr45min, biol_rep1 (MM XIX - 4)	12263-130A4	123.01	15.43	16.61	1.19	1.19	1.98	1.98	1.19	0.40	0.40
Lymphatic Endothelial cells response to VEGFC, 00hr45min, biol_rep2 (MM XIV - 4)	12385-131E9	119.43	14.74	22.68	1.74	1.16	1.74	2.13	0.78	0.39	0.19
Lymphatic Endothelial cells response to VEGFC, 00hr45min, biol_rep3 (MM XXII - 4)	12507-133A5	158.30	17.03	19.26	1.11	0.93	1.48	2.22	0.56	0.37	0.00
Lymphatic Endothelial cells response to VEGFC, 01hr00min, biol_rep1 (MM XIX - 5)	12264-130A5	141.46	19.86	21.60	2.09	0.70	2.09	4.18	0.70	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 01hr00min, biol_rep2 (MM XIV - 5)	12386-131F1	122.84	18.60	25.76	0.24	0.95	1.19	1.19	0.48	0.00	0.48
Lymphatic Endothelial cells response to VEGFC, 01hr00min, biol_rep3 (MM XXII - 5)	12508-133A6	143.39	18.95	22.94	0.82	0.14	1.24	1.24	0.82	0.27	0.00
Lymphatic Endothelial cells response to VEGFC, 01hr20min, biol_rep1 (MM XIX - 6)	12265-130A6	133.04	11.09	22.17	1.54	0.92	3.08	0.62	1.54	0.31	0.00
Lymphatic Endothelial cells response to VEGFC, 01hr20min, biol_rep2 (MM XIV - 6)	12387-131F2	123.14	18.39	25.25	0.62	0.62	1.56	1.25	0.94	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 01hr20min, biol_rep3 (MM XXII - 6)	12509-133A7	155.91	21.78	23.42	0.91	1.10	0.73	2.56	0.55	0.18	0.18
Lymphatic Endothelial cells response to VEGFC, 01hr40min, biol_rep1 (MM XIX - 7)	12266-130A7	145.14	13.16	23.70	1.32	1.32	1.32	0.99	0.33	0.33	0.00
Lymphatic Endothelial cells response to VEGFC, 01hr40min, biol_rep2 (MM XIV - 7)	12388-131F3	108.66	16.11	19.92	1.46	0.29	0.59	1.46	1.17	0.00	0.29
Lymphatic Endothelial cells response to VEGFC, 01hr40min, biol_rep3 (MM XXII - 7)	12510-133A8	147.12	20.66	16.68	0.75	1.24	1.00	3.24	0.75	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 02hr00min, biol_rep1 (MM XIX - 8)	12267-130A8	133.36	15.52	30.55	0.48	1.94	0.97	0.48	0.00	0.00	0.48
Lymphatic Endothelial cells response to VEGFC, 02hr00min, biol_rep2 (MM XIV - 8)	12389-131F4	98.29	12.39	25.31	1.35	2.15	1.35	1.89	0.54	0.54	0.00
Lymphatic Endothelial cells response to VEGFC, 02hr00min, biol_rep3 (MM XXII - 8)	12511-133A9	135.79	18.47	17.56	0.61	1.97	1.06	1.97	1.21	0.61	0.00
Lymphatic Endothelial cells response to VEGFC, 02hr30min, biol_rep1 (MM XIX - 9)	12268-130A9	115.61	14.00	17.63	2.59	3.11	1.56	1.04	1.56	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 02hr30min, biol_rep2 (MM XIV - 9)	12390-131F5	126.05	14.03	19.47	1.88	1.05	2.51	0.84	1.26	0.42	0.00
Lymphatic Endothelial cells response to VEGFC, 02hr30min, biol_rep3 (MM XXII - 9)	12512-133B1	144.81	21.35	21.05	1.65	1.50	1.35	2.26	0.45	0.30	0.00
Lymphatic Endothelial cells response to VEGFC, 03hr00min, biol_rep1 (MM XIX - 10)	12269-130B1	127.26	13.76	28.20	3.44	0.69	0.00	3.44	0.00	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 03hr00min, biol_rep2 (MM XIV - 10)	12391-131F6	100.66	14.68	24.27	0.94	1.13	1.13	2.45	0.56	0.75	0.00
Lymphatic Endothelial cells response to VEGFC, 03hr00min, biol_rep3 (MM XXII - 10)	12513-133B2	146.00	18.13	22.16	0.95	1.17	1.59	3.71	0.85	0.21	0.11
Lymphatic Endothelial cells response to VEGFC, 03hr30min, biol_rep1 (MM XIX - 11)	12270-130B2	141.50	12.11	12.60	2.42	1.45	0.00	1.45	0.97	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 03hr30min, biol_rep2 (MM XIV - 11)	12392-131F7	109.82	17.53	22.16	1.32	1.32	1.32	1.65	0.33	0.33	0.33
Lymphatic Endothelial cells response to VEGFC, 03hr30min, biol_rep3 (MM XXII - 11)	12514-133B3	153.01	18.46	19.57	0.87	1.36	1.49	2.97	0.62	0.12	0.00
Lymphatic Endothelial cells response to VEGFC, 04hr, biol_rep1 (MM XIX - 12)	12271-130B3	146.60	18.88	22.95	1.85	0.74	1.11	2.59	0.37	0.37	0.74
Lymphatic Endothelial cells response to VEGFC, 04hr, biol_rep2 (MM XIV - 12)	12393-131F8	105.75	14.08	16.55	2.22	0.74	1.48	1.24	0.49	0.49	0.00
Lymphatic Endothelial cells response to VEGFC, 04hr, biol_rep3 (MM XXII - 12)	12515-133B4	138.87	18.97	20.90	0.82	2.06	1.24	2.47	0.41	0.27	0.00
Lymphatic Endothelial cells response to VEGFC, 05hr, biol_rep1 (MM XIX - 13)	12272-130B4	139.91	15.12	24.77	0.96	1.29	1.29	1.93	0.00	0.00	0.32
Lymphatic Endothelial cells response to VEGFC, 05hr, biol_rep2 (MM XIV - 13)	12394-131F9	104.99	17.65	17.04	1.52	0.30	1.52	1.22	1.22	0.91	0.00
Lymphatic Endothelial cells response to VEGFC, 05hr, biol_rep3 (MM XXII - 13)	12516-133B5	152.56	15.82	19.46	0.98	1.54	1.96	1.68	0.84	0.14	0.14
Lymphatic Endothelial cells response to VEGFC, 06hr, biol_rep1 (MM XIX - 14)	12273-130B5	132.27	14.58	24.89	3.91	2.49	1.07	2.49	0.00	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 06hr, biol_rep2 (MM XIV - 14)	12395-131G1	99.38	15.03	17.45	0.48	0.97	0.00	0.97	0.48	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 06hr, biol_rep3 (MM XXII - 14)	12517-133B6	162.92	22.41	25.52	1.09	1.24	1.87	2.18	0.62	0.16	0.00
Lymphatic Endothelial cells response to VEGFC, 07hr, biol_rep1 (MM XIX - 15)	12274-130B6	160.07	18.26	29.01	0.36	1.07	1.07	2.15	0.72	0.36	0.00
Lymphatic Endothelial cells response to VEGFC, 07hr, biol_rep2 (MM XIV - 15)	12396-131G2	122.50	15.03	19.60	1.63	1.31	0.98	1.31	0.00	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 07hr, biol_rep3 (MM XXII - 15)	12518-133B7	141.02	19.07	21.42	0.71	1.41	0.47	2.83	0.47	0.24	0.00
Lymphatic Endothelial cells response to VEGFC, 08hr, biol_rep1 (MM XIX - 16)	12275-130B7	179.32	16.46	24.87	1.11	2.10	1.86	1.49	0.62	0.25	0.25
Lymphatic Endothelial cells response to VEGFC, 08hr, biol_rep2 (MM XIV - 16)	12397-131G3	124.99	15.88	22.03	1.54	1.54	0.51	0.77	0.26	0.51	0.00
Lymphatic Endothelial cells response to VEGFC, 08hr, biol_rep3 (MM XXII - 16)	12519-133B8	144.40	12.53	21.18	1.19	2.69	1.19	1.79	0.90	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 00hr00min, biol_rep1	13031-139E7	33.99	15.86	0.00	0.00	2.27	4.53	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 00hr00min, biol_rep2	13097-140D1	45.26	18.41	2.30	3.07	9.21	2.30	1.53	0.00	1.53	0.00
MCF7 breast cancer cell line response to EGF1, 00hr00min, biol_rep3	13163-141B4	28.20	14.84	2.97	2.97	1.48	1.48	0.74	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 00hr15min, biol_rep1	13032-139E8	32.58	18.62	3.81	4.23	2.54	2.12	0.85	3.81	0.42	0.00
MCF7 breast cancer cell line response to EGF1, 00hr15min, biol_rep2	13098-140D2	48.53	24.62	5.63	4.22	4.92	2.81	2.11	1.41	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 00hr15min, biol_rep3	13164-141B5	28.02	13.08	4.67	2.80	3.74	5.60	0.93	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 00hr30min, biol_rep1	13033-139E9	20.61	15.46	2.58	4.64	1.55	0.52	1.55	5.15	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 00hr30min, biol_rep2	13099-140D3	44.01	17.84	4.76	2.38	10.71	0.00	2.38	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 00hr30min, biol_rep3	13165-141B6	40.71	19.45	3.39	2.49	2.26	2.49	0.90	0.00	0.68	0.00
MCF7 breast cancer cell line response to EGF1, 00hr45min, biol_rep1	13034-139F1	23.56	16.87	2.33	2.62	2.62	1.74	1.16	0.58	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 00hr45min, biol_rep2	13100-140D4	37.36	16.21	0.45	4.05	5.85	0.00	2.25	1.35	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 00hr45min, biol_rep3	13166-141B7	44.44	25.20	4.61	4.34	3.12	1.90	0.68	0.68	0.14	0.00
MCF7 breast cancer cell line response to EGF1, 01hr00min, biol_rep1	13035-139F2	31.84	17.97	3.08	2.05	2.57	1.54	1.54	1.03	0.51	0.00
MCF7 breast cancer cell line response to EGF1, 01hr00min, biol_rep2	13101-140D5	33.17	19.41	3.88	4.59	5.29	1.41	1.41	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 01hr00min, biol_rep3	13167-141B8	34.65	9.33	0.67	1.33	2.00	2.67	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 01hr20min, biol_rep1	13036-139F3	32.60	12.73	2.55	3.57	2.55	1.02	0.00	1.53	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 01hr20min, biol_rep2	13102-140D6	39.22	16.01	2.40	4.00	4.00	1.87	1.07	0.80	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 01hr20min, biol_rep3	13168-141B9	31.93	17.01	2.65	4.53	4.72	1.13	1.13	0.94	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 01hr40min, biol_rep1	13037-139F4	30.68	15.34	1.84	8.59	1.23	2.45	0.61	1.23	0.61	0.00
MCF7 breast cancer cell line response to EGF1, 01hr40min, biol_rep2	13103-140D7	38.32	18.75	5.71	3.26	4.08	0.00	1.63	0.82	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 01hr40min, biol_rep3	13169-141C1	28.74	15.20	3.12	2.50	1.67	2.50	1.25	0.62	0.21	0.00
MCF7 breast cancer cell line response to EGF1, 02hr00min, biol_rep1	13038-139F5	26.62	16.82	2.52	3.36	1.96	0.56	0.56	0.84	0.28	0.00
MCF7 breast cancer cell line response to EGF1, 02hr00min, biol_rep2	13104-140D8	32.97	18.55	3.09	3.09	6.18	0.00	0.00	0.00	1.03	0.00
MCF7 breast cancer cell line response to EGF1, 02hr00min, biol_rep3	13170-141C2	32.51	18.29	1.74	3.77	2.61	1.74	0.87	1.45	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 02hr30min, biol_rep1	13039-139F6	23.62	14.95	3.29	2.99	1.79	1.49	0.90	0.90	0.30	0.00
MCF7 breast cancer cell line response to EGF1, 02hr30min, biol_rep2	13105-140D9	34.86	12.72	2.21	1.66	2.77	1.66	1.66	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 02hr30min, biol_rep3	13171-141C3	32.17	21.92	6.72	4.95	3.89	0.71	1.41	2.12	0.35	0.00
MCF7 breast cancer cell line response to EGF1, 03hr00min, biol_rep1	13040-139F7	28.03	15.86	4.43	2.58	2.21	1.11	2.95	1.84	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 03hr00min, biol_rep2	13106-140E1	24.18	21.87	3.45	3.45	4.61	0.00	1.15	0.00	1.15	0.00
MCF7 breast cancer cell line response to EGF1, 03hr00min, biol_rep3	13172-141C4	33.00	19.19	4.22	5.76	3.45	1.15	1.54	0.38	0.38	0.00
MCF7 breast cancer cell line response to EGF1, 03hr30min, biol_rep1	13041-139F8	19.25	13.59	2.26	5.10	2.83	1.13	1.13	2.26	0.57	0.00
MCF7 breast cancer cell line response to EGF1, 03hr30min, biol_rep2	13107-140E2	35.28	14.77	2.46	2.46	2.46	1.64	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 03hr30min, biol_rep3	13173-141C5	33.89	20.33	4.07	3.16	3.62	1.81	0.90	0.90	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 04hr, biol_rep1	13042-139F9	20.11	16.52	2.15	5.03	3.59	0.72	0.72	0.72	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 04hr, biol_rep2	13108-140E3	50.79	14.19	3.73	2.24	7.47	1.49	0.75	0.75	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 04hr, biol_rep3	13174-141C6	31.96	16.35	1.49	2.23	3.34	1.49	0.74	2.23	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 05hr, biol_rep1	13043-139G1	26.71	18.95	1.72	3.02	0.00	1.29	1.29	1.29	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 05hr, biol_rep2	13109-140E4	35.96	10.28	0.86	3.43	4.28	1.71	0.86	0.86	0.86	0.00
MCF7 breast cancer cell line response to EGF1, 05hr, biol_rep3	13175-141C7	37.65	18.66	4.33	4.00	4.00	1.33	1.33	1.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 06hr, biol_rep1	13044-139G2	18.70	15.69	1.21	4.83	1.21	0.60	0.00	1.81	0.60	0.00
MCF7 breast cancer cell line response to EGF1, 06hr, biol_rep2	13110-140E5	36.97	12.09	4.27	7.11	4.98	1.42	2.84	0.00	0.71	0.00
MCF7 breast cancer cell line response to EGF1, 06hr, biol_rep3	13176-141C8	35.75	14.09	2.75	3.78	3.09	1.37	1.03	1.03	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 07hr, biol_rep1	13045-139G3	19.86	16.10	3.76	3.22	0.54	3.22	0.54	1.61	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 07hr, biol_rep2	13111-140E6	35.69	15.49	4.04	1.35	6.73	0.67	2.02	0.67	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 07hr, biol_rep3	13177-141C9	41.86	18.52	1.85	4.44	4.82	1.85	2.96	1.11	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 08hr, biol_rep1	13046-139G4	37.21	25.58	5.81	4.65	1.16	1.16	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 08hr, biol_rep2	13112-140E7	35.96	29.62	3.17	4.23	9.52	0.00	3.17	1.06	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 08hr, biol_rep3	13178-141D1	36.81	18.81	2.40	4.00	2.40	1.20	0.40	1.60	0.00	0.00
MCF7 breast cancer cell line response to HRG, 00hr15min, biol_rep1	13048-139G6	27.62	20.35	3.63	9.45	3.63	1.45	0.00	0.73	0.73	0.00
MCF7 breast cancer cell line response to HRG, 00hr15min, biol_rep2	13114-140E9	58.26	31.43	4.60	4.60	5.37	3.83	1.53	0.77	0.77	0.00
MCF7 breast cancer cell line response to HRG, 00hr15min, biol_rep3	13180-141D3	37.00	24.17	5.43	6.91	3.45	2.47	0.49	2.47	0.00	0.00
MCF7 breast cancer cell line response to HRG, 00hr30min, biol_rep1	13049-139G7	23.52	16.00	4.70	3.76	3.76	0.94	3.76	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 00hr30min, biol_rep2	13115-140F1	48.27	23.13	5.03	6.03	5.53	3.02	1.51	2.01	0.00	0.00
MCF7 breast cancer cell line response to HRG, 00hr30min, biol_rep3	13181-141D4	36.05	20.73	5.86	4.51	2.70	1.35	1.35	1.80	0.00	0.00
MCF7 breast cancer cell line response to HRG, 00hr45min, biol_rep1	13050-139G8	17.21	8.61	0.00	1.72	1.72	0.00	1.72	3.44	1.72	0.00
MCF7 breast cancer cell line response to HRG, 00hr45min, biol_rep2	13116-140F2	48.99	28.06	4.90	3.12	6.23	2.67	0.89	2.67	0.45	0.00
MCF7 breast cancer cell line response to HRG, 00hr45min, biol_rep3	13182-141D5	35.58	22.29	3.13	6.65	3.52	1.17	0.39	1.17	0.00	0.00
MCF7 breast cancer cell line response to HRG, 01hr00min, biol_rep1	13051-139G9	18.47	18.47	2.64	5.94	3.30	1.98	1.98	1.98	1.32	0.00
MCF7 breast cancer cell line response to HRG, 01hr00min, biol_rep2	13117-140F3	53.45	19.20	5.19	6.23	5.71	2.59	0.52	0.52	0.52	0.00
MCF7 breast cancer cell line response to HRG, 01hr00min, biol_rep3	13183-141D6	38.07	15.75	3.06	5.25	3.50	0.44	0.88	1.75	0.00	0.00
MCF7 breast cancer cell line response to HRG, 01hr20min, biol_rep1	13052-139H1	23.48	20.13	4.47	2.24	2.24	1.68	2.80	0.56	0.00	0.00
MCF7 breast cancer cell line response to HRG, 01hr20min, biol_rep2	13118-140F4	42.84	16.78	4.86	3.09	3.97	0.44	0.44	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 01hr20min, biol_rep3	13184-141D7	34.33	17.36	3.47	2.31	3.86	1.16	1.93	0.77	0.00	0.00
MCF7 breast cancer cell line response to HRG, 01hr40min, biol_rep1	13053-139H2	28.36	12.66	1.01	1.52	6.08	1.01	0.51	1.01	0.51	0.00
MCF7 breast cancer cell line response to HRG, 01hr40min, biol_rep2	13119-140F5	38.93	15.38	1.92	2.88	4.33	1.44	0.96	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 01hr40min, biol_rep3	13185-141D8	26.64	15.50	2.78	5.57	2.39	1.19	0.40	0.40	0.00	0.00
MCF7 breast cancer cell line response to HRG, 02hr00min, biol_rep1	13054-139H3	26.13	13.98	3.65	4.86	2.43	1.22	1.22	3.04	0.00	0.00
MCF7 breast cancer cell line response to HRG, 02hr00min, biol_rep2	13120-140F6	26.28	16.60	2.08	3.46	3.46	1.38	0.00	2.08	0.00	0.00
MCF7 breast cancer cell line response to HRG, 02hr00min, biol_rep3	13186-141D9	37.24	17.10	4.94	5.32	4.56	0.76	2.28	2.28	0.00	0.00
MCF7 breast cancer cell line response to HRG, 02hr30min, biol_rep1	13055-139H4	18.59	16.53	2.58	1.55	3.10	1.03	0.52	3.61	0.52	0.00
MCF7 breast cancer cell line response to HRG, 02hr30min, biol_rep2	13121-140F7	27.21	18.74	0.60	5.44	1.81	1.81	0.60	0.60	0.00	0.00
MCF7 breast cancer cell line response to HRG, 02hr30min, biol_rep3	13187-141E1	31.06	18.38	2.85	4.75	2.54	0.63	1.58	1.90	0.00	0.00
MCF7 breast cancer cell line response to HRG, 03hr00min, biol_rep1	13056-139H5	29.32	17.06	4.26	3.20	6.40	1.60	1.60	0.53	0.00	0.00
MCF7 breast cancer cell line response to HRG, 03hr00min, biol_rep2	13122-140F8	29.31	15.52	0.57	3.45	5.75	1.72	0.57	2.30	0.00	0.00
MCF7 breast cancer cell line response to HRG, 03hr00min, biol_rep3	13188-141E2	41.65	22.11	4.63	4.63	5.66	1.54	2.57	2.06	0.00	0.00
MCF7 breast cancer cell line response to HRG, 03hr30min, biol_rep1	13057-139H6	28.29	16.27	2.12	4.24	2.83	1.41	1.41	1.41	0.00	0.00
MCF7 breast cancer cell line response to HRG, 03hr30min, biol_rep2	13123-140F9	32.35	26.10	0.57	3.40	3.97	2.84	0.57	1.70	0.00	0.00
MCF7 breast cancer cell line response to HRG, 03hr30min, biol_rep3	13189-141E3	38.69	21.22	4.16	2.91	3.33	0.00	0.00	0.42	0.42	0.00
MCF7 breast cancer cell line response to HRG, 04hr, biol_rep1	13058-139H7	20.36	13.31	0.00	3.13	0.78	0.00	0.00	3.13	0.00	0.00
MCF7 breast cancer cell line response to HRG, 04hr, biol_rep2	13124-140G1	32.57	14.20	3.76	4.18	2.92	2.92	1.67	0.42	0.42	0.00
MCF7 breast cancer cell line response to HRG, 04hr, biol_rep3	13190-141E4	35.78	16.26	4.18	3.25	4.18	0.46	0.46	1.86	0.46	0.00
MCF7 breast cancer cell line response to HRG, 05hr, biol_rep1	13059-139H8	28.10	16.73	2.68	5.35	2.01	1.34	2.01	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 05hr, biol_rep2	13125-140G2	34.75	17.11	2.14	2.67	4.81	2.14	0.53	0.53	0.00	0.00
MCF7 breast cancer cell line response to HRG, 05hr, biol_rep3	13191-141E5	28.69	13.34	2.02	5.25	2.83	1.21	2.02	2.02	0.00	0.00
MCF7 breast cancer cell line response to HRG, 06hr, biol_rep1	13060-139H9	22.94	13.77	4.59	10.10	0.92	1.84	0.00	0.92	0.00	0.00
MCF7 breast cancer cell line response to HRG, 06hr, biol_rep2	13126-140G3	33.79	21.34	3.56	1.78	6.22	0.89	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 06hr, biol_rep3	13192-141E6	39.89	18.24	5.13	5.70	3.42	1.14	0.57	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 07hr, biol_rep1	13061-139I1	26.07	24.54	3.83	3.07	2.30	1.53	1.53	0.77	0.00	0.00
MCF7 breast cancer cell line response to HRG, 07hr, biol_rep2	13127-140G4	30.09	10.40	0.55	3.28	1.64	2.19	1.09	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 07hr, biol_rep3	13193-141E7	24.95	16.48	4.01	4.90	3.56	1.34	1.34	1.34	0.00	0.00
MCF7 breast cancer cell line response to HRG, 08hr, biol_rep1	13062-139I2	35.09	17.68	4.16	2.08	1.56	2.34	1.30	0.26	0.00	0.00
MCF7 breast cancer cell line response to HRG, 08hr, biol_rep2	13128-140G5	29.84	15.25	3.98	1.99	2.65	1.99	0.66	0.66	0.00	0.00
MCF7 breast cancer cell line response to HRG, 08hr, biol_rep3	13194-141E8	37.41	14.55	2.08	2.08	6.24	2.08	2.08	2.08	0.00	0.00
Macrophage - monocyte derived, donor1	11232-116C8	414.12	21.42	80.00	5.93	1.82	5.70	3.42	0.68	0.68	0.46
Macrophage - monocyte derived, donor2	11313-117C8	286.64	15.60	51.01	1.65	2.39	4.77	2.20	2.20	0.18	0.00
Macrophage - monocyte derived, donor3	11389-118C3	258.89	18.61	89.27	3.01	2.88	3.15	4.19	3.28	0.26	0.26
Mallassez-derived cells, donor1 (MZH3)	12142-128E9	85.49	13.28	13.28	2.12	1.06	1.59	0.00	0.00	0.00	0.00
Mallassez-derived cells, donor2	11929-125I3	49.12	5.39	4.60	1.74	0.95	0.32	0.95	1.11	0.00	0.00
Mallassez-derived cells, donor3	11930-125I4	37.80	5.14	2.92	0.42	1.11	0.42	0.42	0.42	0.00	0.00
Mammary Epithelial Cell, donor1	11273-116H4	93.17	15.44	9.07	0.70	1.99	2.39	0.50	0.30	0.10	0.20
Mammary Epithelial Cell, donor2	11350-117G9	73.55	8.98	5.50	1.74	2.03	2.32	1.74	0.00	0.00	0.00
Mammary Epithelial Cell, donor3	11422-118F9	63.10	16.71	10.23	0.50	3.74	0.75	1.00	0.00	0.00	0.00
Mast cell - stimulated, donor1	11487-119E2	32.54	6.78	3.39	4.75	0.68	1.36	0.00	0.68	0.00	0.00
Mast cell, donor1	11563-120D6	71.81	23.25	4.33	3.03	2.70	1.30	1.08	0.32	0.00	0.00
Mast cell, donor2	11565-120D8	107.28	22.88	6.84	3.57	0.89	0.89	5.35	0.59	0.00	0.30
Mast cell, donor3	11566-120D9	108.06	25.44	8.10	3.60	2.48	1.13	4.50	0.68	0.68	0.45
Mast cell, donor4	11567-120E1	100.70	23.40	7.09	3.19	1.42	1.60	7.45	0.71	0.00	0.18
Mast cell, expanded and stimulated, donor5	11940-126A5	49.90	19.52	2.77	4.88	2.33	1.55	1.00	0.55	0.44	0.00
Mast cell, expanded and stimulated, donor8	11942-126A7	26.27	19.85	1.75	2.92	0.00	1.75	0.58	1.17	0.00	0.00
Mast cell, expanded, donor5	11939-126A4	75.83	29.71	7.11	4.02	2.18	1.72	3.56	0.92	0.11	0.11
Mast cell, expanded, donor8	11941-126A6	56.57	21.93	4.52	5.52	0.33	1.17	2.68	0.00	0.00	0.17
Melanocyte - dark, donor1	11502-119F8	177.11	18.11	19.20	0.70	2.49	1.19	1.09	0.30	0.00	0.50
Melanocyte - dark, donor2	11582-120F7	55.37	10.38	6.58	0.69	2.77	0.35	0.35	0.69	0.00	0.35
Melanocyte - dark, donor3	11663-122F7	225.00	8.55	22.38	2.25	2.10	1.45	0.94	0.36	0.07	0.87
Melanocyte - light, donor1	11274-116H5	215.80	17.16	30.56	1.65	3.53	1.41	5.17	0.24	0.24	0.00
Melanocyte - light, donor2	11351-117H1	156.97	11.60	16.38	2.05	1.36	0.00	10.92	0.68	0.00	1.36
Melanocyte - light, donor3	11423-118G1	109.27	12.14	21.68	2.60	0.87	1.73	0.87	0.87	0.00	0.87
Melanocyte, donor1 (MC+1)	12641-134G4	229.18	10.41	41.75	1.87	1.87	1.87	3.23	1.46	0.62	0.21
Melanocyte, donor2 (MC+2)	12739-135I3	174.54	14.79	25.01	0.00	0.81	2.15	1.34	1.61	0.54	0.27
Melanocyte, donor3 (MC+3)	12837-137B2	184.82	13.66	31.07	2.41	1.34	2.14	2.68	0.54	0.27	0.54
Meningeal Cells, donor1	11493-119E8	57.19	13.52	7.44	0.99	2.98	1.24	0.25	0.12	0.00	0.00
Meningeal Cells, donor2	11573-120E7	55.46	8.36	8.36	0.88	7.92	1.32	0.88	0.00	0.00	0.00
Meningeal Cells, donor3	11654-122E7	71.23	18.42	7.09	0.33	0.98	1.55	0.57	0.16	0.08	0.00
Mesenchymal Stem Cells - Vertebral, donor1	11219-116B4	88.97	16.54	9.12	1.43	4.28	2.57	0.57	0.57	0.00	0.00
Mesenchymal Stem Cells - Wharton's Jelly, donor1	11548-120B9	136.16	14.09	16.10	1.51	2.42	2.72	1.71	1.01	0.10	0.20
Mesenchymal Stem Cells - adipose, donor1	11537-120A7	341.68	52.57	48.62	3.94	7.88	9.20	5.26	0.00	0.00	0.00
Mesenchymal Stem Cells - adipose, donor2	11617-122A6	136.05	17.01	17.01	1.31	5.23	0.00	1.31	1.31	0.00	0.00
Mesenchymal Stem Cells - adipose, donor3	11698-123A6	157.16	15.79	19.38	0.72	2.87	0.72	2.87	0.72	0.00	0.00
Mesenchymal Stem Cells - amniotic membrane, donor1	11547-120B8	156.07	10.59	16.52	1.27	2.12	2.54	2.96	0.85	0.42	0.64
Mesenchymal Stem Cells - amniotic membrane, donor2	11627-122B7	146.27	19.10	26.14	3.02	3.52	1.01	3.52	0.50	1.51	0.00
Mesenchymal Stem Cells - bone marrow, donor1	11536-120A6	95.81	10.55	12.31	1.32	2.86	2.64	0.44	0.44	0.00	0.00
Mesenchymal Stem Cells - bone marrow, donor2	11616-122A5	78.90	16.07	11.69	0.73	2.19	1.46	0.00	0.00	0.00	0.00
Mesenchymal Stem Cells - bone marrow, donor3	11697-123A5	95.55	17.80	15.14	1.43	1.23	3.07	1.23	0.82	0.00	0.00
Mesenchymal Stem Cells - bone marrow, donor4	11464-119B6	120.92	15.24	8.86	2.08	0.83	0.97	0.83	0.42	0.14	0.00
Mesenchymal Stem Cells - hepatic, donor1	11538-120A8	105.94	17.10	14.87	5.20	3.72	1.86	1.49	0.00	0.00	0.00
Mesenchymal Stem Cells - hepatic, donor2	11618-122A7	83.55	12.37	13.42	3.16	1.45	0.66	0.79	0.13	0.13	0.00
Mesenchymal Stem Cells - umbilical, donor1	11539-120A9	112.17	15.43	16.02	2.37	3.56	1.78	0.59	0.30	0.00	0.00
Mesenchymal Stem Cells - umbilical, donor2	11619-122A8	107.44	28.03	18.68	0.00	4.67	0.00	4.67	0.00	0.00	0.00
Mesenchymal Stem Cells - umbilical, donor3	11700-123A8	41.63	14.09	4.48	2.56	3.84	2.56	0.64	0.64	0.64	0.00
Mesenchymal stem cells - adipose, donor0	11217-116B2	169.78	9.22	20.56	0.71	2.13	0.35	1.06	0.00	0.71	0.00
Mesenchymal stem cells - hepatic, donor0	11218-116B3	92.88	10.01	11.88	2.19	3.13	0.94	0.63	0.31	0.00	0.00
Mesenchymal stem cells - umbilical, donor0	11214-116A8	34.11	11.61	5.08	2.18	3.63	1.45	0.73	0.00	0.00	0.00
Mesothelial Cells, donor1	11247-116E5	180.05	15.11	39.78	1.59	3.45	2.12	3.98	0.53	0.27	0.27
Mesothelial Cells, donor2	12156-128G5	180.17	18.52	34.03	1.00	4.50	1.50	2.50	1.00	0.00	0.00
Mesothelial Cells, donor3	11402-118D7	38.30	7.80	14.16	1.16	1.52	1.88	1.08	0.65	0.07	0.00
Monocyte-derived macrophages response to LPS, 00hr00min, donor1 (t1 Subject1)	12698-135D7	478.01	37.81	76.97	6.75	2.70	4.05	1.35	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr00min, donor2 (t1 Subject2)	12796-136F6	392.56	15.52	58.12	4.19	3.45	4.19	2.96	4.93	0.49	0.25
Monocyte-derived macrophages response to LPS, 00hr00min, donor3 (t1 Subject3)	12894-137H5	288.86	25.03	48.88	2.36	0.59	3.53	1.77	4.42	0.59	0.59
Monocyte-derived macrophages response to LPS, 00hr15min, donor1 (t2 Subject1)	12699-135D8	228.17	20.74	44.94	3.46	0.00	3.46	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr15min, donor2 (t2 Subject2)	12797-136F7	281.43	8.06	43.39	3.72	0.93	0.62	3.72	3.10	0.62	0.31
Monocyte-derived macrophages response to LPS, 00hr15min, donor3 (t2 Subject3)	12895-137H6	214.49	15.97	44.81	1.66	1.45	2.28	2.49	1.87	0.00	0.41
Monocyte-derived macrophages response to LPS, 00hr30min, donor1 (t3 Subject1)	12700-135D9	206.13	20.84	32.42	4.63	2.32	2.32	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr30min, donor2 (t3 Subject2)	12798-136F8	381.90	14.77	59.06	1.00	1.75	2.75	6.51	5.01	1.25	0.50
Monocyte-derived macrophages response to LPS, 00hr30min, donor3 (t3 Subject3)	12896-137H7	262.53	26.53	52.13	3.26	0.47	2.33	0.93	0.93	0.47	0.47
Monocyte-derived macrophages response to LPS, 00hr45min, donor1 (t4 Subject1)	12701-135E1	291.99	19.47	58.40	19.47	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr45min, donor2 (t4 Subject2)	12799-136F9	369.45	17.88	61.17	1.22	2.24	2.85	4.27	2.44	0.61	1.02
Monocyte-derived macrophages response to LPS, 00hr45min, donor3 (t4 Subject3)	12897-137H8	242.33	16.23	48.31	2.77	1.19	3.17	1.19	2.38	0.79	1.19
Monocyte-derived macrophages response to LPS, 01hr00min, donor1 (t5 Subject1)	12702-135E2	273.65	8.55	51.31	17.10	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr00min, donor2 (t5 Subject2)	12800-136G1	254.86	15.04	41.59	0.00	0.88	2.65	9.73	6.19	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr00min, donor3 (t5 Subject3)	12898-137H9	244.68	17.86	49.77	2.28	1.52	3.04	2.66	3.04	0.38	0.00
Monocyte-derived macrophages response to LPS, 01hr20min, donor1 (t6 Subject1)	12703-135E3	163.17	22.37	36.85	0.00	0.00	2.63	1.32	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr20min, donor2 (t6 Subject2)	12801-136G2	224.53	9.76	40.32	1.06	1.49	2.33	6.15	3.18	0.64	0.21
Monocyte-derived macrophages response to LPS, 01hr20min, donor3 (t6 Subject3)	12899-137I1	179.56	11.97	30.39	0.92	0.92	0.92	0.00	1.84	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr40min, donor1 (t7 Subject1)	12704-135E4	215.66	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr40min, donor2 (t7 Subject2)	12802-136G3	245.00	13.41	33.38	2.09	0.60	1.49	2.68	1.79	0.30	0.60
Monocyte-derived macrophages response to LPS, 01hr40min, donor3 (t7 Subject3)	12900-137I2	243.12	21.80	65.39	3.35	1.68	5.03	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 02hr00min, donor1 (t8 Subject1)	12705-135E5	237.65	0.00	101.85	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 02hr00min, donor2 (t8 Subject2)	12803-136G4	224.06	12.80	35.13	0.25	0.25	0.50	6.02	5.02	0.25	0.50
Monocyte-derived macrophages response to LPS, 02hr00min, donor3 (t8 Subject3)	12901-137I3	202.73	16.64	33.51	1.43	1.90	1.66	1.90	2.14	0.24	0.00
Monocyte-derived macrophages response to LPS, 02hr30min, donor1 (t9 Subject1)	12706-135E6	105.05	13.82	22.12	1.66	1.11	2.21	0.55	0.00	0.00	0.55
Monocyte-derived macrophages response to LPS, 02hr30min, donor2 (t9 Subject2)	12804-136G5	174.53	8.52	33.62	0.69	0.46	1.15	1.84	2.30	0.46	0.00
Monocyte-derived macrophages response to LPS, 02hr30min, donor3 (t9 Subject3)	12902-137I4	186.99	16.20	38.07	2.10	1.47	1.05	1.68	0.84	0.00	0.00
Monocyte-derived macrophages response to LPS, 03hr00min, donor1 (t10 Subject1)	12707-135E7	149.20	9.17	28.94	0.61	1.02	0.61	0.61	0.82	0.41	0.00
Monocyte-derived macrophages response to LPS, 03hr00min, donor2 (t10 Subject2)	12805-136G6	234.28	9.87	40.12	1.07	1.93	0.43	3.65	2.57	0.43	0.21
Monocyte-derived macrophages response to LPS, 03hr00min, donor3 (t10 Subject3)	12903-137I5	170.50	12.67	42.68	1.56	2.00	1.56	0.89	0.89	0.22	0.22
Monocyte-derived macrophages response to LPS, 03hr30min, donor1 (t11 Subject1)	12708-135E8	113.50	0.00	20.64	0.00	0.00	10.32	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 03hr30min, donor2 (t11 Subject2)	12806-136G7	120.24	7.01	21.68	0.44	0.66	2.19	2.63	0.88	0.00	0.22
Monocyte-derived macrophages response to LPS, 03hr30min, donor3 (t11 Subject3)	12904-137I6	186.05	17.24	42.08	0.51	1.52	3.04	0.00	0.51	0.51	0.00
Monocyte-derived macrophages response to LPS, 04hr, donor1 (t12 Subject1)	12709-135E9	147.47	14.91	16.57	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 04hr, donor2 (t12 Subject2)	12807-136G8	159.00	6.25	24.73	1.36	0.82	1.63	1.36	0.27	0.00	0.00
Monocyte-derived macrophages response to LPS, 04hr, donor3 (t12 Subject3)	12905-137I7	164.10	13.82	32.35	0.59	0.88	1.47	0.29	2.06	0.00	0.00
Monocyte-derived macrophages response to LPS, 05hr, donor1 (t13 Subject1)	12710-135F1	92.68	6.54	17.45	0.00	0.00	0.00	1.09	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 05hr, donor2 (t13 Subject2)	12808-136G9	149.93	7.69	26.43	0.48	2.40	1.44	1.92	0.48	0.48	0.00
Monocyte-derived macrophages response to LPS, 05hr, donor3 (t13 Subject3)	12906-137I8	142.48	12.81	25.61	1.60	1.20	2.00	0.80	4.80	0.80	0.00
Monocyte-derived macrophages response to LPS, 06hr, donor1 (t14 Subject1)	12711-135F2	134.38	8.23	23.31	2.74	0.00	1.37	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 06hr, donor2 (t14 Subject2)	12809-136H1	153.68	9.51	29.03	0.50	0.00	0.50	0.50	1.50	0.50	0.00
Monocyte-derived macrophages response to LPS, 06hr, donor3 (t14 Subject3)	12907-137I9	269.47	0.00	26.95	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 07hr, donor1 (t15 Subject1)	12712-135F3	122.31	10.19	22.42	2.04	0.00	0.00	2.04	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 07hr, donor2 (t15 Subject2)	12810-136H2	134.44	10.95	19.71	2.19	1.31	1.75	2.63	1.31	0.00	0.00
Monocyte-derived macrophages response to LPS, 07hr, donor3 (t15 Subject3)	12908-138A1	155.62	6.62	27.59	2.21	0.00	1.10	1.10	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 08hr, donor1 (t16 Subject1)	12713-135F4	170.98	8.33	32.02	2.56	0.64	1.28	0.64	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 08hr, donor2 (t16 Subject2)	12811-136H3	140.82	10.91	25.54	0.25	0.99	0.99	2.98	2.23	0.50	0.25
Monocyte-derived macrophages response to LPS, 08hr, donor3 (t16 Subject3)	12909-138A2	167.02	2.78	31.32	2.09	1.39	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 10hr, donor1 (t17 Subject1)	12714-135F5	165.74	8.84	41.99	2.21	2.21	2.21	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 10hr, donor2 (t17 Subject2)	12812-136H4	234.53	8.89	31.79	0.68	1.03	0.68	3.08	3.08	0.68	0.00
Monocyte-derived macrophages response to LPS, 10hr, donor3 (t17 Subject3)	12910-138A3	179.42	9.19	32.82	0.88	3.06	3.94	1.75	0.44	0.00	0.00
Monocyte-derived macrophages response to LPS, 12hr, donor1 (t18 Subject1)	12715-135F6	223.00	13.49	53.62	1.42	1.42	2.13	1.07	0.36	0.36	0.00
Monocyte-derived macrophages response to LPS, 12hr, donor2 (t18 Subject2)	12813-136H5	163.00	8.70	31.98	1.12	1.12	1.12	3.37	2.24	0.56	0.00
Monocyte-derived macrophages response to LPS, 12hr, donor3 (t18 Subject3)	12911-138A4	161.26	7.07	36.16	2.49	1.66	1.66	0.00	0.00	0.42	0.42
Monocyte-derived macrophages response to LPS, 14hr, donor1 (t19 Subject1)	12716-135F7	244.75	13.99	57.11	4.66	1.17	1.17	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 14hr, donor2 (t19 Subject2)	12814-136H6	217.80	11.46	32.88	0.90	1.21	0.90	1.81	2.41	0.30	0.30
Monocyte-derived macrophages response to LPS, 14hr, donor3 (t19 Subject3)	12912-138A5	190.33	7.51	36.73	2.50	2.09	1.25	2.50	4.17	0.83	0.00
Monocyte-derived macrophages response to LPS, 16hr, donor1 (t20 Subject1)	12717-135F8	259.88	14.44	57.75	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 16hr, donor2 (t20 Subject2)	12815-136H7	214.26	3.69	41.56	0.00	0.92	4.62	0.92	1.85	0.00	0.00
Monocyte-derived macrophages response to LPS, 16hr, donor3 (t20 Subject3)	12913-138A6	212.85	10.24	37.56	2.85	3.98	1.71	2.85	1.14	0.00	0.57
Monocyte-derived macrophages response to LPS, 18hr, donor1 (t21 Subject1)	12718-135F9	278.02	10.50	62.32	1.38	1.66	2.90	1.11	1.11	0.28	0.41
Monocyte-derived macrophages response to LPS, 18hr, donor2 (t21 Subject2)	12816-136H8	199.54	12.96	35.50	0.78	1.04	1.30	1.81	2.33	0.78	0.00
Monocyte-derived macrophages response to LPS, 18hr, donor3 (t21 Subject3)	12914-138A7	286.56	10.30	49.33	1.72	1.29	1.29	3.00	0.86	0.00	0.43
Monocyte-derived macrophages response to LPS, 20hr, donor1 (t22 Subject1)	12719-135G1	255.98	10.16	57.17	2.54	0.64	0.64	0.00	0.64	0.00	0.00
Monocyte-derived macrophages response to LPS, 20hr, donor2 (t22 Subject2)	12817-136H9	202.04	11.21	40.30	1.60	0.53	1.07	1.60	0.80	0.00	0.00
Monocyte-derived macrophages response to LPS, 20hr, donor3 (t22 Subject3)	12915-138A8	319.98	15.57	57.17	2.99	2.39	2.39	4.79	1.80	0.30	0.60
Monocyte-derived macrophages response to LPS, 22hr, donor1 (t23 Subject1)	12720-135G2	264.71	11.87	57.77	1.27	1.13	2.26	0.99	0.71	0.14	0.00
Monocyte-derived macrophages response to LPS, 22hr, donor2 (t23 Subject2)	12818-136I1	208.31	10.19	38.86	0.64	1.91	2.23	3.19	2.23	0.96	0.32
Monocyte-derived macrophages response to LPS, 22hr, donor3 (t23 Subject3)	12916-138A9	279.73	11.72	48.87	2.65	1.99	2.65	3.32	2.21	0.66	0.00
Monocyte-derived macrophages response to LPS, 24hr, donor1 (t24 Subject1)	12721-135G3	256.72	12.51	51.57	1.90	1.14	2.28	0.76	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 24hr, donor2 (t24 Subject2)	12819-136I2	220.47	10.80	37.79	1.70	1.70	1.99	1.99	1.42	0.28	0.00
Monocyte-derived macrophages response to LPS, 24hr, donor3 (t24 Subject3)	12917-138B1	313.40	13.03	60.96	2.46	3.44	2.46	4.18	4.18	0.49	0.00
Monocyte-derived macrophages response to LPS, 36hr, donor1 (t25 Subject1)	12722-135G4	260.02	14.34	54.09	2.61	1.30	2.61	0.00	0.00	0.65	0.00
Monocyte-derived macrophages response to LPS, 36hr, donor2 (t25 Subject2)	12820-136I3	255.22	10.88	51.45	0.88	2.94	1.47	1.76	2.65	0.29	0.59
Monocyte-derived macrophages response to LPS, 36hr, donor3 (t25 Subject3)	12918-138B2	334.46	14.99	61.41	2.31	1.73	1.73	4.04	2.88	0.29	0.29
Monocyte-derived macrophages response to LPS, 48hr, donor1 (t26 Subject1)	12723-135G5	268.72	24.73	33.80	1.24	1.24	2.47	2.06	1.65	0.00	0.00
Monocyte-derived macrophages response to LPS, 48hr, donor2 (t26 Subject2)	12821-136I4	276.04	8.93	48.84	2.08	1.19	1.19	2.68	2.38	0.60	0.00
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor1 (868_121:MI_0h)	13304-142I1	361.62	3.77	60.27	3.77	3.77	3.77	3.77	0.00	0.00	0.00
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor2 (150_120:MI_0h)	13316-143A4	459.82	7.13	58.81	0.00	0.00	1.78	3.56	10.69	0.00	0.00
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor3 (536_119:MI_0h)	13322-143B1	552.99	15.11	111.71	3.61	0.33	0.99	7.56	6.24	2.30	0.33
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor4 (227_121:MI_0h)	13310-142I7	399.74	21.04	55.75	2.10	1.05	0.00	3.16	6.31	1.05	0.00
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor1 (868_121:MI_24h)	13309-142I6	507.07	18.78	113.27	3.16	0.59	1.78	4.35	8.50	1.98	0.20
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor2 (150_120:MI_24h)	13321-143A9	713.39	28.87	157.39	2.79	1.86	0.00	2.79	5.59	0.93	0.00
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor3 (536_119:MI_24h)	13327-143B6	488.94	19.15	114.91	1.50	1.50	1.13	6.38	3.38	0.75	0.38
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor4 (227_121:MI_24h)	13315-143A3	447.46	21.31	106.00	2.13	2.93	2.13	4.26	6.92	0.80	0.53
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor1 (868_121:Ud_0h)	13305-142I2	384.43	8.71	55.42	1.81	0.68	2.26	3.62	4.30	1.02	0.00
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor2 (150_120:Ud_0h)	13317-143A5	491.40	22.84	101.67	2.21	1.47	2.21	5.16	2.95	0.74	0.74
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor3 (536_119:Ud_0h)	13323-143B2	496.14	10.63	111.39	4.03	1.47	0.73	5.86	6.23	0.73	0.73
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor4 (227_121:Ud_0h)	13311-142I8	432.46	18.67	62.22	1.56	1.56	0.00	17.11	9.33	1.56	0.00
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor1 (868_121:Ud_2h)	13306-142I3	493.29	20.31	76.96	1.07	1.60	2.67	4.81	5.88	1.07	0.53
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor2 (150_120:Ud_2h)	13318-143A6	324.57	7.73	96.60	0.00	0.00	0.00	11.59	7.73	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor3 (536_119:Ud_2h)	13324-143B3	591.82	18.18	107.05	1.01	1.01	3.03	6.06	6.06	1.01	0.00
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor4 (227_121:Ud_2h)	13312-142I9	492.05	15.60	89.39	0.42	2.11	2.11	6.75	10.54	1.26	0.42
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor1 (868_121:Ud_7h)	13307-142I4	655.09	17.71	93.97	2.72	1.36	1.36	14.98	6.81	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor2 (150_120:Ud_7h)	13319-143A7	359.22	13.99	57.86	3.18	1.91	1.91	5.72	3.81	0.00	0.64
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor3 (536_119:Ud_7h)	13325-143B4	415.45	10.53	66.41	2.43	0.00	1.62	4.86	5.67	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor4 (227_121:Ud_7h)	13313-143A1	629.85	19.64	148.02	0.00	1.51	4.53	10.57	9.06	1.51	3.02
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor1 (868_121:Ud_24h)	13308-142I5	713.77	11.42	131.33	0.00	5.71	0.00	0.00	5.71	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor2 (150_120:Ud_24h)	13320-143A8	564.40	48.94	117.45	3.26	3.26	0.00	16.31	13.05	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor3 (536_119:Ud_24h)	13326-143B5	370.69	9.50	42.77	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor4 (227_121:Ud_24h)	13314-143A2	614.90	50.20	87.84	12.55	12.55	0.00	0.00	0.00	12.55	0.00
Multipotent Cord Blood Unrestricted Somatic Stem Cells, donor1	11549-120C1	180.75	13.79	15.94	0.86	2.59	1.51	1.72	1.08	0.22	0.00
Multipotent Cord Blood Unrestricted Somatic Stem Cells, donor2	11629-122B9	148.94	27.70	16.72	1.57	3.66	2.09	2.61	2.09	0.52	0.00
Myoblast differentiation to myotubes, day00, Duchenne Muscular Dystrophy donor1	13496-145C4	103.46	8.68	46.06	2.00	0.00	3.34	1.33	1.33	0.00	0.67
Myoblast differentiation to myotubes, day00, Duchenne Muscular Dystrophy donor2	13505-145D4	364.78	15.86	85.98	0.83	2.09	2.09	0.83	1.25	1.25	0.00
Myoblast differentiation to myotubes, day00, Duchenne Muscular Dystrophy donor3	13514-145E4	509.39	31.56	96.40	1.33	6.65	4.18	8.56	4.75	1.33	0.00
Myoblast differentiation to myotubes, day00, control donor1	13469-144I4	202.67	22.34	28.73	4.79	6.38	3.19	0.00	0.00	0.00	0.00
Myoblast differentiation to myotubes, day00, control donor2	13478-145A4	83.63	6.80	31.96	0.00	0.68	0.00	0.68	0.68	0.00	0.00
Myoblast differentiation to myotubes, day00, control donor3	13487-145B4	477.79	31.24	67.99	0.00	12.86	1.84	27.56	0.00	0.00	0.00
Myoblast differentiation to myotubes, day01, Duchenne Muscular Dystrophy donor1	13497-145C5	66.13	9.63	29.30	1.67	1.26	3.35	1.26	2.09	0.84	0.00
Myoblast differentiation to myotubes, day01, Duchenne Muscular Dystrophy donor2	13506-145D5	284.50	12.32	69.50	1.39	2.56	1.16	3.49	2.09	0.93	0.23
Myoblast differentiation to myotubes, day01, Duchenne Muscular Dystrophy donor3	13515-145E5	161.87	17.83	38.91	1.62	4.05	2.70	1.35	1.08	0.27	0.27
Myoblast differentiation to myotubes, day01, control donor1	13470-144I5	142.12	16.61	20.81	1.68	3.36	1.26	1.68	0.84	0.42	0.00
Myoblast differentiation to myotubes, day01, control donor2	13479-145A5	122.48	11.13	22.27	0.00	0.00	0.00	22.27	0.00	0.00	0.00
Myoblast differentiation to myotubes, day01, control donor3	13488-145B5	161.81	11.42	36.73	1.49	2.48	3.47	2.48	1.49	0.50	0.00
Myoblast differentiation to myotubes, day02, Duchenne Muscular Dystrophy donor1	13498-145C6	159.42	16.24	49.53	1.35	3.52	2.17	5.14	1.62	0.27	0.27
Myoblast differentiation to myotubes, day02, Duchenne Muscular Dystrophy donor2	13507-145D6	194.27	13.15	43.98	1.59	0.91	0.45	1.59	3.85	0.68	0.23
Myoblast differentiation to myotubes, day02, Duchenne Muscular Dystrophy donor3	13516-145E6	228.30	21.88	44.91	1.96	1.47	2.45	1.96	0.49	0.82	0.00
Myoblast differentiation to myotubes, day02, control donor1	13471-144I6	143.43	19.32	22.42	1.82	1.64	1.82	1.28	0.73	0.36	0.18
Myoblast differentiation to myotubes, day02, control donor2	13480-145A6	85.93	11.14	35.01	3.18	1.06	0.53	2.65	2.12	0.53	0.53
Myoblast differentiation to myotubes, day02, control donor3	13489-145B6	162.08	7.20	33.62	1.80	0.60	1.20	0.60	1.20	0.60	0.00
Myoblast differentiation to myotubes, day03, Duchenne Muscular Dystrophy donor1	13499-145C7	251.71	27.24	55.46	3.28	5.25	2.63	11.16	4.27	1.31	0.66
Myoblast differentiation to myotubes, day03, Duchenne Muscular Dystrophy donor2	13508-145D7	185.72	12.68	45.37	1.46	1.63	0.81	2.44	0.98	0.81	0.00
Myoblast differentiation to myotubes, day03, control donor1	13472-144I7	186.96	21.52	28.04	1.41	2.29	1.41	1.23	1.41	0.53	0.18
Myoblast differentiation to myotubes, day03, control donor2	13481-145A7	54.85	9.14	28.83	2.81	0.70	0.70	0.00	0.00	2.11	1.41
Myoblast differentiation to myotubes, day03, control donor3	13490-145B7	177.91	12.41	34.02	2.30	0.00	0.00	4.14	2.76	0.00	0.46
Myoblast differentiation to myotubes, day04, Duchenne Muscular Dystrophy donor1	13500-145C8	100.58	14.46	33.42	1.93	0.64	1.93	2.25	0.32	0.64	0.32
Myoblast differentiation to myotubes, day04, Duchenne Muscular Dystrophy donor2	13509-145D8	536.65	23.80	81.39	2.41	6.55	3.45	10.69	5.17	0.69	0.34
Myoblast differentiation to myotubes, day04, Duchenne Muscular Dystrophy donor3	13518-145E8	427.31	20.23	15.17	0.00	12.64	5.06	12.64	0.00	0.00	0.00
Myoblast differentiation to myotubes, day04, control donor1	13473-144I8	159.07	21.16	30.97	3.79	2.23	2.90	0.89	0.22	0.45	0.00
Myoblast differentiation to myotubes, day04, control donor2	13482-145A8	76.63	8.47	22.02	2.96	0.85	0.00	2.54	2.54	0.42	0.42
Myoblast differentiation to myotubes, day04, control donor3	13491-145B8	215.28	15.90	61.00	3.56	1.90	1.19	2.37	1.66	1.66	0.24
Myoblast differentiation to myotubes, day06, Duchenne Muscular Dystrophy donor1	13501-145C9	100.01	6.87	24.04	3.86	1.29	2.15	0.43	2.15	0.86	0.00
Myoblast differentiation to myotubes, day06, Duchenne Muscular Dystrophy donor2	13510-145D9	117.36	9.03	9.03	9.03	0.00	0.00	18.06	0.00	0.00	0.00
Myoblast differentiation to myotubes, day06, Duchenne Muscular Dystrophy donor3	13519-145E9	169.94	17.33	34.32	2.33	3.33	1.33	1.67	0.67	0.00	0.00
Myoblast differentiation to myotubes, day06, control donor1	13474-144I9	133.91	12.17	16.68	4.96	3.61	0.90	0.45	0.90	0.00	0.45
Myoblast differentiation to myotubes, day06, control donor2	13483-145A9	64.28	5.95	28.57	3.57	0.00	3.57	2.78	0.79	0.40	0.40
Myoblast differentiation to myotubes, day06, control donor3	13492-145B9	132.80	5.57	44.57	3.71	0.00	0.93	1.86	1.86	0.00	0.00
Myoblast differentiation to myotubes, day08, Duchenne Muscular Dystrophy donor1	13502-145D1	118.05	9.84	30.65	4.54	1.89	0.76	4.92	3.41	0.38	0.00
Myoblast differentiation to myotubes, day08, Duchenne Muscular Dystrophy donor2	13511-145E1	116.99	6.84	26.40	2.61	1.96	0.98	1.30	1.30	0.00	0.00
Myoblast differentiation to myotubes, day08, Duchenne Muscular Dystrophy donor3	13520-145F1	224.87	13.95	33.99	1.74	2.61	1.74	0.44	0.44	0.00	0.00
Myoblast differentiation to myotubes, day08, control donor1	13475-145A1	118.05	16.28	23.97	6.33	1.81	1.36	1.36	0.45	0.00	0.00
Myoblast differentiation to myotubes, day08, control donor2	13484-145B1	79.37	5.29	26.46	3.53	0.88	0.00	3.53	3.53	1.76	0.00
Myoblast differentiation to myotubes, day08, control donor3	13493-145C1	124.99	9.31	31.91	1.33	0.00	0.66	0.66	0.66	0.66	0.00
Myoblast differentiation to myotubes, day10, Duchenne Muscular Dystrophy donor1	13503-145D2	120.04	5.95	26.79	5.46	2.98	1.49	2.48	0.99	0.00	0.00
Myoblast differentiation to myotubes, day10, Duchenne Muscular Dystrophy donor2	13512-145E2	119.44	9.57	20.29	3.45	3.83	0.38	0.00	0.38	0.00	0.38
Myoblast differentiation to myotubes, day10, Duchenne Muscular Dystrophy donor3	13521-145F2	100.41	9.68	22.08	6.65	2.42	0.00	1.81	2.42	0.30	0.00
Myoblast differentiation to myotubes, day10, control donor1	13476-145A2	113.16	14.59	17.68	3.54	1.77	1.99	1.33	0.88	0.00	0.00
Myoblast differentiation to myotubes, day10, control donor2	13485-145B2	95.55	4.74	23.04	4.07	2.03	0.68	1.36	3.39	0.68	0.00
Myoblast differentiation to myotubes, day10, control donor3	13494-145C2	275.91	25.55	40.88	5.11	0.00	0.00	5.11	0.00	0.00	0.00
Myoblast differentiation to myotubes, day12, Duchenne Muscular Dystrophy donor1	13504-145D3	118.28	7.93	29.26	3.66	1.83	0.61	1.22	0.00	0.61	0.00
Myoblast differentiation to myotubes, day12, Duchenne Muscular Dystrophy donor2	13513-145E3	125.26	7.55	23.92	1.89	1.57	1.26	0.63	0.94	0.94	0.31
Myoblast differentiation to myotubes, day12, Duchenne Muscular Dystrophy donor3	13522-145F3	156.17	15.44	29.96	3.63	1.51	2.12	1.21	1.51	0.30	0.00
Myoblast differentiation to myotubes, day12, control donor1	13477-145A3	109.18	2.37	29.27	4.75	0.00	0.79	0.79	0.79	0.00	0.00
Myoblast differentiation to myotubes, day12, control donor2	13486-145B3	250.54	20.41	48.75	1.13	4.53	3.40	17.00	2.27	1.13	0.00
Myoblast differentiation to myotubes, day12, control donor3	13495-145C3	151.74	5.06	25.29	0.00	0.00	0.00	25.29	5.06	5.06	0.00
Myoblast, donor1	11241-116D8	86.71	8.07	34.29	1.74	1.24	1.99	3.23	1.24	1.24	0.12
Myoblast, donor2	11322-117D8	139.24	16.49	29.73	1.92	3.26	2.11	4.22	1.92	0.19	0.19
Myoblast, donor3	11398-118D3	227.36	18.16	49.44	2.02	3.53	2.69	1.85	0.84	0.34	0.17
NK T cell leukemia cell line:KHYG-1	10777-110G3	186.65	57.50	17.80	12.84	11.67	4.09	1.31	1.02	0.58	0.00
Natural Killer Cells, donor1	11230-116C6	40.28	5.23	3.69	6.46	0.62	0.92	0.31	0.31	0.00	0.00
Natural Killer Cells, donor2	11311-117C6	30.46	8.75	3.32	5.43	0.60	0.60	1.21	0.00	0.00	0.00
Natural Killer Cells, donor3	11387-118C1	47.30	12.33	4.60	6.81	0.37	1.10	1.66	0.00	0.00	0.00
Neural stem cells, donor1	11275-116H6	95.82	22.87	9.44	2.18	2.90	1.81	1.45	0.36	0.00	0.00
Neural stem cells, donor2	11352-117H2	96.28	9.63	13.48	3.85	7.70	0.00	1.93	0.00	0.00	0.00
Neurons, donor1	11494-119E9	64.86	19.34	5.69	4.55	3.41	0.00	0.00	0.00	0.00	0.00
Neurons, donor2	11574-120E8	87.62	16.07	12.99	7.71	3.96	1.98	0.44	0.22	0.22	0.00
Neurons, donor3	11655-122E8	131.55	27.13	22.20	4.11	0.82	1.64	4.11	0.00	0.00	0.00
Neutrophils, donor1	11233-116C9	272.83	37.12	43.62	9.28	2.78	3.71	0.93	1.86	1.86	0.00
Neutrophils, donor2	11314-117C9	252.20	40.58	23.19	17.39	0.00	2.90	8.70	2.90	2.90	0.00
Neutrophils, donor3	11390-118C4	439.81	65.36	50.70	9.77	2.44	6.11	3.05	2.44	0.61	0.61
Nucleus Pulposus Cell, donor1	11252-116F1	99.14	19.24	10.57	1.90	2.97	1.54	1.07	0.47	0.12	0.00
Nucleus Pulposus Cell, donor2	11409-118E5	105.17	34.19	13.02	2.93	2.93	2.60	1.30	0.98	0.00	0.00
Nucleus Pulposus Cell, donor3	11462-119B4	119.73	23.46	8.82	1.60	4.01	0.80	1.60	1.00	0.00	0.20
Olfactory epithelial cells, donor1	11933-125I7	115.77	19.82	20.65	1.24	2.48	1.79	1.38	0.55	0.41	0.00
Olfactory epithelial cells, donor2	11934-125I8	143.15	19.40	29.24	0.87	1.74	2.75	3.47	3.33	0.58	0.29
Olfactory epithelial cells, donor3	11935-125I9	189.67	22.02	42.11	3.18	1.02	3.29	3.06	1.14	0.23	0.00
Olfactory epithelial cells, donor4	11936-126A1	115.03	19.19	16.07	2.63	0.78	1.95	1.36	0.39	0.00	0.10
Oligodendrocyte - precursors, donor1	11496-119F2	71.62	8.43	16.25	1.81	3.61	3.61	0.60	0.00	0.00	0.00
Osteoblast - differentiated, donor1	11276-116H7	135.49	16.59	18.29	1.28	2.34	2.34	2.77	0.85	0.00	0.00
Osteoblast - differentiated, donor2	11353-117H3	209.19	24.01	32.01	2.29	12.57	2.29	8.00	24.01	2.29	0.00
Osteoblast - differentiated, donor3	11425-118G3	294.22	52.76	57.11	6.83	8.07	3.10	8.07	1.86	1.86	0.00
Osteoblast, donor1	11277-116H8	73.48	20.91	9.19	1.56	4.50	2.54	0.39	0.00	0.00	0.00
Osteoblast, donor2	11354-117H4	67.42	14.05	4.92	0.70	1.40	0.00	0.00	0.00	0.00	0.00
Osteoblast, donor3	11426-118G4	106.46	18.31	18.31	2.31	4.62	1.96	1.96	0.36	0.00	0.00
Pancreatic stromal cells, donor1	11249-116E7	179.00	14.74	29.23	2.53	2.02	1.35	3.54	1.35	0.42	0.00
Pericytes, donor1	11491-119E6	171.91	30.15	12.57	1.89	5.67	2.45	1.45	0.67	0.22	0.00
Pericytes, donor2	11571-120E5	126.09	35.31	8.60	1.81	4.30	1.58	2.49	0.68	0.00	0.23
Pericytes, donor3	11652-122E5	88.70	14.65	11.39	2.03	1.83	1.63	0.81	0.41	0.00	0.00
Perineurial Cells, donor1	11499-119F5	57.75	9.38	4.18	1.92	1.92	1.70	0.11	0.00	0.11	0.11
Perineurial Cells, donor2	11579-120F4	64.87	10.49	5.52	0.74	2.94	1.01	0.74	0.09	0.00	0.00
Peripheral Blood Mononuclear Cells, donor1	11231-116C7	145.35	10.20	13.71	7.65	0.96	1.27	0.00	0.00	0.00	0.00
Peripheral Blood Mononuclear Cells, donor2	11312-117C7	150.84	16.65	20.08	6.12	0.98	1.96	1.71	2.20	0.00	0.00
Peripheral Blood Mononuclear Cells, donor3	11388-118C2	103.01	12.42	18.12	4.01	1.04	1.04	0.91	0.39	0.00	0.26
Placental Epithelial Cells, donor1	11278-116H9	157.85	23.44	31.81	1.20	1.91	1.91	4.07	0.24	0.72	0.00
Placental Epithelial Cells, donor2	11355-117H5	194.05	25.50	24.40	1.11	1.11	1.11	2.22	3.33	0.00	0.00
Placental Epithelial Cells, donor3	11427-118G5	97.97	21.60	18.85	1.18	3.14	3.73	2.75	0.00	0.20	0.00
Preadipocyte - breast donor2 (cytoplasmic fraction)	14319-155D8	189.55	13.29	46.20	1.90	2.85	5.38	14.24	14.24	5.70	0.00
Preadipocyte - breast, donor1	11467-119B9	156.64	13.51	24.95	3.19	0.94	3.00	3.75	1.50	0.19	0.00
Preadipocyte - breast, donor2 (nuclear fraction)	14320-155D9	45.03	4.31	6.79	3.65	0.91	1.31	0.78	0.26	0.00	0.39
Preadipocyte - breast, donor2	11328-117E5	183.72	24.77	37.82	2.48	3.15	1.80	7.43	4.05	2.25	0.23
Preadipocyte - omental, donor1	11468-119C1	116.68	12.25	23.55	1.81	1.07	1.49	3.84	1.92	0.11	0.11
Preadipocyte - omental, donor2	11329-117E6	230.89	18.77	37.97	3.49	1.75	4.36	0.44	1.31	1.75	0.00
Preadipocyte - omental, donor3	11403-118D8	186.37	17.76	44.41	2.86	4.58	5.01	4.58	1.00	0.29	0.00
Preadipocyte - perirenal, donor1	11469-119C2	198.82	7.87	18.70	0.00	5.91	4.92	4.92	2.95	0.00	0.00
Preadipocyte - subcutaneous, donor1	11279-116I1	138.51	16.28	20.27	0.92	4.61	2.46	1.84	0.31	0.00	0.00
Preadipocyte - subcutaneous, donor2	11356-117H6	122.71	22.67	20.36	1.06	2.48	2.83	4.07	1.06	0.53	0.00
Preadipocyte - subcutaneous, donor3	11428-118G6	128.56	20.77	24.86	0.68	5.79	2.89	5.62	1.70	0.34	0.00
Preadipocyte - visceral, donor1	11280-116I2	150.90	20.77	21.70	1.58	2.61	2.33	1.68	0.84	0.28	0.00
Preadipocyte - visceral, donor2	11357-117H7	92.04	17.95	22.55	0.92	1.38	1.84	3.68	1.84	0.00	0.00
Preadipocyte - visceral, donor3	11429-118G7	166.45	20.48	21.84	0.84	4.28	3.55	6.06	2.30	0.31	0.21
Prostate Epithelial Cells (polarized), donor1	11253-116F2	87.04	15.54	15.24	5.13	1.36	0.91	3.47	1.81	0.60	0.15
Prostate Epithelial Cells, donor2	11331-117E8	78.81	9.75	25.05	0.41	1.08	1.22	2.84	1.35	0.68	0.00
Prostate Epithelial Cells, donor3	11404-118D9	104.04	19.72	21.37	2.88	3.37	3.49	2.57	1.47	0.31	0.00
Prostate Stromal Cells, donor1	11254-116F3	92.49	11.62	13.33	1.59	2.16	1.03	1.37	0.91	0.11	0.00
Prostate Stromal Cells, donor2	11332-117E9	116.72	18.47	23.85	0.90	2.33	2.33	1.79	2.69	0.90	0.18
Prostate Stromal Cells, donor3	11405-118E1	166.63	18.46	32.12	2.61	2.71	1.98	4.28	1.15	0.73	0.31
Renal Cortical Epithelial Cells, donor1	11516-119H4	164.61	13.87	18.25	1.82	3.28	1.46	0.36	0.00	0.00	0.36
Renal Cortical Epithelial Cells, donor2	11596-120H3	99.88	9.36	12.48	1.18	0.97	0.76	1.11	0.35	0.00	0.07
Renal Epithelial Cells, donor1	11517-119H5	137.97	17.25	15.72	1.01	3.55	2.03	0.00	0.00	0.00	0.00
Renal Epithelial Cells, donor2	11597-120H4	103.14	13.52	15.65	1.42	3.56	1.42	0.00	0.00	0.00	0.00
Renal Epithelial Cells, donor3	11678-122H4	68.39	9.32	7.83	1.38	0.21	1.59	0.32	0.00	0.11	0.00
Renal Glomerular Endothelial Cells, donor1	11514-119H2	199.49	16.34	16.34	1.36	4.09	4.77	2.04	3.40	0.00	0.00
Renal Glomerular Endothelial Cells, donor2	11594-120H1	195.14	15.90	21.70	0.81	2.83	1.89	2.56	1.35	0.27	0.00
Renal Glomerular Endothelial Cells, donor3	11675-122H1	87.69	12.21	9.55	1.33	2.00	0.00	1.55	0.89	0.00	0.00
Renal Glomerular Endothelial Cells, donor4	11783-124B1	199.63	39.93	30.61	2.66	2.00	2.00	0.67	2.00	1.33	0.00
Renal Mesangial Cells, donor1	11518-119H6	81.65	12.32	7.92	0.66	2.20	1.10	0.88	0.44	0.00	0.22
Renal Mesangial Cells, donor2	11598-120H5	84.02	11.91	9.40	2.51	0.63	2.51	2.51	0.00	1.25	0.00
Renal Mesangial Cells, donor3	11679-122H5	99.04	21.64	16.09	1.39	4.16	1.11	0.83	0.55	0.28	0.00
Renal Proximal Tubular Epithelial Cell, donor1	11515-119H3	104.42	6.71	12.35	0.81	1.34	1.34	0.54	0.00	0.27	0.00
Renal Proximal Tubular Epithelial Cell, donor2	11595-120H2	103.74	10.54	13.07	0.00	2.53	0.42	0.00	1.27	0.00	0.00
Renal Proximal Tubular Epithelial Cell, donor3	11676-122H2	95.84	13.88	15.62	1.16	2.31	2.12	0.96	0.96	0.19	0.00
Retinal Pigment Epithelial Cells, donor0	11215-116A9	118.23	10.11	22.56	1.56	3.89	2.85	0.78	0.78	0.26	0.00
Retinal Pigment Epithelial Cells, donor1	11528-119I7	111.42	9.10	12.51	1.99	2.27	0.85	1.14	1.14	0.00	0.00
Retinal Pigment Epithelial Cells, donor2	11608-120I6	146.14	13.38	16.47	0.00	2.06	0.00	1.03	0.00	0.00	0.00
Retinal Pigment Epithelial Cells, donor3	11689-122I6	88.82	12.80	11.54	1.25	0.50	1.00	2.26	0.75	0.25	0.00
SABiosciences XpressRef Human Universal Total RNA, pool1	10002-101A5	245.36	27.93	33.41	6.55	2.41	3.47	3.07	0.53	0.53	0.40
Saos-2 osteosarcoma cell line, untreated control, day28, biol_rep1 (B1 T17)	12697-135D6	58.96	19.65	5.36	5.36	4.47	0.00	1.79	0.00	0.00	0.00
Saos-2 osteosarcoma cell line, untreated control, day28, biol_rep2 (B2 T17)	12795-136F5	31.37	5.50	4.95	1.65	1.10	1.65	3.30	0.00	0.00	0.00
Saos-2 osteosarcoma cell line, untreated control, day28, biol_rep3 (B3 T17)	12893-137H4	27.84	5.22	3.48	5.22	0.58	0.00	1.16	0.00	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr00min, biol_rep1 (A1 T0)	12662-134I7	40.31	10.92	1.43	2.21	3.25	1.17	0.52	0.78	0.13	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr00min, biol_rep2 (A2 T0)	12760-136B6	60.08	19.46	8.54	1.59	2.28	2.58	1.19	0.60	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr00min, biol_rep3 (A3 T0)	12858-137D5	55.88	11.93	4.24	2.01	1.56	1.56	0.45	0.67	0.22	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr15min, biol_rep1 (A1 T1)	12663-134I8	22.82	13.77	2.36	1.86	2.60	1.12	1.24	0.62	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr15min, biol_rep2 (A2 T1)	12761-136B7	65.73	22.96	8.86	1.75	3.85	2.33	1.75	0.70	0.12	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr15min, biol_rep3 (A3 T1)	12859-137D6	61.25	18.26	8.55	3.70	2.08	1.39	1.16	0.46	0.46	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr30min, biol_rep1 (A1 T2)	12664-134I9	37.24	9.45	1.64	1.64	3.01	1.51	0.14	0.68	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr30min, biol_rep2 (A2 T2)	12762-136B8	51.74	16.79	6.35	1.36	2.87	2.12	1.21	1.06	0.15	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr30min, biol_rep3 (A3 T2)	12860-137D7	60.75	16.49	6.27	1.43	2.15	1.43	0.54	0.00	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr45min, biol_rep1 (A1 T3)	12665-135A1	38.59	13.34	2.01	2.30	4.45	1.58	0.00	0.29	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr45min, biol_rep2 (A2 T3)	12763-136B9	51.08	21.78	6.76	2.36	3.43	1.50	1.29	0.86	0.11	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr45min, biol_rep3 (A3 T3)	12861-137D8	59.96	16.60	5.97	3.98	4.65	1.77	0.44	0.44	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr00min, biol_rep1 (A1 T4)	12666-135A2	26.76	7.84	2.49	1.53	2.68	1.72	0.38	0.96	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr00min, biol_rep2 (A2 T4)	12764-136C1	56.92	22.27	6.89	2.70	2.89	1.96	0.93	0.47	0.09	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr00min, biol_rep3 (A3 T4)	12862-137D9	41.53	14.84	3.19	2.07	1.13	0.56	0.38	0.19	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr20min, biol_rep1 (A1 T5)	12667-135A3	48.31	14.07	3.32	0.93	4.78	1.99	0.27	0.66	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr20min, biol_rep2 (A2 T5)	12765-136C2	55.29	17.52	5.74	1.75	1.95	1.65	0.97	0.29	0.19	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr20min, biol_rep3 (A3 T5)	12863-137E1	55.38	17.95	4.39	2.10	1.72	1.53	0.76	0.19	0.19	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr40min, biol_rep1 (A1 T6)	12668-135A4	43.04	11.85	2.46	1.39	3.10	0.96	0.75	0.43	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr40min, biol_rep2 (A2 T6)	12766-136C3	52.70	17.38	5.33	1.68	0.84	1.40	0.84	0.56	0.28	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr40min, biol_rep3 (A3 T6)	12864-137E2	44.09	16.75	4.96	2.22	2.39	1.37	0.85	0.34	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr00min, biol_rep1 (A1 T7)	12669-135A5	39.02	14.77	2.37	2.92	3.28	2.01	0.73	0.36	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr00min, biol_rep2 (A2 T7)	12767-136C4	58.74	21.83	6.87	1.10	3.31	2.58	0.74	0.49	0.12	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr00min, biol_rep3 (A3 T7)	12865-137E3	55.88	18.67	7.92	2.42	4.57	2.28	1.75	0.54	0.00	0.13
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr30min, biol_rep1 (A1 T8)	12670-135A6	12.50	10.85	1.89	1.18	3.54	0.71	0.47	0.47	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr30min, biol_rep2 (A2 T8)	12768-136C5	58.33	20.44	5.56	1.98	3.37	2.98	0.79	0.79	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr30min, biol_rep3 (A3 T8)	12866-137E4	56.36	15.90	5.38	3.04	3.51	1.64	1.40	0.47	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 03hr, biol_rep1 (A1 T9)	12671-135A7	34.63	9.95	2.90	1.24	3.94	1.04	0.83	0.00	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 03hr, biol_rep2 (A2 T9)	12769-136C6	45.57	18.14	1.99	1.77	1.33	3.32	1.77	2.21	0.22	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 03hr, biol_rep3 (A3 T9)	12867-137E5	44.70	13.58	2.72	2.30	3.13	2.30	1.04	0.21	0.42	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 04hr, biol_rep1 (A1 T10)	12672-135A8	34.18	13.05	2.69	1.88	3.77	2.29	0.13	0.13	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 04hr, biol_rep2 (A2 T10)	12770-136C7	49.39	16.52	5.79	2.55	2.72	1.19	0.17	0.34	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 04hr, biol_rep3 (A3 T10)	12868-137E6	48.20	14.46	5.78	2.12	2.89	1.35	1.35	0.19	0.00	0.19
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 08hr, biol_rep1 (A1 T11)	12673-135A9	30.95	10.83	2.24	3.09	4.30	0.86	0.52	0.86	0.17	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 08hr, biol_rep2 (A2 T11)	12771-136C8	55.55	21.12	7.68	1.65	4.39	2.33	0.41	0.41	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 08hr, biol_rep3 (A3 T11)	12869-137E7	47.94	15.76	5.09	1.97	1.64	2.13	1.15	0.33	0.33	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 24hr, biol_rep1 (A1 T12)	12674-135B1	29.48	8.86	2.22	1.87	4.09	1.36	0.51	0.17	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 24hr, biol_rep2 (A2 T12)	12772-136C9	61.70	14.94	7.10	1.48	2.52	1.48	0.89	0.30	0.15	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 24hr, biol_rep3 (A3 T12)	12870-137E8	43.45	10.66	3.47	1.87	1.60	1.87	0.53	0.53	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day04, biol_rep1 (A1 T13)	12675-135B2	98.58	22.26	4.56	2.49	5.67	2.21	1.38	0.55	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day04, biol_rep2 (A2 T13)	12773-136D1	69.53	19.52	7.86	3.33	5.24	2.62	1.19	0.24	0.24	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day04, biol_rep3 (A3 T13)	12871-137E9	57.64	21.97	5.24	3.63	2.42	1.81	0.20	0.20	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day07, biol_rep1 (A1 T14)	12676-135B3	69.78	18.27	4.80	2.73	4.80	2.73	1.04	1.41	0.28	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day07, biol_rep2 (A2 T14)	12774-136D2	144.29	33.89	13.97	2.79	4.54	3.49	2.79	1.75	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day07, biol_rep3 (A3 T14)	12872-137F1	139.62	25.69	16.62	3.02	4.84	5.44	1.81	0.00	0.60	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day14, biol_rep1 (A1 T15)	12677-135B4	65.11	18.73	2.57	2.45	2.81	1.59	0.86	1.10	0.12	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day14, biol_rep2 (A2 T15)	12775-136D3	116.44	26.20	12.08	9.02	2.77	2.91	1.16	0.73	0.15	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day14, biol_rep3 (A3 T15)	12873-137F2	124.12	29.20	13.39	5.48	1.83	1.22	2.43	1.83	1.22	1.22
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day21, biol_rep1 (A1 T16)	12678-135B5	46.11	11.75	3.32	3.62	3.32	1.81	1.51	0.00	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day21, biol_rep2 (A2 T16)	12776-136D4	126.21	33.02	12.67	3.17	2.49	2.49	2.94	1.58	0.23	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day21, biol_rep3 (A3 T16)	12874-137F3	98.25	28.46	10.48	4.19	3.29	3.59	1.20	2.10	0.30	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day28, biol_rep1 (A1 T17)	12679-135B6	91.74	16.06	3.66	4.72	3.42	2.13	2.83	0.83	0.24	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day28, biol_rep2 (A2 T17)	12777-136D5	99.47	24.12	11.95	3.20	2.13	3.20	2.99	5.98	0.85	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day28, biol_rep3 (A3 T17)	12875-137F4	75.12	21.64	7.81	6.61	3.00	0.60	2.40	3.61	0.60	0.00
Schwann Cells, donor1	11498-119F4	95.54	19.00	9.59	0.75	4.33	3.01	1.32	0.75	0.00	0.19
Schwann Cells, donor2	11578-120F3	78.26	3.40	17.01	0.00	0.00	3.40	3.40	0.00	0.00	0.00
Schwann Cells, donor3	11659-122F3	111.51	20.59	16.43	1.31	3.94	1.53	2.19	0.88	0.00	0.00
Sebocyte, donor1	11220-116B5	89.83	6.57	15.34	1.10	2.74	2.74	1.10	0.55	0.00	0.00
Sebocyte, donor2	11301-117B5	45.96	4.60	12.87	0.46	0.46	0.46	0.46	0.46	0.00	0.00
Sebocyte, donor3	11378-118B1	104.91	14.02	32.36	1.03	2.68	1.86	2.27	0.41	0.21	0.00
Sertoli Cells, donor1	11255-116F4	110.99	13.25	19.88	3.31	1.66	0.00	3.31	0.00	0.00	0.00
Sertoli Cells, donor2	11333-117F1	79.08	16.95	8.47	0.00	0.00	0.00	2.82	2.82	2.82	0.00
Skeletal Muscle Cells, donor1	11281-116I3	71.88	24.55	8.01	1.58	3.08	1.58	2.02	0.00	0.09	0.00
Skeletal Muscle Cells, donor2	11358-117H8	204.56	36.87	30.36	6.51	6.51	2.89	3.61	0.00	1.45	0.00
Skeletal Muscle Cells, donor3	11430-118G8	72.74	15.05	3.34	0.00	4.18	4.18	1.67	0.84	0.00	0.00
Skeletal Muscle Cells, donor4	11451-119A2	71.79	16.18	8.64	1.10	2.83	1.73	2.20	0.94	0.16	0.00
Skeletal Muscle Cells, donor5	11455-119A6	59.01	12.93	8.77	1.64	2.23	1.64	1.64	1.19	0.00	0.00
Skeletal Muscle Cells, donor6	11459-119B1	47.86	7.39	10.62	1.54	3.23	1.54	1.69	0.62	0.00	0.00
Skeletal Muscle Satellite Cells, donor1	11240-116D7	75.48	15.75	10.84	3.78	1.13	1.01	0.88	0.50	0.13	0.00
Skeletal Muscle Satellite Cells, donor2	11321-117D7	54.22	13.41	9.42	2.57	1.85	1.71	1.57	0.57	0.00	0.00
Skeletal Muscle Satellite Cells, donor3	11397-118D2	97.82	16.96	19.35	2.18	2.58	1.09	1.09	0.30	0.20	0.10
Skeletal muscle cells differentiated into Myotubes - multinucleated, donor1	11282-116I4	55.69	15.42	7.50	2.11	2.95	1.60	0.67	0.00	0.08	0.00
Skeletal muscle cells differentiated into Myotubes - multinucleated, donor2	11359-117H9	63.69	16.65	7.96	0.00	3.62	0.00	0.72	0.00	0.00	0.72
Skeletal muscle cells differentiated into Myotubes - multinucleated, donor3	11431-118G9	58.89	14.17	4.82	1.65	3.85	1.51	1.79	0.55	0.28	0.00
Skin - palm, donor1	10286-104F7	26.86	8.06	10.74	10.74	0.00	0.00	0.00	0.00	0.00	0.00
Small Airway Epithelial Cells donor2 (cytoplasmic fraction)	14334-155F5	61.99	7.06	11.96	1.87	0.00	1.01	2.31	0.72	0.29	0.00
Small Airway Epithelial Cells donor2 (nuclear fraction)	14335-155F6	5.73	0.00	1.64	7.36	0.00	0.00	0.82	0.00	0.00	0.00
Small Airway Epithelial Cells donor3 (cytoplasmic fraction)	14316-155D5	53.36	7.27	10.26	1.17	0.65	1.69	2.34	0.78	0.13	0.00
Small Airway Epithelial Cells, donor1	11256-116F5	72.98	11.82	12.65	2.64	1.53	0.83	2.22	0.28	0.14	0.00
Small Airway Epithelial Cells, donor2	11334-117F2	82.28	14.21	13.93	2.53	1.41	2.11	0.98	0.70	0.14	0.00
Small Airway Epithelial Cells, donor3 (nuclear fraction)	14317-155D6	31.93	5.07	3.59	7.19	0.85	1.06	0.00	0.21	0.00	0.21
Small Airway Epithelial Cells, donor3	11406-118E2	132.36	24.21	26.08	4.42	2.62	2.55	1.65	0.60	0.30	0.00
Smooth Muscle Cells - Aortic, donor0 (cytoplasmic fraction)	14313-155D2	114.18	12.96	12.34	1.85	4.01	1.85	3.70	1.85	0.31	0.31
Smooth Muscle Cells - Aortic, donor0 (nuclear fraction)	14314-155D3	35.35	2.67	2.45	4.22	1.33	0.67	1.33	0.67	0.00	0.00
Smooth Muscle Cells - Aortic, donor0	11210-116A4	161.65	12.93	28.80	2.35	2.35	5.29	0.59	0.00	0.00	0.59
Smooth Muscle Cells - Aortic, donor1	11283-116I5	94.36	11.05	10.61	0.44	1.77	2.65	1.99	0.22	0.00	0.00
Smooth Muscle Cells - Aortic, donor2	11360-117I1	108.68	9.06	26.38	0.79	1.97	2.36	1.18	1.18	0.39	0.00
Smooth Muscle Cells - Aortic, donor3	11432-118H1	122.84	12.36	19.31	0.77	3.09	0.77	0.77	1.55	0.00	0.00
Smooth Muscle Cells - Bladder, donor1	11519-119H7	53.04	21.02	5.00	3.00	2.00	1.00	2.00	2.00	0.00	0.00
Smooth Muscle Cells - Brachiocephalic, donor1	11284-116I6	48.97	7.45	13.84	1.20	1.86	1.86	1.06	0.40	0.00	0.00
Smooth Muscle Cells - Brachiocephalic, donor2	11361-117I2	78.02	13.30	11.75	1.11	3.32	2.66	2.44	1.11	0.66	0.22
Smooth Muscle Cells - Brachiocephalic, donor3	11433-118H2	89.49	7.94	10.63	1.41	1.66	1.28	1.41	1.54	0.00	0.26
Smooth Muscle Cells - Brain Vascular, donor1	11234-116D1	140.98	13.02	30.93	0.65	2.93	1.63	1.63	1.63	0.00	0.00
Smooth Muscle Cells - Brain Vascular, donor2	11315-117D1	148.55	17.42	16.83	1.18	4.43	2.95	1.77	0.30	0.00	0.30
Smooth Muscle Cells - Brain Vascular, donor3	11391-118C5	138.52	14.81	34.88	2.42	1.85	2.28	2.85	0.43	0.43	0.00
Smooth Muscle Cells - Bronchial, donor1	11512-119G9	182.03	16.76	22.77	2.44	3.09	1.95	0.33	0.65	0.00	0.00
Smooth Muscle Cells - Bronchial, donor2	11592-120G8	116.29	17.96	14.61	2.44	3.96	2.44	2.13	0.30	0.61	0.00
Smooth Muscle Cells - Carotid, donor1	11285-116I7	89.66	18.18	10.61	1.01	4.29	1.26	1.26	0.00	0.00	0.00
Smooth Muscle Cells - Carotid, donor2	11362-117I3	91.81	12.24	6.12	0.00	0.00	6.12	12.24	0.00	0.00	0.00
Smooth Muscle Cells - Carotid, donor3	11434-118H3	109.67	20.98	6.68	0.95	2.86	0.95	1.43	0.95	0.00	0.00
Smooth Muscle Cells - Colonic, donor1	11239-116D6	96.60	12.09	9.29	1.18	1.77	1.77	1.03	0.29	0.29	0.00
Smooth Muscle Cells - Colonic, donor2	11320-117D6	105.47	14.42	22.17	1.94	1.29	0.65	4.52	1.51	0.65	0.00
Smooth Muscle Cells - Colonic, donor3	11396-118D1	110.42	12.80	34.43	1.78	1.47	1.15	2.73	1.15	0.42	0.00
Smooth Muscle Cells - Coronary Artery, donor1	11286-116I8	124.21	11.91	28.00	1.55	2.17	2.94	1.39	0.62	0.00	0.00
Smooth Muscle Cells - Coronary Artery, donor2	11363-117I4	123.96	16.17	23.71	2.16	1.08	3.23	0.00	1.08	1.08	1.08
Smooth Muscle Cells - Coronary Artery, donor3	11435-118H4	131.20	11.06	15.84	1.49	1.79	2.99	2.09	0.60	0.30	0.00
Smooth Muscle Cells - Esophageal, donor1	11508-119G5	111.30	16.39	11.27	1.02	6.49	2.05	0.68	0.00	0.00	0.00
Smooth Muscle Cells - Esophageal, donor2	11588-120G4	70.21	18.69	7.54	3.93	0.79	1.41	0.55	0.00	0.08	0.00
Smooth Muscle Cells - Internal Thoracic Artery, donor1	11287-116I9	151.87	16.40	20.53	2.52	2.01	1.61	4.93	0.91	0.10	0.00
Smooth Muscle Cells - Internal Thoracic Artery, donor2	11364-117I5	165.20	17.07	27.53	0.91	2.96	2.73	3.41	0.91	0.00	0.23
Smooth Muscle Cells - Internal Thoracic Artery, donor3	11436-118H5	73.06	13.28	9.06	0.60	0.60	0.60	1.81	1.21	0.60	0.00
Smooth Muscle Cells - Intestinal, donor1	11509-119G6	114.71	7.68	11.39	1.32	2.38	1.06	0.53	0.00	0.00	0.00
Smooth Muscle Cells - Prostate, donor1	11257-116F6	109.59	12.38	8.39	2.66	2.80	0.67	1.20	0.00	0.00	0.00
Smooth Muscle Cells - Prostate, donor2	11335-117F3	112.20	17.53	18.16	1.88	2.75	1.75	2.75	0.63	0.75	0.13
Smooth Muscle Cells - Prostate, donor3	11465-119B7	291.97	19.02	37.03	1.78	3.04	1.01	3.04	1.01	0.76	0.25
Smooth Muscle Cells - Pulmonary Artery, donor1	11288-117A1	67.24	9.95	13.12	0.90	2.11	2.41	1.51	0.30	0.00	0.00
Smooth Muscle Cells - Pulmonary Artery, donor2	11365-117I6	53.26	13.50	15.00	0.75	2.25	0.75	2.25	0.00	0.75	0.00
Smooth Muscle Cells - Pulmonary Artery, donor3	11437-118H6	78.83	16.80	7.75	1.29	0.00	0.00	19.38	2.58	0.00	1.29
Smooth Muscle Cells - Subclavian Artery, donor1	11289-117A2	81.39	19.07	4.19	1.40	2.79	4.19	1.86	0.00	0.00	0.00
Smooth Muscle Cells - Subclavian Artery, donor2	11366-117I7	123.19	28.78	17.17	1.01	4.04	4.54	3.03	1.01	0.00	0.00
Smooth Muscle Cells - Subclavian Artery, donor3	11438-118H7	91.82	9.72	10.66	1.25	2.19	2.19	2.19	1.57	0.00	0.00
Smooth Muscle Cells - Tracheal, donor1	11513-119H1	141.30	13.86	17.70	3.24	2.36	0.88	2.36	0.29	0.00	0.29
Smooth Muscle Cells - Tracheal, donor2	11593-120G9	91.72	10.83	9.75	1.25	3.00	2.00	0.17	0.08	0.00	0.08
Smooth Muscle Cells - Tracheal, donor3	11674-122G9	157.43	28.03	28.50	1.87	3.27	1.87	1.40	0.00	0.47	0.00
Smooth Muscle Cells - Umbilical Artery, donor1	11290-117A3	110.96	11.80	15.69	1.01	1.44	1.44	1.30	0.14	0.00	0.00
Smooth Muscle Cells - Umbilical Artery, donor2	11367-117I8	90.25	16.83	13.26	1.78	2.29	2.29	3.06	1.02	0.00	0.00
Smooth Muscle Cells - Umbilical Artery, donor3	11439-118H8	70.70	13.35	8.84	0.94	3.20	1.88	0.94	0.38	0.19	0.00
Smooth Muscle Cells - Umbilical Vein, donor1	11541-120B2	77.70	8.66	7.41	1.54	3.35	1.12	1.12	0.14	0.14	0.00
Smooth Muscle Cells - Umbilical Vein, donor2	11621-122B1	81.94	12.65	8.88	1.34	2.09	2.01	0.17	0.00	0.17	0.00
Smooth Muscle Cells - Umbilical Vein, donor3	11702-123B1	245.23	20.48	40.48	7.14	2.38	0.95	0.95	1.43	0.48	0.00
Smooth Muscle Cells - Umbilical artery, donor0	11212-116A6	117.93	14.19	23.24	2.94	3.43	1.22	1.22	0.00	0.00	0.00
Smooth Muscle Cells - Uterine, donor1	11258-116F7	132.35	14.58	11.27	1.33	3.54	1.99	1.10	0.00	0.22	0.00
Smooth Muscle Cells - Uterine, donor3	11466-119B8	119.08	15.21	16.97	2.05	3.80	2.63	2.63	1.17	0.88	0.00
Smooth muscle cells - airway, asthmatic, donor1	11960-126C7	77.74	11.08	16.13	4.28	0.78	1.55	2.14	2.14	0.39	0.19
Smooth muscle cells - airway, asthmatic, donor2	11961-126C8	154.97	13.22	25.92	0.79	2.38	0.26	4.23	7.14	1.59	0.53
Smooth muscle cells - airway, asthmatic, donor3	11962-126C9	42.77	3.35	4.46	4.46	0.74	0.37	9.67	5.58	1.12	0.37
Smooth muscle cells - airway, asthmatic, donor4	11963-126D1	93.43	8.62	25.87	1.44	2.16	1.08	5.03	3.23	0.00	0.00
Smooth muscle cells - airway, asthmatic, donor5	11964-126D2	135.99	10.50	33.78	1.14	2.27	2.56	1.99	3.41	0.57	0.28
Smooth muscle cells - airway, asthmatic, donor6	11965-126D3	67.75	9.06	13.39	2.36	3.15	2.76	3.94	0.79	0.39	0.00
Smooth muscle cells - airway, control, donor1	11966-126D4	101.33	8.89	14.73	3.81	0.25	0.25	6.09	3.30	0.76	0.00
Smooth muscle cells - airway, control, donor2	11967-126D5	129.78	14.38	19.17	4.79	0.00	0.80	3.59	2.00	0.40	0.40
Smooth muscle cells - airway, control, donor3	11968-126D6	150.06	17.14	25.92	3.76	3.76	0.84	5.43	8.36	1.25	0.42
Smooth muscle cells - airway, control, donor4	11969-126D7	125.13	16.04	21.54	3.67	3.67	1.38	1.83	5.96	1.38	0.00
Synoviocyte, donor1	11291-117A4	107.89	12.46	15.99	1.01	1.18	2.02	1.51	0.50	0.17	0.00
Synoviocyte, donor2	11368-117I9	130.91	22.29	26.48	1.84	2.85	1.51	4.02	0.50	0.50	0.17
Synoviocyte, donor3	11440-118H9	133.60	28.82	16.53	2.68	2.90	2.90	5.36	2.46	0.00	0.00
Trabecular Meshwork Cells, donor1	11532-120A2	70.04	9.65	9.29	1.79	2.14	0.71	0.71	0.00	0.00	0.00
Trabecular Meshwork Cells, donor2	11612-122A1	59.46	13.87	13.87	1.98	1.98	0.00	3.96	0.00	0.00	0.00
Trabecular Meshwork Cells, donor3	11693-123A1	96.79	15.75	15.05	1.85	3.24	2.32	0.93	0.23	0.00	0.00
Tracheal Epithelial Cells, donor1	11292-117A5	61.29	8.67	7.67	0.72	0.86	1.22	0.72	0.29	0.14	0.00
Tracheal Epithelial Cells, donor2	11369-118A1	67.26	8.89	11.21	0.39	0.39	0.77	0.77	0.00	0.00	0.00
Tracheal Epithelial Cells, donor3	11441-118I1	60.70	6.87	6.87	1.72	0.57	2.29	0.57	0.57	0.00	0.00
Universal RNA - Human Normal Tissues Biochain, pool1	10007-101B4	232.88	28.54	35.43	5.66	2.09	3.94	3.69	0.62	0.74	0.37
Urethra, donor2	10319-105A4	30.57	7.19	3.60	12.59	0.00	1.80	0.00	1.80	0.00	0.00
Urothelial Cells, donor1	11520-119H8	77.04	7.70	8.24	1.59	1.33	0.53	0.27	0.27	0.00	0.00
Urothelial Cells, donor2	11600-120H7	59.68	8.81	10.41	1.20	2.40	0.40	1.20	0.00	0.40	0.00
Urothelial Cells, donor3	11681-122H7	61.20	10.31	10.54	1.15	1.15	0.92	0.92	0.46	0.00	0.00
Urothelial cells, donor0	11216-116B1	97.18	14.49	13.82	2.45	0.89	1.11	0.22	0.00	0.00	0.00
Whole blood (ribopure), donor090309, donation1	12179-129A1	188.63	25.80	11.57	5.34	0.89	0.00	0.00	0.00	0.00	0.00
Whole blood (ribopure), donor090309, donation2	12180-129A2	190.14	24.30	11.44	8.58	0.00	1.43	0.00	0.00	0.00	0.00
Whole blood (ribopure), donor090309, donation3	12181-129A3	165.65	15.06	19.17	9.58	0.00	3.42	0.68	1.37	0.00	0.00
Whole blood (ribopure), donor090325, donation1	12176-128I7	112.94	13.77	10.67	11.71	0.69	0.34	0.00	1.38	0.00	0.00
Whole blood (ribopure), donor090325, donation2	12177-128I8	127.25	24.40	11.04	8.13	1.16	0.58	0.58	0.00	0.00	0.00
Whole blood (ribopure), donor090612, donation1	12182-129A4	192.63	28.11	11.45	7.29	0.00	1.04	2.08	0.00	0.00	0.00
Whole blood (ribopure), donor090612, donation2	12183-129A5	175.30	11.01	6.42	9.18	2.75	4.59	0.00	0.92	0.00	0.92
Whole blood (ribopure), donor090612, donation3	12184-129A6	152.45	24.65	13.69	11.87	1.83	2.74	4.56	0.91	0.00	0.00
Wilms' tumor cell line:G-401	10809-111A8	73.52	15.42	9.38	0.86	3.70	1.48	0.74	0.62	0.37	0.12
Wilms' tumor cell line:HFWT	10597-108E3	66.00	14.96	9.68	7.04	3.52	1.76	0.88	0.88	0.00	0.00
acantholytic squamous carcinoma cell line:HCC1806	10717-109I6	72.34	12.29	11.73	0.56	1.12	1.12	0.28	0.00	0.56	0.00
achilles tendon, donor2	10292-104G4	111.59	14.47	14.47	10.33	0.00	0.00	0.00	6.20	0.00	0.00
acute lymphoblastic leukemia (B-ALL) cell line:BALL-1	10455-106G5	64.50	20.14	8.16	4.08	5.35	2.04	0.51	0.51	0.51	0.00
acute lymphoblastic leukemia (B-ALL) cell line:NALM-6	10534-107G3	22.29	9.05	1.63	2.32	3.02	0.93	0.00	0.00	0.00	0.00
acute lymphoblastic leukemia (T-ALL) cell line:HPB-ALL	10429-106D6	33.95	10.68	2.73	7.00	0.71	2.14	0.36	0.00	0.12	0.00
acute lymphoblastic leukemia (T-ALL) cell line:Jurkat	10464-106H5	26.67	12.79	1.63	1.63	0.54	1.36	0.27	0.00	0.00	0.00
acute myeloid leukemia (FAB M0) cell line:KG-1	10827-111C8	24.17	11.81	1.41	2.53	2.81	0.28	0.00	0.00	0.00	0.00
acute myeloid leukemia (FAB M0) cell line:Kasumi-3	10789-110H6	79.31	22.42	7.19	4.44	2.11	1.69	0.63	0.85	0.21	0.00
acute myeloid leukemia (FAB M1) cell line:HYT-1	10828-111C9	40.02	20.14	4.08	0.82	2.45	1.63	0.82	0.82	0.27	0.00
acute myeloid leukemia (FAB M2) cell line:Kasumi-1	10788-110H5	33.49	9.69	4.85	1.32	1.32	1.32	1.32	0.88	0.00	0.00
acute myeloid leukemia (FAB M2) cell line:Kasumi-6	10792-110H9	43.69	15.93	5.72	4.49	0.41	0.82	0.41	0.41	0.00	0.00
acute myeloid leukemia (FAB M2) cell line:NKM-1	10765-110E9	88.14	12.43	10.10	8.15	11.65	3.49	0.00	0.78	0.00	0.39
acute myeloid leukemia (FAB M3) cell line:HL60	10829-111D1	18.03	6.26	1.66	1.47	0.92	1.29	0.55	0.00	0.00	0.00
acute myeloid leukemia (FAB M4) cell line:FKH-1	10830-111D2	50.71	7.80	0.00	3.90	3.90	0.00	0.00	0.00	0.00	0.00
acute myeloid leukemia (FAB M4) cell line:HNT-34	10831-111D3	17.43	11.62	3.02	0.23	1.63	1.63	0.23	0.00	0.00	0.00
acute myeloid leukemia (FAB M4eo) cell line:EoL-1	10832-111D4	19.68	8.54	1.04	2.59	0.52	1.55	0.52	0.00	0.00	0.00
acute myeloid leukemia (FAB M4eo) cell line:EoL-3	10833-111D5	26.01	11.69	3.51	1.17	1.75	0.58	0.88	0.58	0.00	0.00
acute myeloid leukemia (FAB M5) cell line:NOMO-1	10764-110E8	42.29	13.48	8.37	3.25	2.79	0.46	0.00	0.00	0.00	0.00
acute myeloid leukemia (FAB M5) cell line:P31/FUJ	10770-110F5	62.51	22.62	6.58	3.70	2.06	3.29	1.23	0.82	0.82	0.00
acute myeloid leukemia (FAB M5) cell line:THP-1 (cytoplasmic fraction)	14298-155B5	86.25	18.42	10.13	1.53	5.53	0.92	0.61	1.23	0.31	0.00
acute myeloid leukemia (FAB M5) cell line:THP-1 (fresh)	10399-106A3	136.97	17.07	17.07	2.13	3.41	2.99	1.28	0.00	0.00	0.43
acute myeloid leukemia (FAB M5) cell line:THP-1 (revived)	10400-106A4	111.31	27.90	13.65	2.73	4.85	0.91	0.30	0.00	0.00	0.00
acute myeloid leukemia (FAB M5) cell line:THP-1 (thawed)	10405-106A9	110.24	25.03	11.55	1.20	4.81	1.68	0.00	0.00	0.00	0.00
acute myeloid leukemia (FAB M5) cell line:U-937 DE-4	10834-111D6	71.05	18.71	7.35	3.12	1.78	1.11	0.89	0.45	0.22	0.22
acute myeloid leukemia (FAB M6) cell line:EEB	10835-111D7	14.01	7.67	2.00	2.67	1.00	1.33	0.33	0.00	0.00	0.00
acute myeloid leukemia (FAB M6) cell line:F-36E	10836-111D8	20.44	3.72	1.86	0.00	3.72	1.86	0.00	0.00	0.00	0.00
acute myeloid leukemia (FAB M6) cell line:F-36P	10837-111D9	9.42	6.03	0.00	0.75	0.75	0.00	0.00	0.00	0.00	0.00
acute myeloid leukemia (FAB M7) cell line:M-MOK	10699-109G6	34.89	27.04	4.36	3.93	3.05	1.74	0.00	0.00	0.00	0.00
acute myeloid leukemia (FAB M7) cell line:MKPL-1	10802-111A1	31.87	7.50	3.75	9.37	13.12	1.87	0.00	0.00	0.00	0.00
adenocarcinoma cell line:IM95m	10796-110I4	116.81	19.78	17.43	3.06	2.83	0.71	0.71	0.24	0.47	0.24
adipose tissue, adult, pool1	10010-101C1	115.25	15.05	16.75	2.48	0.93	2.17	1.86	0.62	0.47	0.16
adipose, donor1	10184-103D4	45.74	10.56	4.10	9.97	2.93	0.00	5.86	2.35	0.00	0.00
adipose, donor2	10185-103D5	111.52	30.82	12.17	10.95	5.68	1.62	3.24	1.22	0.41	0.00
adipose, donor3	10186-103D6	79.24	21.51	11.44	7.35	3.54	1.91	4.63	1.63	0.27	0.00
adipose, donor4	10187-103D7	71.07	21.67	6.07	1.73	3.47	0.87	6.07	3.47	0.00	0.00
adrenal cortex adenocarcinoma cell line:SW-13	10810-111A9	54.45	24.94	3.95	3.47	19.41	5.68	0.16	0.16	0.00	0.16
adrenal gland, adult, pool1	10081-102A9	134.59	18.19	43.65	0.00	10.91	0.00	3.64	0.00	0.00	0.00
adult T-cell leukemia cell line:ATN-1	10421-106C7	27.88	11.61	2.93	6.27	2.13	0.80	0.27	0.40	0.13	0.00
alveolar cell carcinoma cell line:SW 1573	10708-109H6	95.04	15.36	15.01	2.14	1.07	0.36	0.36	0.71	0.36	0.00
amniotic membrane cells, donor1	12235-129G3	249.24	24.34	37.79	3.71	2.78	6.26	3.25	3.48	1.16	0.00
amniotic membrane cells, donor2	12236-129G4	180.89	21.30	19.27	2.70	1.35	1.35	2.03	1.01	0.34	0.00
amniotic membrane cells, donor3	12237-129G5	169.10	25.63	18.85	2.06	2.65	2.95	0.88	1.77	0.29	0.00
amygdala - adult, donor10196	10167-103B5	15.42	4.74	2.37	8.30	2.37	1.19	1.19	1.19	0.00	0.00
amygdala, adult, donor10252	10151-102I7	54.75	12.77	6.89	10.54	3.65	2.03	0.41	0.61	0.00	0.00
amygdala, newborn, donor10223	10360-105E9	33.25	6.46	5.16	9.36	0.65	1.61	0.97	0.97	0.00	0.00
anaplastic carcinoma cell line:8305C	10428-106D5	88.24	19.23	12.48	1.91	1.27	1.53	1.40	0.38	0.38	0.00
anaplastic large cell lymphoma cell line:Ki-JK	10795-110I3	28.68	9.05	5.52	3.31	1.32	0.88	0.22	0.00	0.00	0.00
anaplastic squamous cell carcinoma cell line:RPMI 2650	10805-111A4	38.08	16.37	3.01	10.02	5.34	1.34	0.00	0.33	0.00	0.00
aorta, adult, pool1	10052-101G7	101.60	20.59	15.69	3.92	1.96	2.55	0.78	0.39	0.20	0.00
appendix, adult	10189-103D9	30.27	8.93	5.05	13.58	0.39	0.00	0.00	0.00	0.00	0.39
argyrophil small cell carcinoma cell line:TC-YIK	10589-108D4	46.09	19.95	5.85	4.47	2.41	1.03	0.34	0.34	0.34	0.00
artery, adult	10190-103E1	80.16	16.30	8.15	1.36	0.00	1.36	4.08	1.36	1.36	0.00
astrocytoma cell line:TM-31	10425-106D2	70.41	21.15	7.97	5.07	4.06	2.17	0.43	0.00	0.14	0.00
b cell line:RPMI1788	10427-106D4	26.62	11.90	3.12	1.64	1.93	1.19	0.45	0.15	0.00	0.00
basal cell carcinoma cell line:TE 354.T	10702-109G9	278.83	14.15	40.23	1.94	1.39	2.50	3.33	3.05	0.55	0.28
bile duct carcinoma cell line:HuCCT1	10432-106D9	58.05	10.32	5.16	0.10	1.29	0.89	0.50	0.10	0.10	0.00
bile duct carcinoma cell line:TFK-1	10496-107C1	87.20	14.06	9.54	2.18	0.50	1.67	0.33	0.33	0.00	0.00
biphenotypic B myelomonocytic leukemia cell line:MV-4-11	10718-109I7	36.35	20.69	4.47	7.27	3.36	3.36	0.56	0.00	0.00	0.00
bladder, adult, pool1	10011-101C2	78.76	16.30	8.91	4.45	0.98	2.17	1.52	0.22	0.11	0.11
blood, adult, pool1	10053-101G8	192.67	19.93	35.43	2.21	0.00	4.43	2.21	0.00	2.21	0.00
bone marrow stromal cell line:StromaNKtert	10686-109F2	248.34	17.98	19.70	4.28	4.28	1.71	1.71	2.57	0.00	0.00
bone marrow, adult	10192-103E3	83.68	15.52	15.52	2.02	2.02	1.35	3.37	0.00	0.00	0.67
brain, adult, donor1	10084-102B3	41.00	12.30	3.08	9.23	3.08	0.00	1.03	0.00	0.00	0.00
brain, adult, pool1	10012-101C3	35.97	10.36	3.45	6.46	2.90	2.45	0.78	0.00	0.22	0.22
brain, fetal, pool1	10085-102B4	72.13	10.69	5.34	16.03	2.67	5.34	0.00	0.00	0.00	0.00
breast carcinoma cell line:MCF7	10482-107A5	56.16	33.37	4.96	2.97	8.59	0.99	0.99	0.00	0.00	0.00
breast carcinoma cell line:MDA-MB-453	10419-106C5	6.49	3.50	0.25	1.12	0.50	0.37	0.00	0.00	0.00	0.00
breast, adult, donor1	10080-102A8	217.82	17.05	46.72	1.89	3.16	4.42	3.79	3.16	0.63	0.00
bronchial squamous cell carcinoma cell line:KNS-62	10760-110E4	104.30	33.16	37.22	2.67	3.68	3.68	1.52	1.14	0.51	0.13
bronchioalveolar carcinoma cell line:NCI-H358	10709-109H7	77.61	17.63	9.28	0.93	0.93	1.24	0.31	0.31	0.00	0.00
bronchioalveolar carcinoma cell line:NCI-H650	10715-109I4	19.11	5.53	0.92	1.84	0.92	0.00	0.46	1.61	0.46	0.00
bronchogenic carcinoma cell line:ChaGo-K-1	10710-109H8	104.10	23.72	15.01	3.87	2.91	2.91	0.73	1.45	0.00	0.00
carcinoid cell line:NCI-H1770	10703-109H1	30.56	13.16	2.82	25.86	5.17	1.88	0.94	0.47	0.00	0.00
carcinoid cell line:NCI-H727	10735-110B6	68.14	15.53	11.59	2.30	3.94	1.64	0.44	0.00	0.00	0.00
carcinoid cell line:SK-PN-DW	10719-109I8	30.42	14.89	2.22	3.80	2.22	0.32	0.63	0.63	0.32	0.00
carcinosarcoma cell line:JHUCS-1	10642-109A3	52.97	26.09	3.19	5.06	3.99	1.06	1.60	0.53	0.00	0.00
caudate nucleus - adult, donor10196	10177-103C6	41.45	11.51	4.61	13.82	4.61	3.45	0.00	0.00	0.00	0.00
caudate nucleus, adult, donor10252	10164-103B2	52.04	18.57	7.36	16.06	3.68	2.18	0.33	0.00	0.00	0.17
caudate nucleus, adult, donor10258	10379-105H1	73.36	21.40	5.35	10.70	1.53	2.29	0.00	0.76	0.00	0.00
caudate nucleus, newborn, donor10223	10354-105E3	50.17	15.02	7.32	8.79	1.83	0.37	2.93	1.46	0.00	0.00
cerebellum - adult, donor10196	10173-103C2	8.74	5.83	0.00	29.13	2.91	0.00	0.00	0.00	0.00	0.00
cerebellum, adult, donor10252	10166-103B4	27.97	11.74	3.42	23.91	1.07	1.28	0.64	0.21	0.00	0.00
cerebellum, adult, pool1	10083-102B2	25.18	9.31	4.83	14.14	2.07	1.03	0.69	0.69	0.34	0.00
cerebellum, newborn, donor10223	10357-105E6	28.23	14.95	4.98	42.34	0.83	1.66	0.83	0.83	0.00	0.00
cerebral meninges, adult	10188-103D8	43.62	13.87	6.81	4.03	5.29	1.01	0.76	0.50	0.50	0.00
cerebrospinal fluid, donor2	10294-104G6	46.05	3.65	4.39	4.39	2.92	0.00	0.00	2.19	0.73	1.46
cervical cancer cell line:D98-AH2	10552-107I3	28.76	17.97	4.74	6.18	2.88	1.01	0.72	0.00	0.00	0.29
cervical cancer cell line:ME-180	10553-107I4	20.38	4.14	1.49	0.99	0.33	0.50	0.00	0.50	0.00	0.00
cervix, adult, pool1	10013-101C4	72.65	22.68	7.45	3.67	1.99	2.31	1.68	0.21	0.00	0.00
cholangiocellular carcinoma cell line:HuH-28	10536-107G5	188.25	16.16	26.89	1.25	1.95	2.93	0.56	0.28	0.14	0.00
chondrosarcoma cell line:SW 1353	10700-109G7	154.14	24.82	35.27	1.31	6.53	1.31	0.00	0.00	0.00	0.00
choriocarcinoma cell line:BeWo	10423-106C9	129.12	25.85	11.81	2.11	2.73	2.73	2.86	0.37	0.12	0.25
choriocarcinoma cell line:SCH	10785-110H2	179.03	27.60	24.64	3.33	3.57	4.31	0.62	0.74	0.12	0.00
choriocarcinoma cell line:T3M-3	10618-108G6	231.49	24.90	31.31	3.32	5.93	4.27	2.37	0.71	0.24	0.47
chorionic membrane cells, donor1	12238-129G6	428.80	20.23	82.91	2.56	4.27	11.68	3.70	1.99	1.71	0.00
chorionic membrane cells, donor2	12239-129G7	197.37	11.34	27.94	3.58	2.49	2.88	3.18	1.19	1.49	0.00
chorionic membrane cells, donor3	12240-129G8	409.37	25.83	90.66	3.85	1.65	15.39	9.89	4.95	2.20	0.00
chronic lymphocytic leukemia (T-CLL) cell line:SKW-3	10416-106C2	3.03	3.03	0.00	0.00	0.00	1.01	0.00	0.00	0.00	0.00
chronic myeloblastic leukemia (CML) cell line:KCL-22	10801-110I9	28.43	11.91	2.88	1.92	3.84	1.15	0.00	0.00	0.38	0.00
chronic myelogenous leukemia (CML) cell line:MEG-A2	10766-110F1	22.17	3.38	3.17	2.32	3.59	0.42	0.00	0.00	0.00	0.21
chronic myelogenous leukemia cell line:K562 ENCODE, biol_rep1	10824-111C5	5.14	3.85	0.51	1.54	1.54	0.77	0.00	0.00	0.00	0.00
chronic myelogenous leukemia cell line:K562 ENCODE, biol_rep2	10825-111C6	7.26	5.56	1.21	1.45	0.73	0.24	0.24	0.00	0.00	0.00
chronic myelogenous leukemia cell line:K562 ENCODE, biol_rep3	10826-111C7	5.09	6.11	0.20	2.65	1.02	0.20	0.20	0.00	0.20	0.00
chronic myelogenous leukemia cell line:K562	10454-106G4	12.66	5.30	1.18	1.77	1.18	0.29	0.00	0.00	0.00	0.00
chronic myelogenous leukemia cell line:KU812	10409-106B4	11.99	3.65	1.04	0.26	0.78	0.26	0.00	0.00	0.00	0.00
clear cell carcinoma cell line:JHOC-5	10638-108I8	40.23	18.06	3.43	1.14	2.29	1.83	2.29	2.51	0.23	0.00
clear cell carcinoma cell line:TEN	10636-108I6	55.00	18.74	6.42	0.69	1.56	1.39	0.52	0.52	0.00	0.00
colon carcinoma cell line:CACO-2	10513-107D9	66.81	11.35	8.79	0.92	2.38	0.73	0.18	0.00	0.00	0.00
colon carcinoma cell line:COLO-320	10420-106C6	49.03	14.82	3.42	4.56	0.76	0.38	0.00	0.00	0.00	0.00
colon, adult, donor1	10082-102B1	107.10	17.85	16.66	4.76	2.38	0.00	0.00	2.38	0.00	0.00
colon, adult, pool1	10014-101C5	139.71	23.74	14.92	5.88	1.41	2.35	4.23	0.59	0.82	0.00
colon, fetal, donor1	10070-101I7	110.00	25.34	11.74	4.33	1.85	1.85	1.85	0.00	0.00	1.24
common myeloid progenitor CMP, donor1	12130-128D6	68.75	22.92	4.58	32.08	4.58	0.00	0.00	0.00	0.00	0.00
common myeloid progenitor CMP, donor2	12134-128E1	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
cord blood derived cell line:COBL-a 24h infection(-C)	10452-106G2	38.67	3.40	4.25	2.97	0.00	0.42	0.42	0.42	0.00	0.00
cord blood derived cell line:COBL-a 24h infection	10453-106G3	39.69	12.23	5.28	3.02	0.60	1.06	1.06	0.30	0.00	0.00
cord blood derived cell line:COBL-a untreated	10449-106F8	43.15	11.99	5.78	2.40	0.85	0.42	0.28	0.14	0.00	0.00
corpus callosum, adult, pool1	10042-101F6	50.20	13.27	4.31	19.35	1.99	2.21	0.77	0.22	0.11	0.22
cruciate ligament, donor2	10295-104G7	91.58	9.73	12.97	4.86	0.81	1.62	1.62	2.43	0.00	0.00
diaphragm, fetal, donor1	10069-101I6	63.40	18.46	4.01	4.01	2.41	2.41	0.80	0.80	0.00	0.00
diencephalon, adult	10193-103E4	38.88	8.88	4.32	7.92	1.68	0.96	0.48	0.24	0.00	0.00
diffuse large B-cell lymphoma cell line:CTB-1	10631-108I1	21.35	12.17	2.07	0.69	1.38	0.46	0.92	1.15	0.23	0.00
ductal cell carcinoma cell line:KLM-1	10438-106E6	27.95	10.26	2.56	2.31	1.03	1.28	0.00	0.00	0.00	0.00
ductal cell carcinoma cell line:MIA Paca2	10488-107B2	172.84	12.28	26.24	1.44	3.37	1.44	2.65	0.72	0.24	0.00
ductus deferens, adult	10196-103E7	42.36	19.93	5.48	6.48	1.00	1.99	1.00	0.00	0.00	0.00
duodenum, fetal, donor1, tech_rep1	10071-101I8	93.61	10.08	8.64	2.88	1.44	2.88	2.88	0.00	0.00	0.00
duodenum, fetal, donor1, tech_rep2	10071-101I8	64.00	13.24	5.15	5.89	0.00	0.00	2.21	0.00	0.00	0.74
dura mater, adult, donor1	10041-101F5	136.76	18.09	10.74	8.67	2.64	1.73	1.16	0.08	0.17	0.08
embryonic kidney cell line: HEK293/SLAM infection, 24hr	10451-106G1	35.09	9.99	3.11	2.00	1.33	0.89	1.55	0.22	0.00	0.22
embryonic kidney cell line: HEK293/SLAM untreated	10450-106F9	30.81	7.45	3.73	1.72	1.29	0.29	0.57	0.29	0.14	0.00
embryonic pancreas cell line:1B2C6	10604-108F1	97.43	9.25	11.10	1.23	0.00	0.62	0.62	0.00	0.00	0.00
embryonic pancreas cell line:1C3D3	10605-108F2	65.69	13.92	10.90	1.82	0.91	1.21	2.42	0.61	0.30	0.00
embryonic pancreas cell line:1C3IKEI	10606-108F3	86.14	13.89	11.11	0.93	2.47	1.23	0.93	0.62	0.31	0.00
embryonic pancreas cell line:2C6	10603-108E9	88.00	18.39	13.13	1.31	1.31	0.00	0.00	1.31	0.00	0.00
endometrial carcinoma cell line:OMC-2	10497-107C2	203.80	22.79	24.13	3.02	2.68	3.02	1.34	0.34	0.00	0.34
endometrial stromal sarcoma cell line:OMC-9	10448-106F7	102.94	30.99	10.33	2.72	4.35	5.44	1.45	0.54	0.00	0.00
endometrioid adenocarcinoma cell line:JHUEM-1	10643-109A4	27.98	9.65	5.15	0.32	1.29	0.48	0.80	1.93	0.32	0.00
epidermoid carcinoma cell line:A431	10426-106D3	55.69	8.23	5.67	0.56	1.00	1.11	0.33	0.11	0.00	0.00
epidermoid carcinoma cell line:Ca Ski	10431-106D8	72.15	10.56	6.82	0.66	1.87	1.10	0.22	0.11	0.00	0.00
epididymis, adult	10197-103E8	62.17	18.63	7.33	6.28	2.51	2.30	2.93	0.84	0.21	0.21
epithelioid sarcoma cell line:HS-ES-1	10443-106F2	135.36	30.34	14.19	3.02	2.48	3.55	0.89	0.00	0.00	0.00
epithelioid sarcoma cell line:HS-ES-2R	10495-107B9	111.29	18.88	16.12	1.57	0.00	0.79	0.00	0.00	0.00	0.00
epitheloid carcinoma cell line: HelaS3 ENCODE, biol_rep1	10815-111B5	55.83	11.79	5.90	2.75	2.62	1.70	1.05	0.52	0.26	0.39
epitheloid carcinoma cell line: HelaS3 ENCODE, biol_rep2	10816-111B6	60.04	14.57	7.68	3.05	3.74	1.48	0.98	0.20	0.20	0.10
epitheloid carcinoma cell line: HelaS3 ENCODE, biol_rep3	10817-111B7	50.53	13.67	6.83	2.69	3.70	1.57	1.46	0.34	0.11	0.34
esophagus, adult, pool1	10015-101C6	76.55	17.73	8.71	3.40	1.49	2.02	1.59	0.64	0.32	0.00
extraskeletal myxoid chondrosarcoma cell line:H-EMC-SS	10410-106B5	95.93	33.06	11.27	2.25	4.51	2.13	0.13	0.38	0.00	0.13
eye - muscle inferior rectus, donor1	10272-104E2	38.63	14.49	9.66	24.15	0.00	0.00	0.00	0.00	0.00	0.00
eye - muscle lateral, donor2	10298-104H1	54.71	4.21	2.10	2.10	2.10	0.00	0.00	0.00	0.00	0.00
eye - muscle medial, donor2	10299-104H2	17.86	5.95	5.95	8.93	0.00	0.00	0.00	0.00	0.00	0.00
eye - muscle superior, donor2	10297-104G9	52.74	3.44	3.44	6.88	2.29	0.00	0.00	1.15	0.00	0.00
eye - vitreous humor, donor1	10268-104D7	110.76	10.20	13.12	18.95	4.37	0.00	1.46	5.83	0.00	0.00
eye, fetal, donor1	10054-101G9	71.44	18.81	7.12	2.80	3.81	2.54	2.03	0.51	0.25	0.25
fibrosarcoma cell line:HT-1080	10758-110E2	66.93	12.57	9.75	0.38	2.05	1.28	0.51	0.51	0.26	0.13
fibrous histiocytoma cell line:GCT TIB-223	10711-109H9	84.52	14.01	20.89	1.66	2.14	2.14	0.47	0.00	0.24	0.00
frontal lobe, adult, pool1	10040-101F4	32.37	10.51	2.72	7.88	2.06	1.41	0.38	0.00	0.00	0.19
gall bladder carcinoma cell line:TGBC14TKB	10470-106I2	40.53	6.91	5.10	3.30	1.50	0.30	1.20	0.00	0.00	0.00
gall bladder carcinoma cell line:TGBC2TKB	10415-106C1	90.98	16.73	10.06	5.21	1.83	1.65	0.46	0.09	0.00	0.00
gall bladder, adult	10198-103E9	70.74	18.59	9.42	4.83	1.69	0.72	1.69	0.24	0.00	0.24
gamma delta positive T cells, donor1	11937-126A2	11.81	6.98	1.07	10.20	0.00	0.54	0.00	0.54	0.00	0.00
gamma delta positive T cells, donor2	11938-126A3	38.47	8.22	3.36	11.20	0.75	0.37	0.75	0.00	0.00	0.00
gastric adenocarcinoma cell line:MKN1	10614-108G2	51.54	11.41	6.13	0.84	2.11	0.42	2.11	0.63	0.63	0.00
gastric adenocarcinoma cell line:MKN45	10612-108F9	47.77	15.09	3.87	1.74	4.45	0.97	0.39	0.00	0.19	0.00
gastric cancer cell line:AZ521	10549-107H9	93.78	30.33	9.18	1.31	6.39	4.75	1.48	0.66	0.00	0.00
gastric cancer cell line:GSS	10560-108A2	20.13	10.98	0.92	0.92	0.00	0.92	0.00	0.00	0.00	0.00
gastrointestinal carcinoma cell line:ECC12	10615-108G3	62.60	13.02	9.60	1.60	2.28	0.91	1.60	1.60	0.46	0.00
giant cell carcinoma cell line:LU65	10487-107B1	40.16	8.15	1.38	2.52	0.46	0.34	0.46	0.23	0.23	0.00
giant cell carcinoma cell line:Lu99B	10433-106E1	57.10	3.50	6.58	0.70	0.00	1.26	0.14	0.00	0.00	0.00
glassy cell carcinoma cell line:HOKUG	10688-109F4	29.18	13.47	3.99	2.99	1.50	1.25	0.25	0.00	0.00	0.00
glioblastoma cell line:A172, tech_rep1	10444-106F3	75.15	19.32	10.98	2.64	1.79	1.69	0.21	0.00	0.00	0.21
glioblastoma cell line:A172, tech_rep2	10444-106F3	99.43	14.61	12.22	2.11	3.79	1.97	0.56	0.42	0.14	0.00
glioblastoma cell line:T98G	10485-107A8	66.44	19.76	8.72	2.76	1.21	0.88	0.44	0.33	0.11	0.11
glioma cell line:GI-1	10413-106B8	167.23	30.46	21.38	1.76	4.39	2.05	2.34	0.59	0.00	0.00
globus pallidus - adult, donor10196	10175-103C4	50.29	11.66	7.29	12.39	2.92	3.64	0.00	0.00	0.00	0.00
globus pallidus, adult, donor10252	10161-103A8	71.76	17.33	8.30	22.70	2.44	1.71	0.49	0.24	0.00	0.00
globus pallidus, adult, donor10258	10367-105F7	62.98	20.54	9.58	9.58	1.37	1.37	0.00	0.00	0.00	0.00
globus pallidus, newborn, donor10223	10364-105F4	43.70	11.19	9.06	6.40	0.00	1.07	0.00	1.60	0.00	0.53
granulocyte macrophage progenitor, donor1	12131-128D7	85.65	29.37	9.79	31.81	7.34	0.00	0.00	0.00	0.00	0.00
granulocyte macrophage progenitor, donor2	12135-128E2	32.79	10.93	21.86	0.00	0.00	0.00	0.00	0.00	0.00	0.00
granulocyte macrophage progenitor, donor3	12139-128E6	62.72	15.68	0.00	10.45	5.23	0.00	0.00	0.00	0.00	0.00
granulosa cell tumor cell line:KGN	10624-108H3	24.32	8.64	6.40	0.96	0.96	0.64	1.28	0.00	0.00	0.00
hIPS +CCl2, biol_rep1	14383-156B9	74.84	6.89	5.97	1.84	6.89	2.75	0.92	1.84	0.00	0.00
hIPS +CCl2, biol_rep2	14384-156C1	15.09	2.74	2.74	2.74	2.74	1.37	1.83	1.83	0.00	0.00
hIPS +CCl2, biol_rep3	14385-156C2	31.56	3.86	5.15	2.58	2.58	0.00	1.29	0.00	0.00	0.00
hIPS, biol_rep1	14380-156B6	21.56	2.87	1.44	0.00	1.44	0.00	2.87	0.00	0.00	0.00
hIPS, biol_rep2	14381-156B7	21.95	4.80	1.37	0.69	3.43	2.06	0.00	0.69	0.00	0.00
hIPS, biol_rep3	14382-156B8	23.17	2.21	5.52	11.03	3.31	0.00	1.10	0.00	0.00	1.10
hairy cell leukemia cell line:Mo	10712-109I1	29.31	8.33	3.16	2.30	1.15	1.44	0.57	0.00	0.00	0.00
heart - mitral valve, adult	10205-103F7	67.87	12.56	11.36	2.69	1.79	0.90	0.60	0.00	0.00	0.00
heart - pulmonic valve, adult	10206-103F8	88.90	23.53	12.81	3.66	0.78	0.78	2.09	0.00	0.26	0.00
heart - tricuspid valve, adult	10207-103F9	114.07	12.49	24.98	3.33	2.50	0.83	1.67	0.83	0.83	0.00
heart, adult, diseased post-infarction, donor1	10050-101G5	101.01	18.16	14.28	2.86	2.04	2.04	1.43	0.41	0.61	0.00
heart, adult, diseased, donor1	10051-101G6	120.08	24.27	11.07	1.70	2.98	1.28	3.41	0.43	0.43	0.00
heart, adult, pool1	10016-101C7	157.30	19.78	19.32	2.30	1.84	2.76	0.46	0.00	0.00	0.00
heart, fetal, pool1	10046-101G1	132.15	24.03	15.30	7.91	2.77	1.44	0.51	0.10	0.31	0.00
hepatic mesenchymal tumor cell line:LI90	10778-110G4	115.39	10.18	27.46	2.47	2.47	1.85	0.62	0.62	0.00	0.00
hepatoblastoma cell line:HuH-6	10633-108I3	89.19	10.70	9.51	1.19	2.38	1.19	0.00	0.00	0.00	1.19
hepatocellular carcinoma cell line: HepG2 ENCODE, biol_rep1	10818-111B8	78.23	13.04	8.40	2.10	2.10	1.33	0.99	0.22	0.00	0.00
hepatocellular carcinoma cell line: HepG2 ENCODE, biol_rep2	10819-111B9	80.35	10.92	9.22	2.43	2.55	1.58	1.34	0.36	0.12	0.24
hepatocellular carcinoma cell line: HepG2 ENCODE, biol_rep3	10820-111C1	70.94	15.26	9.60	1.92	2.22	2.22	0.81	0.00	0.10	0.30
hepatoma cell line:Li-7	10484-107A7	62.61	9.01	7.01	1.00	1.33	0.78	0.89	0.44	0.00	0.11
hereditary spherocytic anemia cell line:WIL2-NS	10808-111A7	14.67	9.15	1.21	0.80	1.71	1.01	0.00	0.00	0.00	0.00
hippocampus - adult, donor10196	10169-103B7	27.44	10.41	2.84	6.62	0.00	0.00	0.00	0.00	0.00	0.00
hippocampus, adult, donor10252	10153-102I9	56.74	15.31	7.35	11.43	2.45	2.04	0.61	0.20	0.00	0.00
hippocampus, adult, donor10258	10374-105G5	5.48	0.00	0.50	4.98	2.49	0.50	0.50	0.00	0.00	0.00
hippocampus, newborn, donor10223	10363-105F3	29.96	11.98	8.46	8.81	0.70	0.70	0.70	0.35	0.00	0.35
iPS differentiation to neuron, control donor C11-CRL2429, day00, rep1	13421-144D1	78.12	17.09	7.32	1.83	1.22	0.00	4.88	3.05	2.44	0.00
iPS differentiation to neuron, control donor C11-CRL2429, day00, rep2	13425-144D5	84.63	34.17	8.05	1.18	2.16	2.55	1.96	2.55	0.39	0.00
iPS differentiation to neuron, control donor C11-CRL2429, day00, rep3	13429-144D9	68.30	22.34	9.14	1.52	3.81	2.03	3.05	2.54	0.00	0.00
iPS differentiation to neuron, control donor C11-CRL2429, day06, rep1	13422-144D2	113.34	24.25	20.86	7.89	1.13	0.56	7.89	1.13	0.56	0.00
iPS differentiation to neuron, control donor C11-CRL2429, day06, rep2	13426-144D6	147.18	35.12	15.75	8.52	2.32	1.81	9.81	4.13	2.07	0.00
iPS differentiation to neuron, control donor C11-CRL2429, day06, rep3	13430-144E1	79.34	20.88	13.67	13.29	2.28	1.90	7.97	2.28	0.76	0.00
iPS differentiation to neuron, control donor C11-CRL2429, day12, rep1	13423-144D3	60.14	15.47	9.34	9.93	1.46	1.17	5.55	2.92	0.29	0.00
iPS differentiation to neuron, control donor C11-CRL2429, day12, rep2	13427-144D7	83.37	23.05	7.54	10.77	1.72	2.15	3.66	3.02	0.65	0.00
iPS differentiation to neuron, control donor C11-CRL2429, day12, rep3	13431-144E2	76.32	21.27	12.51	7.51	1.67	0.83	4.59	1.25	0.00	0.00
iPS differentiation to neuron, control donor C11-CRL2429, day18, rep1	13424-144D4	70.80	23.92	12.55	2.84	2.13	1.18	2.13	2.13	0.47	0.00
iPS differentiation to neuron, control donor C11-CRL2429, day18, rep2	13428-144D8	92.41	31.50	12.86	3.86	3.70	1.77	2.57	2.25	1.45	0.00
iPS differentiation to neuron, control donor C11-CRL2429, day18, rep3	13432-144E3	88.20	23.57	12.79	8.08	3.37	2.69	2.02	0.00	1.35	0.00
iPS differentiation to neuron, control donor C32-CRL1502, day00, rep1	13433-144E4	54.46	18.31	3.60	0.94	2.19	1.56	1.41	1.41	0.47	0.00
iPS differentiation to neuron, control donor C32-CRL1502, day00, rep2	13437-144E8	37.83	18.67	3.93	0.98	5.90	0.00	3.44	0.49	0.00	0.00
iPS differentiation to neuron, control donor C32-CRL1502, day00, rep3	13441-144F3	31.42	10.47	2.62	0.87	0.87	0.00	2.62	2.62	0.87	0.00
iPS differentiation to neuron, control donor C32-CRL1502, day06, rep1	13434-144E5	99.66	24.82	11.84	8.97	3.05	1.34	3.82	0.76	0.95	0.00
iPS differentiation to neuron, control donor C32-CRL1502, day06, rep2	13438-144E9	105.09	21.37	9.16	9.16	3.05	1.74	3.92	0.44	1.31	0.00
iPS differentiation to neuron, control donor C32-CRL1502, day06, rep3	13442-144F4	46.48	9.00	7.00	6.00	2.00	1.50	7.50	2.00	1.50	0.00
iPS differentiation to neuron, control donor C32-CRL1502, day12, rep1	13435-144E6	76.68	22.80	10.93	9.04	3.01	1.13	2.83	2.07	0.57	0.00
iPS differentiation to neuron, control donor C32-CRL1502, day12, rep2	13439-144F1	69.12	23.19	9.55	11.37	4.09	3.18	4.09	3.18	0.00	0.00
iPS differentiation to neuron, control donor C32-CRL1502, day12, rep3	13443-144F5	54.19	19.73	8.77	10.34	2.19	1.88	3.76	1.57	0.63	0.00
iPS differentiation to neuron, control donor C32-CRL1502, day18, rep1	13436-144E7	57.48	21.07	8.98	5.06	2.45	2.78	2.78	1.14	0.33	0.00
iPS differentiation to neuron, control donor C32-CRL1502, day18, rep2	13440-144F2	53.71	18.00	6.68	4.06	3.48	1.45	1.74	1.16	0.00	0.00
iPS differentiation to neuron, control donor C32-CRL1502, day18, rep3	13444-144F6	46.93	23.91	7.77	6.58	2.99	1.20	4.48	2.69	1.20	0.00
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day00, rep1	13445-144F7	64.48	28.45	7.02	2.03	1.66	1.48	2.96	1.48	0.55	0.00
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day00, rep2	13449-144G2	69.89	24.53	9.13	0.57	4.56	1.71	1.71	0.29	0.29	0.00
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day00, rep3	13453-144G6	63.70	13.07	5.31	2.86	2.45	1.63	4.49	1.63	0.00	0.00
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day06, rep1	13446-144F8	71.82	20.07	7.39	4.58	2.46	2.11	5.63	1.41	0.00	0.00
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day06, rep2	13450-144G3	83.62	23.44	10.45	4.43	2.85	1.90	3.48	0.95	0.95	0.32
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day06, rep3	13454-144G7	76.87	20.28	8.17	4.24	4.54	1.51	5.14	1.21	0.61	0.00
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day12, rep1	13447-144F9	51.71	13.45	8.27	8.27	2.59	1.03	1.55	1.55	0.00	0.00
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day12, rep2	13451-144G4	60.44	11.95	7.31	5.31	4.65	1.99	2.66	1.99	0.00	0.00
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day12, rep3	13455-144G8	40.28	11.29	9.49	7.95	0.77	1.03	1.54	2.05	0.26	0.00
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day18, rep1	13448-144G1	62.63	15.85	10.23	2.30	3.07	1.53	2.81	2.56	1.02	0.00
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day18, rep2	13452-144G5	43.92	15.90	5.30	5.30	3.03	1.51	2.27	2.27	0.00	0.00
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day18, rep3	13456-144G9	71.24	18.48	14.45	3.70	2.35	2.69	2.35	3.02	1.01	0.34
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day00, rep1	13457-144H1	63.03	28.50	8.21	1.69	1.93	2.66	2.90	0.48	0.00	0.00
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day00, rep2	13461-144H5	51.70	25.40	11.14	1.78	2.67	1.78	4.90	0.89	0.00	0.00
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day00, rep3	13465-144H9	55.61	20.49	7.32	2.93	2.44	1.46	1.95	1.95	0.49	0.00
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day06, rep1	13458-144H2	77.93	20.17	8.86	10.39	2.75	0.92	3.67	1.53	0.00	0.00
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day06, rep2	13462-144H6	22.77	0.00	3.25	9.76	6.51	0.00	9.76	6.51	0.00	0.00
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day06, rep3	13466-144I1	37.40	9.27	7.94	9.27	1.32	0.33	6.62	3.64	0.99	0.00
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day12, rep1	13459-144H3	51.99	19.16	5.47	12.04	1.64	0.00	0.55	2.74	0.00	0.00
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day12, rep2	13463-144H7	50.66	13.75	9.77	7.24	3.98	1.45	1.45	1.09	1.09	0.00
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day12, rep3	13467-144I2	44.13	12.81	7.47	10.32	1.07	2.49	3.20	1.07	0.00	0.00
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day18, rep1	13460-144H4	42.96	11.93	5.97	3.58	1.19	0.00	3.58	1.19	0.00	0.00
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day18, rep2	13464-144H8	86.81	23.16	10.16	6.09	3.79	2.03	2.98	0.41	0.41	0.00
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day18, rep3	13468-144I3	73.01	22.36	15.36	4.31	1.62	2.96	4.58	1.89	0.00	0.27
immature langerhans cells, donor1	11904-125F5	38.26	8.48	1.21	1.70	1.94	0.24	0.73	0.97	0.00	0.00
immature langerhans cells, donor2	11905-125F6	33.27	15.05	4.75	1.58	2.38	0.00	0.00	0.00	0.00	0.00
insula, adult, pool1	10039-101F3	37.38	11.83	2.93	9.37	3.60	1.99	0.76	0.00	0.09	0.00
keratoacanthoma cell line:HKA-1	10791-110H8	100.47	22.11	14.63	3.58	3.90	2.28	0.33	0.00	0.00	0.00
kidney, adult, pool1	10017-101C8	121.86	17.22	12.32	4.21	1.60	2.00	2.20	0.10	0.20	0.20
kidney, fetal, pool1	10045-101F9	85.73	19.66	10.19	6.58	2.48	1.98	0.57	0.07	0.14	0.14
large cell lung carcinoma cell line:IA-LM	10509-107D5	95.01	18.18	12.21	0.28	1.14	1.28	0.71	0.71	0.14	0.00
large cell lung carcinoma cell line:NCI-H460	10839-111E2	80.18	15.90	8.02	4.01	2.49	0.83	2.76	1.94	0.69	0.00
large cell non-keratinizing squamous carcinoma cell line:SKG-II-SF	10692-109F8	25.87	5.50	4.40	5.32	1.10	1.10	0.00	0.00	0.00	0.00
left atrium, adult, donor1	10079-102A7	164.00	21.25	29.97	0.00	1.63	2.72	1.63	2.72	1.63	0.00
left ventricle, adult, donor1	10078-102A6	113.27	21.24	13.65	1.52	1.52	2.02	2.02	0.00	0.00	0.00
leiomyoblastoma cell line:G-402	10721-110A1	56.36	11.22	6.29	0.55	3.56	1.64	0.55	0.00	0.27	0.00
leiomyoma cell line:10964C	10569-108B2	105.62	11.50	20.48	2.51	2.51	2.16	7.18	4.67	1.08	2.16
leiomyoma cell line:15242A	10570-108B3	96.74	8.15	15.22	4.35	1.09	1.63	3.80	4.89	1.63	0.00
leiomyoma cell line:15425	10571-108B4	63.13	11.90	17.00	0.73	2.19	3.40	5.58	2.91	1.21	0.24
leiomyosarcoma cell line:Hs 5.T	10722-110A2	139.69	31.75	6.35	12.70	6.35	0.00	0.00	0.00	6.35	0.00
lens epithelial cell line:SRA 01/04	10647-109A8	70.05	11.50	10.46	4.18	2.09	1.05	3.14	1.05	0.00	0.00
leukemia, chronic megakaryoblastic cell line:MEG-01	10752-110D5	21.13	7.67	3.07	2.24	1.77	0.47	0.12	0.00	0.00	0.00
liposarcoma cell line:KMLS-1	10782-110G8	84.82	12.03	16.09	2.81	1.87	1.41	1.56	0.62	0.31	0.00
liposarcoma cell line:SW 872	10726-110A6	86.02	14.26	16.45	1.95	3.29	1.46	0.61	0.49	0.24	0.00
liver, adult, pool1	10018-101C9	141.48	16.53	10.70	1.78	2.59	1.46	2.11	0.32	0.32	0.00
liver, fetal, pool1	10086-102B5	78.08	10.35	11.29	0.94	1.88	1.88	1.88	0.00	0.00	0.00
locus coeruleus - adult, donor10196	10182-103D2	43.46	13.42	6.71	9.77	1.60	1.75	0.15	0.29	0.15	0.00
locus coeruleus, adult, donor10252	10165-103B3	47.24	15.32	6.64	14.76	1.66	1.11	0.37	0.18	0.18	0.00
locus coeruleus, adult, donor10258	10375-105G6	44.86	11.00	7.34	5.08	2.82	1.41	2.54	0.28	1.13	0.00
locus coeruleus, newborn, donor10223	10362-105F2	28.60	2.52	4.63	5.47	0.00	0.84	4.21	2.10	0.84	0.42
lung adenocarcinoma cell line:A549	10499-107C4	101.17	26.57	9.96	1.66	3.60	4.01	0.14	0.55	0.00	0.00
lung adenocarcinoma cell line:PC-14	10408-106B3	152.36	42.74	17.24	8.27	2.07	4.83	1.38	0.00	0.00	0.00
lung adenocarcinoma, papillary cell line:NCI-H441	10742-110C4	180.06	35.33	16.48	4.09	2.77	2.90	0.40	0.66	0.13	0.00
lung, adult, pool1	10019-101D1	206.37	20.67	34.73	2.84	2.13	3.43	3.31	0.47	0.47	0.47
lung, fetal, donor1	10068-101I5	60.22	15.98	3.42	4.57	1.14	0.86	0.00	0.29	0.00	0.00
lung, right lower lobe, adult, donor1	10075-102A3	186.04	18.33	58.65	5.04	2.75	3.67	4.12	2.75	0.92	0.00
lymph node, adult, donor1	10077-102A5	119.29	16.09	17.99	4.26	2.84	0.47	3.31	1.89	0.00	0.00
lymphangiectasia cell line:DS-1	10727-110A7	24.77	8.99	1.53	1.53	2.19	0.88	0.22	0.22	0.00	0.00
lymphoma, malignant, hairy B-cell cell line:MLMA	10775-110G1	51.32	20.38	3.47	5.28	4.68	2.57	0.91	1.06	0.30	0.00
malignant trichilemmal cyst cell line:DJM-1	10412-106B7	49.27	11.04	4.25	0.85	0.85	0.85	0.85	0.85	0.00	0.00
mature adipocyte, donor1	12231-129F8	107.00	19.09	13.32	4.00	2.22	3.55	1.33	2.22	0.00	0.00
mature adipocyte, donor2	12232-129F9	165.82	23.04	18.26	1.04	2.08	1.25	2.70	0.83	0.21	1.04
mature adipocyte, donor3	12233-129G1	121.14	18.97	11.62	2.13	1.66	3.79	2.37	0.71	1.66	0.24
mature adipocyte, donor4	12234-129G2	99.50	23.95	10.79	3.42	2.37	1.32	1.58	0.53	0.00	0.53
maxillary sinus tumor cell line:HSQ-89	10414-106B9	78.63	34.55	7.62	3.34	6.19	2.38	1.19	0.00	0.24	0.00
medial frontal gyrus - adult, donor10196	10170-103B8	22.56	4.51	2.26	5.64	5.64	2.26	1.13	1.13	0.00	0.00
medial frontal gyrus, adult, donor10252	10150-102I6	35.68	15.26	5.70	11.40	2.57	1.29	0.55	0.00	0.18	0.00
medial frontal gyrus, adult, donor10258	10368-105F8	36.53	8.90	3.18	7.62	6.67	1.59	0.95	0.32	0.32	0.32
medial frontal gyrus, newborn, donor10223	10352-105E1	25.16	3.41	2.13	4.69	0.43	0.00	1.28	0.85	0.00	0.00
medial temporal gyrus - adult, donor10196	10183-103D3	40.50	10.29	4.22	7.59	1.52	1.69	0.68	0.84	0.00	0.00
medial temporal gyrus, adult, donor10252	10156-103A3	37.35	13.37	3.82	12.95	1.49	1.27	0.85	0.00	0.00	0.00
medial temporal gyrus, adult, donor10258, tech_rep1	10376-105G7	17.34	1.93	0.00	3.85	1.93	3.85	0.00	0.00	0.00	0.00
medial temporal gyrus, adult, donor10258, tech_rep2	10376-105G7	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
medial temporal gyrus, newborn, donor10223	10353-105E2	26.92	8.26	4.31	8.61	1.08	0.72	2.15	1.08	0.00	0.00
medulla oblongata - adult, donor10196	10174-103C3	48.02	10.38	1.95	8.44	1.30	1.95	0.65	0.65	0.00	0.00
medulla oblongata, adult, donor10252	10155-103A2	52.79	9.44	6.35	14.24	1.55	1.24	0.62	0.31	0.31	0.15
medulla oblongata, adult, pool1	10038-101F2	46.77	9.31	5.71	10.20	1.88	1.88	0.24	0.33	0.00	0.24
medulla oblongata, newborn, donor10223	10361-105F1	30.20	11.11	6.25	4.86	0.69	3.12	1.39	0.35	0.69	0.00
medulloblastoma cell line:D283 Med	10838-111E1	12.40	5.54	2.21	3.32	0.66	0.00	0.44	0.66	0.00	0.00
medulloblastoma cell line:ONS-76	10759-110E3	78.50	16.02	15.28	1.10	5.14	2.08	0.49	0.00	0.24	0.00
melanoma cell line:COLO 679	10514-107E1	66.55	8.05	7.33	1.29	1.44	0.86	1.01	0.43	0.29	0.14
melanoma cell line:G-361	10465-106H6	171.29	19.27	21.17	2.17	4.89	1.90	5.97	0.81	0.27	0.00
meningioma cell line:HKBMM	10691-109F7	65.85	14.29	9.23	2.71	2.17	1.63	3.80	2.35	1.09	0.00
merkel cell carcinoma cell line:MKL-1	10843-111E6	47.58	23.79	6.17	5.29	2.64	0.88	0.00	0.00	0.00	0.88
merkel cell carcinoma cell line:MS-1	10844-111E7	51.33	15.29	4.93	7.78	2.07	2.59	0.52	0.52	0.00	0.00
mesenchymal precursor cell - adipose, donor1	11747-123G1	99.73	16.26	8.44	0.46	5.68	2.15	1.69	1.23	0.00	0.15
mesenchymal precursor cell - adipose, donor2	11748-123G2	98.89	14.18	11.45	1.09	3.64	0.91	1.27	1.09	0.00	0.18
mesenchymal precursor cell - adipose, donor3	11749-123G3	32.71	9.11	6.63	0.41	4.56	1.66	1.66	2.07	0.00	0.00
mesenchymal precursor cell - bone marrow, donor1	11750-123G4	219.98	15.03	20.93	2.53	4.07	2.11	2.95	1.69	0.42	0.42
mesenchymal precursor cell - bone marrow, donor2	11751-123G5	135.76	12.71	14.06	2.12	3.47	0.58	3.66	1.73	0.00	0.00
mesenchymal precursor cell - bone marrow, donor3	11840-124H4	133.26	12.49	18.05	2.78	3.47	0.00	3.47	4.86	0.00	0.00
mesenchymal precursor cell - cardiac, donor1	11752-123G6	263.97	17.16	27.12	3.43	4.63	1.20	6.69	2.92	0.86	0.34
mesenchymal precursor cell - cardiac, donor2	11753-123G7	150.67	12.19	13.69	1.96	4.37	1.73	3.91	1.15	0.35	0.12
mesenchymal precursor cell - cardiac, donor3	11754-123G8	116.32	11.27	9.55	1.33	2.52	1.19	1.06	0.93	0.13	0.13
mesenchymal precursor cell - cardiac, donor4	11755-123G9	158.13	11.75	18.64	0.95	3.92	2.03	2.43	0.68	0.27	0.14
mesenchymal precursor cell - ovarian cancer left ovary, donor1	11756-123H1	92.19	12.52	8.11	0.85	2.70	1.00	1.71	0.85	0.14	0.00
mesenchymal precursor cell - ovarian cancer left ovary, donor2	11833-124G6	182.46	15.48	25.69	2.63	2.96	2.96	5.27	0.33	0.33	0.00
mesenchymal precursor cell - ovarian cancer left ovary, donor3	11760-123H5	67.80	12.45	7.33	1.66	3.74	1.11	1.52	0.42	0.28	0.00
mesenchymal precursor cell - ovarian cancer left ovary, donor4	11836-124G9	115.20	13.61	16.76	2.09	2.79	2.09	3.49	0.70	0.35	0.00
mesenchymal precursor cell - ovarian cancer metastasis, donor1	11758-123H3	154.96	12.66	16.95	2.45	3.47	1.84	2.04	1.02	0.20	0.00
mesenchymal precursor cell - ovarian cancer metastasis, donor2	11835-124G8	102.80	14.02	19.41	1.44	1.44	1.08	2.52	2.16	0.36	0.00
mesenchymal precursor cell - ovarian cancer metastasis, donor3	11762-123H7	98.28	12.83	14.69	2.28	3.41	0.83	1.24	0.62	0.21	0.00
mesenchymal precursor cell - ovarian cancer metastasis, donor4	11838-124H2	94.16	7.75	16.19	1.14	1.14	1.14	2.74	2.28	0.23	0.23
mesenchymal precursor cell - ovarian cancer right ovary, donor1	11757-123H2	24.75	5.45	2.94	1.26	0.00	0.84	1.68	1.26	0.00	0.00
mesenchymal precursor cell - ovarian cancer right ovary, donor2	11759-123H4	150.63	11.66	13.75	0.90	2.09	1.34	2.39	0.60	0.15	0.00
mesenchymal precursor cell - ovarian cancer right ovary, donor3 (SOC-57-02)	11761-123H6	84.20	13.39	11.29	0.26	3.15	1.49	1.23	0.70	0.00	0.00
mesenchymal precursor cell - ovarian cancer right ovary, donor3 (SOC-57-02-G)	11842-124H6	118.18	8.47	21.35	2.95	3.68	2.58	3.31	2.95	0.37	0.00
mesenchymal precursor cell - ovarian cancer right ovary, donor4	11837-124H1	82.70	14.02	15.74	0.57	1.72	1.14	2.00	2.29	0.57	0.00
mesenchymal stem cell line:Hu5/E18	10568-108B1	133.88	11.79	21.89	2.11	2.11	2.95	5.89	8.42	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr00min, biol_rep1	13229-141I7	123.30	13.70	16.90	1.37	4.57	0.46	0.91	1.83	0.46	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr00min, biol_rep2	13230-141I8	107.17	15.09	18.16	2.56	3.84	1.02	1.79	2.56	0.26	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr00min, biol_rep3	13231-141I9	115.17	19.63	18.85	1.05	4.45	2.62	1.05	1.31	0.52	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr15min, biol_rep1	13232-142A1	97.36	19.72	11.09	1.23	1.85	1.23	4.01	0.62	0.00	0.31
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr15min, biol_rep2	13233-142A2	76.02	16.95	11.30	2.59	3.53	1.18	1.88	3.06	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr15min, biol_rep3	13234-142A3	91.72	15.23	11.17	1.69	3.05	0.34	1.69	1.69	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr30min, biol_rep1	13235-142A4	93.13	17.29	11.79	3.54	2.36	0.79	2.36	2.36	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr30min, biol_rep2	13236-142A5	72.75	14.83	8.34	2.32	0.93	0.93	0.00	2.78	0.46	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr30min, biol_rep3	13237-142A6	96.61	48.30	48.30	0.00	0.00	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr45min, biol_rep1	13238-142A7	122.29	16.15	17.02	2.88	5.77	1.73	2.60	2.02	0.29	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr45min, biol_rep2	13239-142A8	105.08	16.96	11.82	1.34	2.68	1.34	2.68	1.34	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr45min, biol_rep3	13240-142A9	95.66	18.27	10.82	2.16	2.16	1.92	2.88	1.44	0.24	0.24
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr00min, biol_rep1	13241-142B1	102.67	20.53	19.80	1.47	3.67	0.73	1.47	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr00min, biol_rep2	13242-142B2	90.29	12.75	11.08	1.01	3.02	1.01	2.69	2.01	0.00	0.34
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr00min, biol_rep3	13243-142B3	65.91	11.46	12.69	2.46	3.28	1.64	1.23	0.82	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr20min, biol_rep1	13244-142B4	67.87	16.75	7.73	1.72	3.44	0.43	4.30	1.29	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr20min, biol_rep2	13245-142B5	87.50	16.41	13.67	10.94	2.73	2.73	5.47	5.47	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr20min, biol_rep3	13246-142B6	51.65	0.00	5.16	5.16	5.16	5.16	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr40min, biol_rep1	13247-142B7	82.17	12.67	13.64	2.27	2.92	0.32	2.27	4.55	0.32	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr40min, biol_rep2	13248-142B8	103.30	11.64	5.82	0.00	0.00	1.45	1.45	5.82	5.82	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr40min, biol_rep3	13249-142B9	111.95	13.86	22.92	3.20	2.13	0.53	3.20	4.80	1.60	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr00min, biol_rep1	13250-142C1	100.59	16.36	12.27	2.45	2.45	0.82	1.64	3.27	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr00min, biol_rep2	13251-142C2	103.79	16.71	13.99	2.72	1.17	1.17	3.89	5.05	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr00min, biol_rep3	13252-142C3	102.84	6.30	14.69	4.20	4.20	0.00	0.00	6.30	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr30min, biol_rep1	13253-142C4	54.64	12.92	10.93	1.99	2.98	1.99	0.99	3.97	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr30min, biol_rep2	13254-142C5	47.67	4.77	9.53	4.77	4.77	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr30min, biol_rep3	13255-142C6	86.57	11.86	12.45	3.56	2.37	1.78	2.37	2.37	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 03hr00min, biol_rep1	13256-142C7	91.38	14.62	14.62	3.66	0.00	0.00	4.87	1.22	1.22	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 03hr00min, biol_rep2	13257-142C8	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 03hr00min, biol_rep3	13258-142C9	99.44	13.93	14.57	0.00	0.63	0.63	3.80	1.90	1.27	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 12hr00min, biol_rep1	13259-142D1	57.94	10.69	4.83	3.10	2.41	1.38	0.00	2.07	0.34	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 12hr00min, biol_rep2	13260-142D2	42.98	6.45	4.30	8.60	2.15	0.00	0.00	4.30	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 12hr00min, biol_rep3	13261-142D3	47.90	15.97	7.98	3.99	7.98	7.98	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day01, biol_rep1	13262-142D4	86.10	10.33	0.00	3.44	3.44	3.44	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day01, biol_rep2	13263-142D5	69.27	15.08	5.70	3.67	0.81	1.63	2.44	1.63	0.41	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day01, biol_rep3	13264-142D6	89.77	19.07	7.94	9.53	1.59	0.00	3.18	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day02, biol_rep1	13265-142D7	90.20	9.43	11.79	3.54	1.77	0.00	1.18	1.77	0.59	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day02, biol_rep2	13266-142D8	69.82	11.22	7.48	3.74	0.94	0.31	0.31	1.25	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day02, biol_rep3	13267-142D9	73.52	10.69	12.03	6.68	0.00	0.00	2.67	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day04, biol_rep1	13268-142E1	59.13	7.10	9.46	3.55	2.37	0.00	1.18	0.00	0.00	1.18
mesenchymal stem cells (adipose derived), adipogenic induction, day04, biol_rep2	13269-142E2	53.93	7.70	10.27	10.27	2.57	2.57	5.14	0.00	0.00	2.57
mesenchymal stem cells (adipose derived), adipogenic induction, day04, biol_rep3	13270-142E3	68.84	8.26	11.01	2.75	0.69	0.00	1.38	1.38	1.38	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day08, biol_rep1	13271-142E4	57.40	11.38	11.88	2.47	0.99	0.00	2.47	0.49	0.49	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day08, biol_rep2	13272-142E5	52.71	6.73	5.61	2.24	1.12	1.12	0.00	1.12	0.00	1.12
mesenchymal stem cells (adipose derived), adipogenic induction, day08, biol_rep3	13273-142E6	59.15	7.00	5.72	5.72	1.91	0.64	1.91	0.64	0.00	0.64
mesenchymal stem cells (adipose derived), adipogenic induction, day12, biol_rep1	13274-142E7	87.04	9.67	11.69	2.01	2.42	0.40	1.61	2.01	0.00	0.81
mesenchymal stem cells (adipose derived), adipogenic induction, day12, biol_rep2	13275-142E8	98.13	17.44	13.08	2.18	4.36	2.18	2.18	2.18	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day12, biol_rep3	13276-142E9	49.42	17.74	6.34	6.34	3.80	0.00	1.27	1.27	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day14, biol_rep1	13277-142F1	162.65	23.67	16.99	2.43	3.64	4.25	8.50	3.64	0.61	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day14, biol_rep2	13278-142F2	244.02	18.08	9.04	9.04	0.00	0.00	4.52	22.59	4.52	9.04
mesenchymal stem cells (adipose derived), adipogenic induction, day14, biol_rep3	13279-142F3	169.68	20.59	27.18	4.12	4.94	3.29	7.41	1.65	0.00	0.00
mesenchymal stem cells (adipose derived), undifferentiated control, biol_rep1	13280-142F4	85.52	12.70	9.72	4.17	0.99	1.19	1.19	0.79	0.40	0.00
mesenchymal stem cells (adipose derived), undifferentiated control, biol_rep2	13281-142F5	74.31	11.36	13.63	5.84	3.24	0.32	3.24	3.24	0.32	0.32
mesenchymal stem cells (adipose derived), undifferentiated control, biol_rep3	13282-142F6	88.62	9.17	14.26	2.04	1.02	1.02	6.11	1.02	1.02	0.00
mesodermal tumor cell line:HIRS-BM	10696-109G3	183.37	23.21	24.76	4.64	0.77	3.09	0.00	0.00	0.00	0.00
mesothelioma cell line:ACC-MESO-1	10493-107B7	322.71	45.59	34.73	5.91	4.72	7.56	1.18	0.71	0.00	0.00
mesothelioma cell line:ACC-MESO-4	10494-107B8	45.41	8.34	6.02	1.62	1.85	1.16	0.23	0.23	0.00	0.00
mesothelioma cell line:Mero-14, tech_rep1	10849-111F3	149.58	12.82	8.55	4.27	0.00	0.00	0.00	0.00	0.00	0.00
mesothelioma cell line:Mero-14, tech_rep2	10849-111F3	269.92	12.43	26.72	2.47	0.92	1.23	4.21	1.34	0.00	0.00
mesothelioma cell line:Mero-25	10850-111F4	34.95	7.26	4.77	1.59	0.45	0.68	0.91	0.45	0.23	0.00
mesothelioma cell line:Mero-41	10851-111F5	109.28	18.09	19.56	2.44	2.20	1.47	2.20	1.71	0.24	0.00
mesothelioma cell line:Mero-48a	10852-111F6	46.50	13.06	4.87	3.32	2.88	1.55	0.89	0.22	0.22	0.00
mesothelioma cell line:Mero-82	10853-111F7	79.89	8.41	16.03	1.31	1.31	1.58	1.84	0.26	0.53	0.00
mesothelioma cell line:Mero-83	10854-111F8	66.56	6.47	10.89	1.70	1.70	0.85	1.02	0.34	0.00	0.17
mesothelioma cell line:Mero-84	10855-111F9	40.70	8.59	3.79	1.26	1.26	1.01	0.76	0.76	0.00	0.00
mesothelioma cell line:Mero-95	10856-111G1	39.13	9.94	7.25	1.24	2.07	1.04	0.83	1.04	0.00	0.00
mesothelioma cell line:NCI-H2052	10847-111F1	54.50	9.94	6.79	0.33	0.66	1.49	0.66	0.50	0.17	0.00
mesothelioma cell line:NCI-H226	10846-111E9	80.18	8.69	9.59	0.90	2.53	0.72	1.27	0.54	0.18	0.00
mesothelioma cell line:NCI-H2452	10848-111F2	89.00	12.81	16.06	0.85	1.20	2.39	2.39	0.85	0.34	0.00
mesothelioma cell line:NCI-H28	10845-111E8	46.57	14.50	5.85	2.04	2.80	2.29	0.76	0.00	0.00	0.00
mesothelioma cell line:No36	10857-111G2	70.46	8.16	11.09	1.30	0.65	0.33	0.98	1.30	0.33	0.00
mesothelioma cell line:ONE58	10858-111G3	129.24	17.07	20.86	1.08	0.00	0.81	1.35	1.63	0.27	0.27
migratory langerhans cells, donor1	11901-125F2	50.48	6.14	3.84	4.22	0.19	0.77	1.34	2.30	0.19	0.00
migratory langerhans cells, donor2	11902-125F3	41.28	7.08	5.62	2.08	0.49	0.49	0.85	1.47	0.00	0.00
migratory langerhans cells, donor3	11903-125F4	112.89	12.74	10.95	4.13	0.54	0.54	2.15	1.44	0.00	0.00
mixed mullerian tumor cell line:HTMMT	10689-109F5	126.02	17.63	14.37	5.22	3.26	0.98	3.92	5.22	0.00	0.33
mucinous adenocarcinoma cell line:JHOM-1	10648-109A9	72.69	7.63	13.14	1.06	1.48	0.64	1.70	1.06	0.21	0.00
mucinous cystadenocarcinoma cell line:MCAS	10784-110H1	248.79	30.18	33.17	3.46	5.07	5.53	0.23	0.69	0.23	0.00
mycosis fungoides, T cell lymphoma cell line:HuT 102 TIB-162	10744-110C6	22.84	6.28	4.57	2.47	1.14	0.76	0.95	0.00	0.00	0.00
myelodysplastic syndrome cell line:SKM-1	10772-110F7	51.19	16.82	4.44	1.66	3.14	1.29	1.29	1.11	0.00	0.00
myeloma cell line:PCM6	10474-106I6	80.25	32.22	8.30	4.15	3.16	2.57	0.59	0.20	0.00	0.00
myxofibrosarcoma cell line:MFH-ino	10600-108E6	82.18	15.22	10.65	2.54	0.51	4.06	0.51	0.00	0.00	0.00
myxofibrosarcoma cell line:NMFH-1	10684-109E9	235.37	25.11	35.89	2.94	4.71	1.96	1.77	0.78	0.20	0.00
nasal epithelial cells, donor1, tech_rep1	12226-129F3	171.82	18.61	18.16	4.12	2.67	2.67	0.89	0.33	0.00	0.00
nasal epithelial cells, donor1, tech_rep2	12226-129F3	119.94	14.63	15.30	5.07	2.06	1.10	1.62	0.88	0.07	0.00
nasal epithelial cells, donor2	12227-129F4	192.64	9.38	23.18	3.86	1.66	1.10	1.66	0.00	0.00	0.00
neuroblastoma cell line:CHP-134	10508-107D4	36.58	20.94	3.22	8.51	1.84	0.92	0.23	0.23	0.00	0.00
neuroblastoma cell line:NB-1	10539-107G8	44.15	17.21	3.55	4.68	2.99	2.43	0.56	0.00	0.00	0.00
neuroblastoma cell line:NBsusSR	10607-108F4	68.12	13.50	8.86	4.43	2.95	1.05	1.27	0.63	0.21	0.00
neuroblastoma cell line:NH-12	10555-107I6	35.78	17.70	0.75	5.03	3.91	1.30	0.37	0.00	0.00	0.00
neuroectodermal tumor cell line:FU-RPNT-1	10637-108I7	36.77	25.62	2.85	4.03	1.90	0.71	1.42	0.24	0.24	0.00
neuroectodermal tumor cell line:FU-RPNT-2	10663-109C6	47.83	15.84	3.33	0.95	3.64	0.63	0.63	0.32	0.16	0.00
neuroectodermal tumor cell line:TASK1	10774-110F9	63.20	17.71	6.04	3.02	6.44	2.82	1.21	0.20	0.00	0.00
neuroepithelioma cell line:SK-N-MC	10728-110A8	73.11	20.98	5.09	1.91	6.36	1.91	0.00	0.00	0.00	0.00
neurofibroma cell line:Hs 53.T	10729-110A9	95.82	10.11	13.57	1.60	2.40	3.99	0.80	0.27	0.27	0.00
neutrophil PMN, donor1	12133-128D9	1353.61	89.25	59.50	193.37	0.00	14.87	0.00	0.00	0.00	0.00
neutrophil PMN, donor2	12137-128E4	664.03	26.56	39.84	0.00	0.00	0.00	0.00	0.00	0.00	0.00
neutrophil PMN, donor3	12141-128E8	767.12	28.41	85.24	0.00	0.00	0.00	0.00	0.00	0.00	0.00
non T non B acute lymphoblastic leukemia (ALL) cell line:P30/OHK	10430-106D7	20.29	9.81	1.69	9.81	1.18	1.01	0.17	0.00	0.00	0.00
non-small cell lung cancer cell line:NCI-H1385	10730-110B1	47.23	9.61	4.00	5.60	1.60	1.60	0.00	0.00	0.00	0.00
normal embryonic palatal mesenchymal cell line:HEPM	10813-111B3	82.72	11.22	13.14	1.92	4.49	0.96	1.60	0.64	0.64	0.00
normal intestinal epithelial cell line:FHs 74 Int	10812-111B2	87.24	15.50	11.30	1.58	1.31	2.10	2.89	1.05	0.26	0.00
nucleus accumbens, adult, pool1	10037-101F1	39.65	12.00	2.53	10.12	2.16	1.50	0.84	0.19	0.09	0.00
occipital cortex - adult, donor10196	10172-103C1	28.85	0.00	4.12	8.24	2.06	0.00	0.00	0.00	0.00	0.00
occipital cortex, adult, donor10252	10163-103B1	50.99	15.03	5.90	16.37	3.22	1.07	0.00	0.27	0.00	0.00
occipital cortex, newborn, donor10223	10355-105E4	24.75	8.73	2.91	8.73	0.36	0.36	0.73	0.00	0.36	1.46
occipital lobe, adult, donor1	10076-102A4	33.32	9.45	3.67	7.35	2.10	0.52	0.52	2.36	0.79	0.00
occipital lobe, fetal, donor1	10073-102A1	52.78	22.31	5.58	16.73	7.72	4.29	1.29	2.15	0.00	0.00
occipital pole, adult, pool1	10036-101E9	27.44	9.78	2.60	7.96	3.94	1.66	0.39	0.00	0.08	0.00
olfactory region, adult	10195-103E6	28.85	10.89	3.06	7.45	1.91	1.53	0.57	0.00	0.00	0.00
optic nerve, donor1	10277-104E7	40.02	14.01	6.00	26.01	0.00	2.00	0.00	0.00	0.00	0.00
oral squamous cell carcinoma cell line:Ca9-22	10434-106E2	21.30	4.67	4.33	1.94	0.46	0.23	0.23	0.00	0.00	0.00
oral squamous cell carcinoma cell line:HO-1-u-1	10550-107I1	77.90	19.65	8.52	9.34	2.20	1.79	0.41	0.27	0.00	0.00
oral squamous cell carcinoma cell line:HSC-3	10545-107H5	32.68	8.47	3.89	0.68	1.02	0.17	0.68	0.51	0.00	0.00
oral squamous cell carcinoma cell line:SAS	10544-107H4	60.30	15.71	4.50	0.23	3.70	2.31	0.69	0.00	0.00	0.00
osteoclastoma cell line:Hs 706.T	10704-109H2	146.40	25.87	22.93	2.94	2.94	1.18	0.88	0.00	0.00	0.00
osteosarcoma cell line:143B/TK^(-)neo^(R)	10510-107D6	64.47	16.82	10.28	2.80	5.61	1.87	0.00	0.00	0.00	0.00
osteosarcoma cell line:HS-Os-1	10558-107I9	96.06	12.30	14.42	1.06	3.18	2.12	0.85	0.00	0.00	0.00
ovary, adult, pool1	10020-101D2	73.55	18.08	8.82	1.75	2.62	1.66	1.40	0.17	0.09	0.00
pagetoid sarcoma cell line:Hs 925.T	10732-110B3	56.83	7.15	11.92	1.83	3.12	1.47	0.92	0.00	0.00	0.00
pancreas, adult, donor1	10049-101G4	144.86	21.63	30.10	7.53	2.82	2.82	3.76	0.94	0.00	0.00
pancreatic carcinoma cell line:NOR-P1	10698-109G5	293.23	24.32	55.07	4.19	0.84	2.52	4.47	1.12	0.00	0.00
papillary adenocarcinoma cell line:8505C	10437-106E5	122.48	11.07	17.38	2.56	1.02	0.85	4.60	3.07	0.68	0.00
papillotubular adenocarcinoma cell line:TGBC18TKB	10417-106C3	217.91	28.81	22.85	3.31	1.49	1.99	1.99	0.66	0.66	0.00
paracentral gyrus, adult, pool1	10035-101E8	28.01	9.79	2.38	8.42	3.84	1.65	0.27	0.09	0.00	0.00
parietal cortex, adult, donor10258	10373-105G4	14.68	5.87	2.94	8.07	2.94	0.73	0.00	0.00	0.00	0.73
parietal lobe - adult, donor10196	10171-103B9	28.21	5.64	1.88	4.70	0.00	1.88	0.00	0.00	0.00	0.00
parietal lobe, adult, donor10252	10157-103A4	28.50	11.69	3.14	11.12	1.43	0.57	0.29	0.00	0.00	0.00
parietal lobe, adult, pool1	10034-101E7	36.66	9.16	4.05	8.28	3.00	1.50	0.53	0.09	0.00	0.09
parietal lobe, fetal, donor1	10072-101I9	52.37	19.40	3.88	15.52	3.88	1.94	0.97	0.97	0.00	0.00
parietal lobe, newborn, donor10223	10356-105E5	26.92	4.11	5.23	7.85	0.37	1.12	1.12	0.37	0.00	0.00
parotid gland, adult	10199-103F1	165.88	24.67	30.22	8.02	1.23	6.17	4.32	1.23	1.23	1.23
penis, adult	10200-103F2	58.55	13.43	8.06	6.98	0.54	1.61	1.07	0.54	0.00	0.00
peripheral neuroectodermal tumor cell line:KU-SN	10697-109G4	70.28	34.40	7.25	0.74	3.16	2.05	1.86	1.67	0.00	0.00
pharyngeal carcinoma cell line:Detroit 562	10723-110A3	150.21	21.85	27.39	4.37	3.06	3.06	1.89	0.58	0.29	0.29
pineal gland - adult, donor10196	10179-103C8	54.18	13.55	7.10	23.22	2.58	2.58	0.00	0.00	0.00	0.00
pineal gland, adult, donor10252	10160-103A7	62.18	13.03	3.55	28.43	2.37	2.37	0.00	0.00	0.00	0.00
pineal gland, adult, donor10258	10377-105G8	48.91	12.54	6.27	8.78	0.63	3.76	1.25	0.00	0.00	0.63
pituitary gland - adult, donor10196	10180-103C9	60.71	9.11	9.11	10.12	3.04	2.02	1.01	1.01	0.00	1.01
pituitary gland, adult, donor10252	10162-103A9	124.56	23.45	14.07	17.20	3.13	2.61	1.04	0.52	0.52	0.52
pituitary gland, adult, donor10258	10378-105G9	83.42	14.47	6.81	11.92	0.85	0.85	0.85	0.00	0.00	0.00
placenta, adult, pool1	10021-101D3	175.87	17.09	21.72	2.80	2.15	2.90	1.72	0.32	0.22	0.22
plasma cell leukemia cell line:ARH-77	10840-111E3	23.57	10.20	2.52	4.24	0.53	0.53	0.40	0.26	0.13	0.00
pleomorphic hepatocellular carcinoma cell line:SNU-387	10706-109H4	81.24	14.47	14.01	4.05	2.02	2.02	0.78	0.78	0.31	0.16
pons, adult, pool1	10033-101E6	27.46	6.11	3.01	7.23	1.81	1.12	0.17	0.00	0.00	0.09
postcentral gyrus, adult, pool1	10032-101E5	36.88	10.46	3.57	9.41	3.84	1.05	0.26	0.09	0.00	0.00
promyelocytes/myelocytes PMC, donor1	12132-128D8	125.48	39.74	4.18	33.46	6.27	0.00	0.00	0.00	0.00	0.00
promyelocytes/myelocytes PMC, donor2	12136-128E3	132.19	44.06	5.51	0.00	5.51	0.00	0.00	0.00	0.00	0.00
promyelocytes/myelocytes PMC, donor3	12140-128E7	58.68	11.74	11.74	0.00	0.00	0.00	0.00	0.00	0.00	0.00
prostate cancer cell line:DU145	10490-107B4	138.82	14.86	14.27	2.33	1.31	2.04	1.02	0.87	0.44	0.15
prostate cancer cell line:PC-3	10439-106E7	92.20	12.34	16.70	2.00	1.82	1.82	0.36	0.18	0.00	0.00
prostate, adult, pool1	10022-101D4	101.21	19.68	10.25	4.44	2.27	2.63	1.09	0.09	0.00	0.00
putamen, adult, donor10196	10176-103C5	47.45	12.75	4.01	12.75	2.83	3.30	0.47	0.47	0.24	0.00
putamen, adult, donor10252	10152-102I8	62.74	21.57	3.92	19.61	0.00	1.96	0.00	1.96	0.00	0.00
putamen, adult, donor10258, tech_rep1	10372-105G3	32.78	4.37	3.28	3.28	3.28	0.00	0.00	1.09	0.00	0.00
putamen, adult, donor10258, tech_rep2	10372-105G3	67.89	21.02	8.94	9.18	6.04	4.83	0.48	0.97	0.00	0.24
putamen, newborn, donor10223	10365-105F5	20.99	5.25	0.75	6.00	0.75	0.00	3.00	0.75	0.75	0.00
rectal cancer cell line:TT1TKB	10469-106I1	98.05	18.33	11.64	2.33	0.00	0.58	0.29	0.00	0.29	0.29
rectum, fetal, donor1	10067-101I4	57.03	22.26	18.08	11.13	1.39	1.39	0.00	1.39	0.00	0.00
renal cell carcinoma cell line:OS-RC-2	10411-106B6	85.01	16.96	6.36	2.33	0.85	2.97	1.70	0.21	0.00	0.21
renal cell carcinoma cell line:TUHR10TKB	10471-106I3	133.38	18.64	16.57	8.28	2.49	0.83	1.66	0.00	0.83	0.00
retina, adult, pool1	10030-101E3	151.29	20.18	17.89	8.15	2.09	3.18	1.29	0.40	0.10	1.79
retinoblastoma cell line:Y79	10475-106I7	47.02	17.41	4.68	5.98	2.08	2.34	0.00	0.52	0.00	0.00
rhabdomyosarcoma cell line:KYM-1	10787-110H4	19.30	7.62	1.48	0.61	2.21	1.60	0.12	0.00	0.00	0.00
rhabdomyosarcoma cell line:RMS-YM	10477-106I9	124.01	27.84	14.62	2.53	2.53	2.81	0.84	0.28	0.28	0.00
sacrococcigeal teratoma cell line:HTST	10695-109G2	73.51	14.40	10.61	2.27	2.27	1.52	0.00	0.00	0.00	0.00
salivary acinar cells, donor1	11771-123I7	148.58	15.21	23.63	2.43	1.78	0.81	3.24	1.13	0.32	0.16
salivary acinar cells, donor2	11772-123I8	126.53	24.51	16.94	1.38	1.51	0.69	2.89	1.93	0.14	0.00
salivary acinar cells, donor3	11773-123I9	155.58	21.19	27.14	5.30	0.66	2.65	0.00	0.00	0.00	0.00
salivary gland, adult, pool1	10093-102C3	95.52	21.73	5.72	8.58	2.29	1.14	0.57	0.57	0.00	0.00
schwannoma cell line:HS-PSS, tech_rep1	10442-106F1	133.30	30.10	19.39	1.60	4.55	2.95	2.36	0.42	0.34	0.17
schwannoma cell line:HS-PSS, tech_rep2	10442-106F1	203.72	36.21	25.98	1.88	5.29	4.00	2.35	0.59	0.59	0.35
seminal vesicle, adult	10201-103F3	40.74	22.22	3.70	5.82	0.53	0.53	0.00	0.53	0.53	0.00
serous adenocarcinoma cell line:JHOS-2	10639-108I9	27.21	5.59	3.89	0.24	0.00	0.73	1.46	1.46	0.49	0.00
serous adenocarcinoma cell line:SK-OV-3-R after co-culture with SOC-57-02-G, biol_rep1	11843-124H7	79.01	14.34	14.34	1.26	1.26	1.76	0.50	0.50	0.50	0.00
serous adenocarcinoma cell line:SK-OV-3-R, biol_rep1	11841-124H5	55.19	14.05	6.02	0.00	2.01	0.00	0.00	0.00	0.00	0.00
serous cystadenocarcinoma cell line:HTOA	10693-109F9	137.68	16.66	24.71	2.69	0.81	2.28	1.21	0.40	0.00	0.00
signet ring carcinoma cell line:Kato III	10436-106E4	103.56	21.11	9.39	1.22	2.76	0.99	0.44	0.11	0.22	0.00
signet ring carcinoma cell line:NUGC-4	10483-107A6	113.67	18.19	15.61	1.55	1.81	2.32	1.42	0.39	0.13	0.13
skeletal muscle - soleus muscle, donor1	10282-104F3	56.04	5.67	6.38	12.06	0.71	0.00	0.00	0.00	0.00	0.71
skeletal muscle, adult, pool1	10023-101D5	266.74	28.55	30.70	1.44	2.16	2.88	3.84	0.60	1.08	0.84
skeletal muscle, fetal, donor1	10066-101I3	77.39	22.11	12.06	1.01	3.02	1.01	0.00	0.00	1.01	0.00
skin, adult, donor1	10074-102A2	61.07	13.57	20.36	0.00	6.79	0.00	0.00	0.00	0.00	0.00
skin, fetal, donor1	10065-101I2	61.23	6.94	5.68	4.42	3.79	0.63	1.89	0.00	0.00	0.00
small cell cervical cancer cell line:HCSC-1	10800-110I8	61.37	15.68	8.67	2.00	2.33	2.33	0.67	0.00	0.00	0.33
small cell gastrointestinal carcinoma cell line:ECC10	10610-108F7	57.68	12.29	4.41	3.15	1.89	1.26	1.58	0.32	0.00	0.00
small cell lung carcinoma cell line:DMS 144	10841-111E4	62.45	32.96	5.98	2.70	13.69	7.90	2.89	2.89	0.39	0.00
small cell lung carcinoma cell line:LK-2	10541-107H1	45.99	22.25	5.27	2.64	2.47	1.32	0.33	0.00	0.00	0.00
small cell lung carcinoma cell line:NCI-H82	10842-111E5	32.97	15.76	2.25	4.02	0.97	1.13	0.16	0.64	0.00	0.00
small cell lung carcinoma cell line:WA-hT	10562-108A4	154.94	31.16	20.92	3.05	5.23	1.53	1.53	0.00	0.00	0.00
small intestine, adult, pool1	10024-101D6	205.92	28.91	25.56	9.08	1.91	1.79	2.75	0.24	0.24	2.03
small intestine, fetal, donor1	10064-101I1	157.98	23.10	39.31	2.46	2.95	2.21	3.19	1.97	0.00	0.74
small-cell gastrointestinal carcinoma cell line:ECC4	10609-108F6	73.86	25.13	4.62	13.34	2.05	2.05	4.62	5.13	2.05	0.00
smooth muscle, adult, pool1	10048-101G3	70.82	15.77	8.27	3.62	1.81	2.07	0.52	0.00	0.26	0.26
somatostatinoma cell line:QGP-1	10781-110G7	82.01	40.47	8.04	10.72	7.50	3.75	0.00	0.27	0.00	0.00
spinal cord - adult, donor10196	10181-103D1	52.30	18.12	11.01	8.95	1.61	0.92	0.00	0.46	0.00	0.00
spinal cord, adult, donor10252	10159-103A6	52.83	9.86	8.28	16.17	0.39	0.39	0.39	0.39	0.00	0.39
spinal cord, adult, donor10258	10369-105F9	12.45	2.77	1.38	6.92	2.77	0.00	0.00	0.00	0.00	0.00
spinal cord, fetal, donor1	10056-101H2	41.47	9.76	6.10	6.71	4.27	1.22	1.22	0.61	0.61	0.00
spinal cord, newborn, donor10223	10359-105E8	36.28	4.13	5.05	3.67	0.92	0.46	3.67	1.84	1.84	0.46
spindle cell sarcoma cell line:Hs 132.T	10737-110B8	209.39	15.38	41.67	2.24	3.88	2.84	0.60	0.45	0.30	0.15
spleen, adult, pool1	10025-101D7	157.82	16.63	23.57	3.63	1.10	1.98	1.87	0.22	0.11	0.00
spleen, fetal, pool1	10044-101F8	100.59	14.06	12.79	5.40	1.91	2.30	0.95	0.08	0.08	0.00
splenic lymphoma with villous lymphocytes cell line:SLVL	10424-106D1	27.22	14.08	2.59	0.41	0.72	1.76	0.31	0.31	0.00	0.00
squamous cell carcinoma cell line:EC-GI-10	10463-106H4	89.81	20.51	10.44	6.27	1.71	3.42	0.38	0.19	0.00	0.00
squamous cell carcinoma cell line:JHUS-nk1	10646-109A7	66.40	23.41	8.39	1.40	2.80	3.84	1.75	2.45	0.00	0.00
squamous cell carcinoma cell line:T3M-5	10616-108G4	33.62	8.21	3.52	2.35	1.56	0.78	0.00	0.00	0.00	0.00
squamous cell lung carcinoma cell line:EBC-1	10486-107A9	184.03	43.00	21.27	4.39	10.24	4.05	1.01	1.58	0.34	0.23
squamous cell lung carcinoma cell line:LC-1F	10457-106G7	41.51	13.13	3.39	5.51	1.27	0.42	1.69	2.12	0.42	0.00
squamous cell lung carcinoma cell line:RERF-LC-AI	10501-107C6	178.11	22.00	31.31	2.96	2.12	1.27	2.54	1.69	0.00	0.00
stomach, fetal, donor1	10062-101H8	130.29	24.56	13.88	11.75	3.20	3.20	2.14	0.00	0.00	1.07
submaxillary gland, adult	10202-103F4	58.68	10.82	7.41	10.25	1.14	2.85	0.57	2.28	0.57	0.57
substantia nigra - adult, donor10196	10178-103C7	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
substantia nigra, adult, donor10252	10158-103A5	49.64	13.29	6.23	23.06	1.45	0.62	0.62	0.00	0.21	0.42
substantia nigra, adult, donor10258	10371-105G2	16.55	2.59	1.03	5.17	4.66	1.03	0.52	0.52	0.00	0.00
substantia nigra, newborn, donor10223	10358-105E7	31.80	15.54	7.07	6.36	0.71	0.00	0.71	2.12	0.00	0.00
synovial sarcoma cell line:HS-SY-II	10441-106E9	75.89	24.76	9.17	2.29	5.73	4.36	1.60	0.46	0.00	0.00
temporal lobe, adult, pool1	10031-101E4	41.45	13.82	4.49	8.56	4.66	2.29	0.51	0.08	0.08	0.08
temporal lobe, fetal, donor1, tech_rep1	10063-101H9	73.36	24.22	12.11	7.83	3.56	4.27	1.42	2.14	0.71	0.00
temporal lobe, fetal, donor1, tech_rep2	10063-101H9	34.28	15.38	5.27	12.31	0.44	1.32	0.44	0.00	0.44	0.00
tenocyte, donor1	11763-123H8	144.53	16.06	15.36	1.75	4.19	1.40	2.44	2.09	0.35	0.00
tenocyte, donor2	11765-123I1	176.64	24.42	22.89	4.58	4.58	2.29	4.96	1.53	0.38	0.76
tenocyte, donor3	11768-123I4	131.59	13.34	19.65	1.85	4.45	3.71	2.97	1.11	0.00	0.00
teratocarcinoma cell line:NCC-IT-A3	10790-110H7	48.95	18.53	6.46	4.08	4.93	2.04	0.51	0.51	0.17	0.00
teratocarcinoma cell line:NCR-G1	10798-110I6	70.45	14.03	8.32	0.92	4.78	1.39	1.39	0.31	0.00	0.00
teratocarcinoma cell line:PA-1	10807-111A6	89.11	21.70	12.71	1.08	9.92	1.70	0.77	0.46	0.00	0.15
testicular germ cell embryonal carcinoma cell line:ITO-II	10786-110H3	87.09	15.11	12.06	1.52	6.22	1.78	1.65	0.38	0.25	0.00
testicular germ cell embryonal carcinoma cell line:NEC14	10591-108D6	96.81	23.07	15.13	6.43	6.43	0.76	1.89	0.38	0.38	0.00
testicular germ cell embryonal carcinoma cell line:NEC15	10593-108D8	73.40	17.56	6.87	3.71	3.38	0.65	1.20	0.55	0.11	0.00
testicular germ cell embryonal carcinoma cell line:NEC8	10590-108D5	38.76	17.91	3.26	1.63	2.93	0.65	1.63	0.65	0.00	0.00
testis, adult, pool1	10026-101D8	130.78	28.78	16.64	3.44	9.66	3.33	3.01	0.43	1.18	0.00
testis, adult, pool2	10096-102C6	45.11	18.04	8.57	8.57	9.92	4.51	3.16	2.26	0.00	0.00
thalamus - adult, donor10196	10168-103B6	34.22	4.42	4.42	12.14	6.62	1.10	1.10	0.00	0.00	1.10
thalamus, adult, donor10252	10154-103A1	46.10	14.22	5.94	16.57	0.94	1.41	0.47	0.16	0.00	0.00
thalamus, adult, donor10258, tech_rep1	10370-105G1	30.79	6.16	3.08	9.24	1.54	0.00	3.08	0.00	0.00	0.00
thalamus, adult, donor10258, tech_rep2	10370-105G1	68.84	9.88	13.34	5.27	1.98	1.98	1.65	0.82	0.16	0.49
thalamus, newborn, donor10223	10366-105F6	30.49	4.60	3.45	1.73	0.58	1.73	2.88	2.30	0.00	0.00
throat, adult	10209-103G2	61.17	11.73	9.49	3.99	0.00	0.50	1.00	1.50	0.00	0.25
throat, fetal, donor1	10061-101H7	57.89	14.02	10.66	4.88	4.57	1.83	1.22	2.13	0.30	0.00
thymic carcinoma cell line:Ty-82	10803-111A2	30.21	17.29	2.19	2.98	1.99	0.40	1.19	0.60	0.00	0.00
thymus, adult, pool1	10027-101D9	32.21	10.24	3.98	6.26	2.78	0.80	0.40	0.50	0.20	0.00
thymus, fetal, pool1	10043-101F7	47.38	11.12	5.92	14.65	1.14	1.14	0.73	0.21	0.10	0.00
thyroid carcinoma cell line:KHM-5M	10776-110G2	113.55	14.49	15.02	0.93	0.66	0.53	1.73	2.39	0.27	0.00
thyroid carcinoma cell line:TCO-1	10783-110G9	65.38	9.36	10.90	1.54	3.77	1.54	0.70	0.00	0.00	0.00
thyroid, adult, pool1	10028-101E1	116.92	23.05	14.28	5.32	3.64	3.17	1.68	0.00	0.37	0.00
thyroid, fetal, donor1	10060-101H6	66.18	17.40	10.28	7.12	4.22	2.37	0.53	0.00	0.26	0.26
tongue epidermis (fungiform papillae), donor1	10288-104F9	21.56	3.08	0.00	15.40	0.00	0.00	0.00	0.00	0.00	0.00
tongue, adult	10203-103F5	53.49	13.49	5.58	3.26	1.16	0.70	1.16	0.47	0.00	0.23
tongue, fetal, donor1	10059-101H5	93.79	24.04	16.55	1.58	2.76	1.97	1.97	0.39	0.00	0.00
tonsil, adult, pool1	10047-101G2	45.28	10.82	5.91	9.22	1.40	1.00	0.50	0.10	0.00	0.00
trachea, adult, pool1	10029-101E2	86.38	15.38	11.94	3.52	1.96	1.72	1.06	0.25	0.25	0.00
trachea, fetal, donor1	10058-101H4	62.32	13.85	9.62	3.85	1.15	1.92	1.92	0.77	0.00	0.00
transitional cell carcinoma cell line:Hs 769.T	10707-109H5	143.48	9.57	27.63	2.13	2.48	1.06	2.13	0.71	0.35	0.35
transitional-cell carcinoma cell line:5637	10418-106C4	85.92	18.24	9.32	1.62	2.84	1.72	0.81	0.41	0.10	0.00
transitional-cell carcinoma cell line:JMSU1	10492-107B6	84.14	17.86	8.77	1.72	2.98	2.35	0.78	0.47	0.00	0.00
tridermal teratoma cell line:HGRT	10694-109G1	62.78	5.71	7.61	0.00	0.00	1.90	0.00	0.00	0.00	1.90
tubular adenocarcinoma cell line:SUIT-2	10797-110I5	121.39	17.44	18.71	0.51	2.71	1.35	0.93	0.25	0.00	0.17
umbilical cord, fetal, donor1	10057-101H3	66.77	20.87	12.52	2.09	4.17	0.00	4.17	0.00	0.00	0.00
uterus, adult, pool1	10100-102D1	50.51	16.04	3.92	5.97	2.05	2.05	0.17	0.00	0.00	0.17
uterus, fetal, donor1	10055-101H1	54.26	15.36	7.17	3.07	3.58	3.07	1.02	1.02	1.02	0.51
vagina, adult	10204-103F6	94.35	18.74	19.39	3.88	1.29	0.00	1.29	0.65	0.00	0.00
vein, adult	10191-103E2	59.18	12.93	10.96	4.16	0.44	0.66	1.32	0.66	0.22	0.22
xeroderma pigentosum b cell line:XPL 17	10563-108A5	28.57	10.68	1.34	1.34	1.34	1.34	0.00	0.00	0.00	0.00